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ABSTRACT 
The clinical success of restoring bone and tooth function through implants critically depends on the 
maintenance of an infection-free, integrated interface between the host tissue and the biomaterial 
surface. The surgical site infections, which are the infections within one year of surgery, occur in 
approximately 160,000-300,000 cases in the US annually. Antibiotics are the conventional treatment for 
the prevention of infections. They are becoming ineffective due to bacterial antibiotic-resistance from 
their wide-spread use.  There is an urgent need both to combat bacterial drug resistance through new 
antimicrobial agents and to limit the spread of drug resistance by limiting their delivery to the implant 
site. This work aims to reduce surgical site infections from implants by designing of chimeric antimicrobial 
peptides to integrate a novel and effective delivery method. 
 In recent years, antimicrobial peptides (AMPs) have attracted interest as natural sources for new 
antimicrobial agents. By being part of the immune system in all life forms, they are examples of 
antibacterial agents with successfully maintained efficacy across evolutionary time. Both natural and 
synthetic AMPs show significant promise for solving the antibiotic resistance problems. In this work, AMP1 
and AMP2 was shown to be active against three different strains of pathogens in Chapter 4. In the 
literature, these peptides have been shown to be effective against multi-drug resistant bacteria. However, 
their effective delivery to the implantation site limits their clinical use. In recent years, different groups 
adapted covalent chemistry-based or non-specific physical adsorption methods for antimicrobial peptide 
coatings on implant surfaces. Many of these procedures use harsh chemical conditions requiring multiple 
reaction steps. Furthermore, none of these methods allow the orientation control of these molecules on 
the surfaces, which is an essential consideration for biomolecules. In the last few decades, solid binding 
peptides attracted high interest due to their material specificity and self-assembly properties. These 
peptides offer robust surface adsorption and assembly in diverse applications. In this work, a design 
method for chimeric antimicrobial peptides that can self-assemble and self-orient onto biomaterial 
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surfaces was demonstrated. Three specific aims used to address this two-fold strategy of self-assembly 
and self-orientation are: 1) Develop classification and design methods using rough set theory and genetic 
algorithm search to customize antibacterial peptides; 2) Develop chimeric peptides by designing spacer 
sequences to improve the activity of antimicrobial peptides on titanium surfaces; 3) Verify the approach 
as an enabling technology by expanding the chimeric design approach to other biomaterials.  
In Aim 1, a peptide classification tool was developed because the selection of an antimicrobial peptide for 
an application was difficult among the thousands of peptide sequences available. A rule-based rough-set 
theory classification algorithm was developed to group antimicrobial peptides by chemical properties. 
This work is the first time that rough set theory has been applied to peptide activity analysis. The 
classification method on benchmark data sets resulted in low false discovery rates. The novel rough set 
theory method was combined with a novel genetic algorithm search, resulting in a method for customizing 
active antibacterial peptides using sequence-based relationships.  
Inspired by the fact that spacer sequences play critical roles between functional protein domains, in Aim 
2, chimeric peptides were designed to combine solid binding functionality with antimicrobial functionality. 
To improve how these functions worked together in the same peptide sequence, new spacer sequences 
were engineered. The rough set theory method from Aim 1 was used to find structure-based relationships 
to discover new spacer sequences which improved the antimicrobial activity of the chimeric peptides.  
In Aim 3, the proposed approach is demonstrated as an enabling technology. In this work, calcium 
phosphate was tested and verified the modularity of the chimeric antimicrobial self-assembling peptide 
approach. Other chimeric peptides were designed for common biomaterials zirconia and urethane 
polymer. Finally, an antimicrobial peptide was engineered for a dental adhesive system toward applying 
spacer design concepts to optimize the antimicrobial activity.  
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This work develops new antibacterial peptides to bring infection-free interfaces to implanted surfaces. 
Bacterial infection of surgical sites has high costs for patient health and for healthcare. About 160,000-
300,000 surgical site infections occur annually in the United States.1 This represents 2%-5% of surgical 
procedures. The need for surgical procedures is increasing. For example, nearly 3 million annual total 
knee replacements are projected in the US by 2030.2 Therefore, the expected surgical site infections for 
knee replacement surgeries alone will be between 60,000 - 150,000 if the average surgical site surgery 
rate is not improved. This number can be reduced if a new approach addresses this problem threatening 
the formation and maintenance of the integration of the implanted material and the host tissue. 
The recommended strategies for preventing surgical site infections are to administer antibiotic drugs 
pro-actively, to use topical antiseptics to kill bacteria on the skin and to oversee the adherence to 
approved protocols for post-operative care.1 The role of bactericidal antibiotics can be put into a wider 
context than the killing of bacteria. Certain types of antibiotics have been observed for more than 15 
years to have direct effects on immune cells.3 As these antibiotics require larger doses to kill bacteria 
due to drug resistance, their effects on the immune system and surrounding tissues become of greater 
importance. Therefore, synergistic solutions to treating bacterial infections while maintaining host-cell 
viability are important.4 New antibacterial agents are needed to replace current antibiotics to improve 
surgical outcomes.5-9 
Antimicrobial peptides are promising antibacterial agents due to their maintained innate immune 
response against their bacterial targets.10-13 The specificity of the antimicrobial peptides is an advantage 
for the host to maintain the viability of the host cells. While antimicrobial peptides are promising 
treatments against bacteria for their potency and specificity among bacterial strains, the lack of delivery 
systems which can target specific biomaterial locations limit their use.5 Their delivery may result in 
immediate attack by the proteases even before they reach the implantation site. Localized delivery can 
solve the problem of sub-inhibitory concentrations or immediate protease attack when delivered by 
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systemic methods. Therefore, different groups have used covalent chemistries14-16 or physical 
adsorption17-19 to deliver antimicrobial peptides at the implant surface.20, 21  
The delivery of antimicrobial peptides to the implant surface through covalent chemistry approaches for 
surface chemical modification require harsh conditions and the availability of specific chemical groups 
on the implant surface. These approaches, therefore, are limited by the implant surface chemistry to 
which types of surfaces can be functionalized. Among these approaches, the use of self-assembled 
monolayers (SAM) has been the most commonly studied approach by different groups to deliver a 
single-layer of antimicrobial peptides to a material surface.22-24  The approach covalently bonds alkyl 
chains with two chemical entities to a material. The first 
chemical entity is a functional group, called the anchor 
group, that binds directly with the material surface. The 
compatibility of the implant surface with this approach is 
restricted by the availability of these complementary 
chemical groups at the surface. The second chemical entity 
is the antimicrobial peptide.  The SAM approach lacks self-
organization and any orientation control of antimicrobial 
peptides which limits their efficacy. There are many 
studies reporting that antimicrobial peptides immobilized through the SAM approach resulted in loss of 
function.25, 26 To solve this important issue, the chemical linkers between the surface and the biological 
function may need to move beyond being limited to the hydrophobic interactions of alkyl chains.  
As an alternative approach for the delivery of antimicrobial peptides, physical adsorption approaches 
offer a wide variety of surfaces to be functionalized, removing chemical functional surface group 
restrictions. A common approach is to use high-surface area modifications, such as coating with 
nanometer-scale features such as tubes.27-29 Depending on the non-covalent interactions between the 
 
Figure 1.1 Self-assembled monolayers 
(SAM) attach to a surface to change the 
material’s interfacial properties. 
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implant surface and the antimicrobial peptide, the strength of the binding for the adsorption can be 
weak. If the antimicrobial peptide changes of conformation of the residues responsible for its activity, 
the peptide denatures as it adsorbs to the implant surface. Providing orientation control for active 
agents while non-specifically adsorbed is an unmet challenge.30 
In the recent years, solid binding peptides have attracted high interest due to the non-covalent nature of 
the biological self-assembly process.31-35 Solid binding peptides are discovered through a combinatorial 
biology based biopanning process, namely phage and cell surface display. These systems rely on the 
genotype-to-phenotype relations where large molecular libraries are genetically engineered into the 
genomes of display vectors to express short peptides on the coat (phage display) or surface proteins 
(cell surface). When the host interacts with the material of technological interest, the displayed 
molecular library members of short peptides will have an opportunity to develop a stable, non-covalent 
interaction with the material. To differentiate the strength of the interactions among peptides, the 
stringency of the environment is increased throughout serial washing steps. When robust binding hosts 
are recovered, their DNA is extracted to identify the sequence. By translating the DNA sequence to 
amino acids, the sequences of the short peptides that interact with the material surface are identified. 
Before this work, Tamerler’s group has also developed bioinformatics-based analysis through scoring 
matrices to improve the prediction of binding for peptides to material surfaces.36-38 
Using solid binding peptides to provide new functions to surfaces is an active area of research .33, 39, 40 
Solid binding peptides have multiple amino acid residues and structural mechanisms to adsorb 
specifically on materials through molecular recognition .5, 6, 30, 41, 42 In this work, the approach is to use 
chimeric antimicrobial peptides with solid binding peptides to coat a variety of biomaterials, while also 
providing self-organization capability to the antimicrobial peptides adsorbed onto the surface.  
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In this work, the hypothesis is that designing chimeric antimicrobial peptides that can self-assemble on 
implant surfaces will reduce bacterial viability on different implant surfaces. The approach is to develop 
chimeric antimicrobial peptides as single oligopeptide chains of amino acids with two distinct functional 
units that are combined with a spacer sequence between them. One functional unit is the solid binding 
peptide for the implantable materials surface. The other functional unit is an antimicrobial peptide. The 
spacer sequence provides self-organized orientation of the biological signal (Figure 1.2).  
This design method includes 
tailoring the antimicrobial 
peptides specifically towards 
the problematic strains of drug-
resistant bacteria as well as 
their self-assembly onto 
different biomaterial surfaces, 
i.e. titanium and calcium 
phosphate and dental adhesive 
systems as case studies.  
Titanium is the most commonly 
used implantable material. It is 
used in a wide range of 
applications varying from joint 
replacements, to dental implants, and to surgical tools.43 The second material chosen to functionalize 
with antibacterial activity is calcium phosphate. This mineral, in different phases, has been used in the 
field to promote osseous integration to improve patient outcomes.44-47 The significance of this work is 
immediately to enable antibacterial functionality through the delivery of antimicrobial peptides to a 
 
Figure 1.2 Implant Surface at the Nanoscale. 
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second surface type. The self-assembly of molecular recognition to titanium is expected to transfer to 
calcium phosphate surfaces when the solid binding peptide is exchanged. Beyond the examples of 
adding antimicrobial functionality in this work, biological signals that require orientation control can be 
effectively displayed on these surfaces if the antimicrobial peptide is exchanged for a biological signal. 
Prior to this work, Tamerler’s group has established through integration of titanium binding chimeric 
peptides integrin-binding domain for mammalian cell recruitment48 or Wnt-signaling peptide for 
controlling stem cell differentiation onto the implant surface.41 The current work explores the 
classification and design of chimeric antimicrobial peptides with spacer engineering to display biological 
functionality effectively onto the selected biomaterials. The efficacy of modular design principles with 
this approach is dependent on the interaction between the functional domains of the chimeric peptide. 
To address negative interactions between the functional domains seen in Tamerler’s group’s previous 
works,6, 49-51 this work provides a spacer design method to lessen the negative interactions. 
Many antimicrobial peptide sequences have been reported in the literature include naturally occurring 
peptides, peptide mimics and in silico designed peptides. In the LAMP database, there are over 5,500 
entries with sparse data about the activity of the antimicrobial peptides against specific bacterial strains. 
Therefore, there is an unsolved challenge to differentiate active peptides from non-active ones for 
targeted bacteria.   First, this work attacks this problem by developing and implementing a novel 
antimicrobial peptide classification methodology. The classification method utilizes a rough set theory 
approach combined with different machine learning modules. Then this approach is integrated with 
computer aided molecular design (CAMD) for the discovery of functional antimicrobial peptides. Next, 
this work further explores structure-function relationships of peptide folding using a spacer as a tunable 
parameter to enhance the activity of the chimeric molecules. Finally, this work demonstrates the design 
of chimeric and active peptides on a variety of material surfaces. This work follows the summary of 
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these methodologies by the aims, i.e. explained in separate chapters. A dental adhesive system chapter 
follows showing another area of application of these methodologies.  
 Antimicrobial Peptide Classification by Rough Set Theory 
Rough Set Theory 
Rough set theory uses the intersections of sets to describe the relationship between data classification 
labels, called decisions, and columns of features in a data table. Sets are collections of cases, which are 
the rows of the data table. The cases are amino acids in this example and the features are amino acid 
properties. The classification label is the amino acid charge at pH 7.4.  
A rule is a series of value ranges for columns in a data table that assigns a label. The support of a rule is 
the number of cases that the rule can correctly label in the data table. The coverage of the rule is the 
number of cases that the rule will label in the data table. The cases which are part of any rule’s support 
are said to be distinguishable. Those cases that are part of a rule’s coverage and not part of any rule’s 
support are said to be indistinguishable. These cases are vague. Cases must be vague if all columns in a 
data table agree but the data classification labels do not agree. 
Distinguishability in rough set theory is like the concept of correlation in linear regression analysis. 
Highly correlated variables imply predictability of the value of one variable given the other variable of 
the linear relationship. Distinguishability is knowing the value of the classification label with certainty 
among the values in the data table given ranges of values for features. While distinguishability implies 
predictability, it does not imply or require a linear relationship to discover.  
Before discussing the mechanics of rule induction by rough set theory, the relationship between the 
features and classification labels in Table 1.1 is discussed. The isoelectric point of an amino acid, Column 
1, is the pH at which the amino acid is uncharged. The size of an amino acid is given in Column 2. This pH 
can be determined from the response to an electric field. The partition coefficient, in Column 3, is the 
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concentration ratio of the amino acid in octanol compared to water after mixing the system. The charge 
of an amino acid, Column 4, is the force applied by an electric field equal to the force on a single 
electron in the opposite direction that would be applied by the field. The isoelectric point directly relates 
to the charge of an amino acid at pH 7.4. Amino acids with isoelectric points much below 7.4 are 
negatively charged at pH 7.4, amino acids with isoelectric points close to 7.4 are not charged, and amino 
acids with isoelectric points higher than 7.4 are positively charged at pH 7.4.  
There is no theoretical relationship between the size of an amino acid and its charge. There are 
however, empirical patterns between the size and the charge of the amino acid that can be discovered 
through rough set theory if combined with at least one other feature. The partition coefficient and 
charge do have a theoretical relationship in that a high partition coefficient implies low polarity to be 
soluble with octanol. Low polarity implies no charge. The partition coefficient does not create a 
distinguishable rule set for charge on its own. This is because the sign of the charge is not related to the 
partition coefficient, even if the presence of charge has an impact on the value of the partition 
coefficient. The direct relationship between isoelectric point and charge at pH 7.4 will be the first one 
examined by rough set theory to cover the rule induction mechanics. The second relationship will be the 
combination of two indirect relationships of size and partition coefficient to charge at pH 7.4 to explore 
the concept of overfitting. 
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Table 1.1 Amino acid properties to distinguish amino acids based on charge at pH 7.4 of rough set 
theory rules. 
Amino Acid 
Amino Acid 
Isoelectric 
Point52 
Amino Acid 
Size53 
Amino Acid 
Partition 
Coefficients54 
Amino Acid 
Charge at pH 7.4 
Alanine 6.00 2.5 0.28 0 
Arginine 10.76 7.5 0.10 +1 
Asparagine 5.41 5.0 0.25 0 
Aspartic Acid 2.77 2.5 0.21 -1 
Cysteine 5.05 3.0 0.28 0 
Glutamine 5.65 6.0 0.35 0 
Glutamic Acid 3.22 5.0 0.33 -1 
Glycine 5.97 0.5 0.17 0 
Histidine 7.59 6.0 0.21 +1 
Isoleucine 6.02 5.5 0.82 0 
Leucine 5.98 5.5 1.00 0 
Lysine 9.74 7.0 0.09 1 
Methionine 5.74 6.0 0.74 0 
Phenylalanine 5.48 6.5 2.18 0 
Proline 6.30 5.5 0.39 0 
Serine 5.68 3.0 0.12 0 
Threonine 5.66 5.0 0.21 0 
Tryptophan 5.89 7.0 5.70 0 
Tyrosine 5.66 7.0 1.26 0 
Valine 5.96 5.0 0.60 0 
 
The simplest relationship between classification labels and features to find in a data table is a single 
feature column that can distinguish among all classification labels. To classify the charge of the amino 
acids, the isoelectric point can be used to distinguish among all amino acid charges at pH 7.4. Table 1.2 
shows the rules that distinguish which isoelectric points relate to charge at pH 7.4. Rough set theory 
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accomplishes these inducted rules by selecting each classification label individually. Beginning with the 
classification label of -1, only two cases exist: glutamate and aspartate. Listing the amino acids sorted by 
isoelectric points in increasing order would put these two amino acids at the first and second positions. 
Cut points are introduced between each unique value in the sorted list, so there are twenty intervals 
ordered by increasing value sharing the minimum isoelectric point as the left bound and twenty 
intervals ordered by decreasing value sharing the maximum isoelectric point as the right bound. Of the 
forty intervals generated with the cut points, only twenty-two contain an amino acid with a -1 label. The 
other eighteen intervals are discarded. The remaining intervals are evaluated by the relevance, that is 
how many -1 labeled cases that they contain. Two of the intervals have one case, and twenty have two 
cases. The intervals with the maximum relevance of two are kept. Finally, to maximize the conditional 
probability of the inducted rules, the minimum number of cases from among those with maximum 
relevance is selected. Only one interval has two -1 cases and two total cases. This is the interval that 
uses the cut point between the second and third amino acid in the sorted order by isoelectric point. 
Therefore, the boundaries for this inducted rule is the first cut point, which is the minimum value, and 
the third cut point, which is the average of 3.22 and 5.05. The other two rules in Table 1.2 can be 
calculated in the same way. 
Table 1.2 Rough set theory rules separating amino acids by charge at pH 7.4 based on their isoelectric 
point (pH at which they have no charge). 
Rule 
Number 
Condition 
Number Property 
Lower 
Value 
Upper 
Value Support Coverage 
Charge at 
pH 7.4 
1 1 Isoelectric Point 2.77 4.135 2 2 -1 
2 1 Isoelectric Point 4.135 6.945 15 15 0 
3 1 Isoelectric Point 6.945 10.76 3 3 +1 
    Total 20 20  
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The second example of rule induction will include two features, the size of the amino acid and its 
partition coefficient in labeling the charge of the amino acid at pH 7.4. Rough set theory can distinguish 
among all amino acids in the data table because there are unique value pairs for each of the twenty 
amino acids using both features. If only the size feature is used, only eight amino acids can be correctly 
labeled with charge, as seen in Table 1.3.   
 
Table 1.3 Rough set theory rules separating amino acids by charge based on their size. 
Rule 
Number 
Condition 
Number Property 
Lower 
Value 
Upper 
Value Support Coverage Charge 
1 1 Size 5.25 5.75 3 3 0 
2 1 Size 2.75 4.0 2 2 0 
3 1 Size 0.5 1.5 1 1 0 
4 1 Size 6.25 6.75 1 1 0 
5 1 Size 7.25 7.5 1 1 +1 
    Total 8 8  
 
Rules which distinguish amino acids based on partition coefficient and size are: 
Rule 1: Partition Coefficient >= 0.34  Amino Acid Charge = 0 at pH 7.4 
Rule 2: Partition Coefficient <= 0.23 & Size >= 5.5  Amino Acid Charge = +1 at pH 7.4 
These rules allow for a new perspective on empirical relationships for the canonical amino acid between 
size, partition coefficient and amino acid charge. Rule 1 gives information which will likely hold for non-
canonical amino acids. A review of commercially-available non-canonical amino acids for computational 
modeling has been published.55 If the partition coefficient is greater than 0.34, then any amino acid is 
likely to be uncharged at pH 7.4. The partition coefficient is higher for molecules more soluble in octanol 
than in water. Because polar molecules are, in general, more soluble in water than in octanol, charged 
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amino acids will have smaller partition coefficients. Rule 2, because it is based on size, is an empirical 
relationship that may not generalize to non-canonical amino acids. If the partition coefficient is less than 
0.23, then any amino acid will likely be charged at pH 7.4, but there are negatively charged non-
canonical amino acids with sizes larger than 5.5, such as α-aminoadipic acid.55 Rough set theory can find 
empirical relationships within data tables. For the inducted rules to avoid overfitting, the underlying 
relationships between the features and classification labels must be applicable in the domain in which 
the data table is describing.  
Often, there are multiple reductions for a single data table, demonstrated by the multiple variations of 
rough set theory algorithms in the literature.56 The rule set from a data table is called a reduction. 
Finding all reducts for a data table is related to the Satisfiability Problem,56, 57 in that if there is a 
polynomially-bound solution to finding all reducts, then there is a polynomially-bound solution to the 
Satisfiability Problem. Therefore, finding all reducts for a data table is known to be NP-Hard.58, 59 
Using the principles of rough set theory in the literature, such as modified learning from experience 
module 2 (MLEM2),60 open-loop feedback feature selection,61 and interesting rule induction module 
(IRIM),62 the CLN-MLEM2 method was built in this work for discovering which amino acid chemical 
properties relate clearly or which relate vaguely to antimicrobial activity. The rough set theory approach 
used in this work has heuristic methods to reduce overfitting. During rule induction, redundant features 
are removed. Value ranges are selected for maximizing the largest support. This work is the first time 
that rough set theory has been applied to describe peptide activity. In the future, many other different 
sequence-based and structure-based relationships can be explored for a wide variety of peptide 
functions. 
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 Antimicrobial Peptide Classification 
In the literature, the sequence representation used within classification approaches predicts which types 
of sequences are likely to be classified correctly.10 The first literature example, AntiBP,63 is an 
antibacterial peptide prediction approach that uses a sliding window to represent sequences, leading to 
strong sensitivity to reordering amino acids of a given sequence. However, this representation leads to 
weak sensitivity for adding new amino acids at the ends of antibacterial regions that change key 
physicochemical properties of the overall sequence. Therefore, longer sequences are more difficult for 
sliding window representations to classify correctly.  
Sliding window representations enable order sensitivity but are limited by a dependence on the length 
of the peptide.64 CAMP65, 66 addresses length dependence by calculating overall physicochemical 
properties of sequences. While using overall sequence properties lead to strong sensitivity to adding 
new amino acids, this method has weak sensitivity for reordering amino acids in the same sequence. The 
overall sequence property representation is order insensitive but length independent. iAMP-2L67 
partially addresses order sensitivity by calculating autocorrelation of properties. This method is not 
sensitive to reordering among positions which are correlated and uses order-insensitive representations 
for many of its properties. EFC-FCBF12, 68 combines a motif-searching method that provides some order 
sensitivity with a support-vector machine (SVM) method that calculates overall properties for length 
independence. This method does not fully address order sensitivity because the twenty canonical amino 
acids are compressed to four categories in motifs. Therefore, this method is insensitive to reordering 
among the amino acids in the same category.  
In work, a high-selectivity classification method named condition-limit number Modified Learning from 
Experience Module 2 (CLN-MLEM2) was developed. The condition-limit number refers to a user-defined 
parameter limiting the number of features in the rules inducted by the method. Therefore, the 
15 
 
performance of rule sets with less features can be directly compared to rule sets with more features. 
CLN-MLEM2 was developed from a rough set theory approach to discover key physicochemical 
properties for classifying peptides according to antibacterial activity. Order sensitivity is addressed by 
using the physicochemical properties of tripeptides within the full peptide sequences to distinguish 
among groups of similar active and inactive peptides by physicochemical properties. Length dependence 
is addressed by using the properties of full sequences. The method in this work combines order 
sensitivity with length independence through rules that determine classifications with both types of 
representations in a single rule. The observed low false positive rate is aided by inducting rules of 
inactive peptides. 
 Computer Aided Molecular Design of Peptides 
More than three decades of research has been performed on antimicrobial peptides derived from 
natural sources. In the 1980s Merrifield’s group, who developed solid phase peptide synthesis (SPPS) in 
the 1960s,69 investigated antimicrobial peptides from the Cecropia moth.70-72  Cantisani et al used 
alanine scanning of myxinidin to find new antimicrobial peptides by point substitutions showing 
improved activity across different bacteria.73 While the rational design of antimicrobial peptide 
derivatives is a valuable tool for developing new antimicrobial peptides that are closely related by 
sequence to existing antimicrobial peptides, the approach limits the development of empirical rules that 
can more broadly explore peptide sequence space. 
Concurrent with Merrifield’s development of SPPS, QSAR models were pioneered by Hansch and 
Fujita.74 An outstanding review of QSAR and its history has been recently published.75 Traditional QSAR 
methods build molecular structure-function relationships.  For peptides, the molecular structure is 
encoded by the amino acid sequence, which is often called the primary structure. Secondary structure, 
the hydrogen bonding of the backbone, and tertiary structure, the three-dimensional position of atoms, 
are complementary descriptions of the molecular structure of peptides. More recently, machine 
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learning methods have been used to generalize molecular structure relationships to binary or to 
categorical functions.75 The rough set theory method in this work for describing antibacterial activity is 
an example.  
Computer-aided molecular design (CAMD) is an approach to improve molecular design beyond the trial-
and-error method.76-79 CAMD solves two problems simultaneously. The first problem is the forward 
problem, which is to understand which structures of the studied molecule leads to a targeted property. 
The second problem in CAMD is the reverse problem of using property values to search for candidate 
structures. In this work, the solutions for the forward problem are the rough set theory rules from the 
CLN-MLEM2 method.  
The mathematical formulation for this work is of the form: 
min 𝑆 =  
1
𝑃
|𝑃 − 𝑃∗| 
Such that 𝑃 = 𝑓 (𝑥) 
ℎ (𝑥) > 0 
S is the “distance” of the peptide sequences from meeting all the objective targets. This optimization is a 
single-object approach that weighs multiple target property values to rank the overall value of the 
peptides. N is the number of the targeted properties. 𝑃∗  is the target property vector, and  𝑃  is the 
scaling vector weighing for normalizing the scale of each property. 𝑓 (𝑥) is a function of the peptide 
sequence. Two examples of 𝑓 (𝑥) explored in this work are the sum of the amino acid values for a 
property in the AAindex80 and secondary structure frequencies resulting from a customized PyRosetta81 
script. ℎ (𝑥) is the difference between the sum of the rough set theory rules matched by the peptide 
sequence for activity and the sum of the rough set theory rules for inactivity. Since ℎ (𝑥) is required to 
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be strictly positive, peptide sequences that do not match any rules or which match an equal number of 
rules for activity and inactivity are not included in the feasible region.  
The second problem in CAMD is the reverse problem. In this work, the solutions for this problem are 
customized peptides which are antibacterial according to the boundaries of the rough set theory rules. 
The algorithm for the reverse problem must be a derivative-free approach to incorporate discontinuous 
activity descriptions from the rough set theory approach in this work. 
Pattern Search Methods 
Pattern search  methods, which only rely on function evaluations for optimization, can be deterministic 
or stochastic.82  Derivative-free optimization methods have been used informally in experimental design 
and data analysis throughout the history of science.83 In the 1960s and 1970s, many popular approaches 
for derivative-free optimization were developed including the direct search method,84 the simplex 
method,85, and genetic algorithms.86 The direct search method and the simplex method may require too 
many function evaluations by partitioning the search space. The methods that partition the search space 
cover the entire search space at a coarse-grained level. However, due to the “curse of dimensionality”, 
the coarse-grained search space grows exponentially with an increasing number of dimensions. For 
peptide design, each amino acid is another dimension for each vector of amino acid sequences.  
Genetic algorithms do not partition the search space, and they avoid evaluating some of the regions of 
the search space which are suboptimal. Instead, genetic algorithms rely on recombination operators to 
explore novel solutions for improved optimization. This property reduces the increase of the function 
evaluations when using recombination operators compared to partitioning approaches when the search 
space increases exponentially. For example, the increase in length of the peptide or protein being 
designed exponentially increases the size of the search space exponentially. 
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Genetic Algorithm 
A genetic algorithm optimizes multiple generations of solutions toward defined goals through an 
evolutionary process. The genetic algorithm is a stochastic, or also called metaheuristic, optimization 
method. While deterministic optimization methods typically guarantee globally optimal solutions, many 
real-world combinatorial optimization problems do not fit currently available deterministic approaches. 
For this work, stochastic optimization methods are selected because of the description of antibacterial 
activity developed in this work is the form of inducted rules. The rough set theory rules form non-linear 
boundaries that are computationally fast to evaluate as the intersections of sets, but the rules are 
discontinuous discrete functions.  
Among stochastic methods, simulated annealing and Tabu search are appropriate for the optimization 
of discontinuous functions. Simulated annealing uses a temperature parameter to shift from accepting 
non-improving moves in a strategy to escape local minima to only accepting improving moves as the 
annealing occurs once per simulation.87  Genetic algorithms combine small and large moves with 
mutation to optimize for a local minimum and crossover to shift between local minima continually for 
each generation. Tabu search is a stochastic search method that combines neighborhood searches with 
intermediate and long-term moves to find new local minima until solutions meet a stopping condition, 
usually the repetition of previous solutions.88 Genetic algorithms also incorporate multiple levels of 
moves to optimize local minima and to find new minima to optimize. 
In the literature, genetic algorithms have been successfully integrated into the CAMD framework77, 78 
and antimicrobial peptides design.89 Genetic algorithms rely on evolutionary concepts to drive new 
solutions which are improved according to set fitness criteria.90  
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Feasible solutions for antimicrobial peptides in this work are explored through a genetic algorithm. In 
peptide design, genetic algorithms 
are a common approach,91-97 
partially due to the motivation of 
genetic algorithms relating to 
biological sequences. While genetic 
algorithms are inspired by nature’s 
genetic code, not all aspects of how 
the genetic code functions in nature 
has been incorporated into genetic algorithms in peptide design. Integrating the codon table concept 
generates novel sequences to take advantage of the transition probabilities encoded in reading frame 
shifts. Reading frame shifts are changes to the nucleic acid base position which results in different 
codons being read downstream in the nucleic acid code. The DNA code of ATGATG would result in two 
codons for methionine if read from the first letter or in a stop codon, ending the transcription, if read 
from the second letter. 
As part of Aim 1, the codon-based genetic algorithm addressed the reverse problem of CAMD (Figure 
1.3, Step 3 and 4). Earlier in Aim1, CLN-MLEM2 addressed the forward problem of CAMD finding key 
physicochemical properties to distinguish active peptides from inactive peptides. In Aim 2, Step 2 of the 
CAMD process is exchanged from boundaries calculated from primary peptide structure (sequences) to 
boundaries calculated from secondary peptide structure (hydrogen bonds in the peptide backbone). 
Secondary structure features are of interest in chimeric peptide design because the spacer sequence 
impacts the folding of the solid binding peptide and the antimicrobial peptide. To understand the effect 
of the spacer domain on the folding of the chimeric peptide, this work addresses how to identify low 
free-energy structures of peptides.   
 
Figure 1.3 Computer-Aided Molecular Design Flow Chart 
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 Spacer Engineering through Peptide Structure 
Peptide folding is the rearranging of peptides in their environments into active or inactive states. The 
modeling of peptide folding is the optimization of arrangements of peptide atoms in 3D space fitting a 
combination of empirical data or thermodynamic principles. Currently, there is a critical opportunity to 
understand sequence-structure relationships for peptides which are being engineered, and often, have 
unsolved structures.  Peptides are often intrinsically disordered,98-101 having non-crystalized active 
structures. Examples of these peptides are subsequences of the microtubule-associated tau protein102 
and alpha-synuclein.103 Therefore, a single conformation or small collection of conformations may be 
limiting in their ability to describe the structure of peptides and how the structure relates to the 
function of the peptide. A large group of conformations, which would be large enough for stable 
statistical estimates, may be necessary to describe the dynamic, non-crystalized active states of 
intrinsically disordered peptides. This large group of conformations will be referred to as an ensemble.  
A recent review of de novo peptide folding methods groups approaches into two main categories.104 The 
first group uses molecular dynamics to generate peptide structural ensembles.105, 106 While this approach 
is robust and can take into account buffering salts and even surface adsorption,22, 107, 108 it is 
computationally expensive and not ideal for screening peptide designs.  
For screening peptide designs, the second category of available approaches of specialized peptide-
specific approaches currently produces few peptide conformations per model. While the native 
structure may be contained in these structure models, the intrinsically disordered nature of peptides 
may need more diversity to describe occurring structure features.98, 99  PEP-FOLD3 is a tool for 
generating structural conformations for peptides from 5 to 50 amino acids long.109, 110 While the method 
generates 100 structures to cluster for the best clusters, the tool’s user cannot investigate trends for the 
original 100 structures generated. The five best structures, one from each of the best clusters, is the 
user output. For the user, this approach is not ensemble structure analysis.  PEP-FOLD3 uses a coarse-
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grain modeling approach which generates time-elapsed motions like molecular dynamics, but it lacks 
effects due to thermodynamic effects of solvation, electrostatics, or salt bridges. Structural optimization 
with full-atom descriptions such as the Rosetta approach addresses these issues with a computationally 
inexpensive solution that identifies likely structures.  
Spacer domains on the same polypeptide chains as peptide domains influence the folding of the peptide 
domains. Figure 1.2 shows an example of a chimeric peptide with the spacer domain labeled. 
Understanding the effect of the spacer on chimeric peptide folding is a method for rationally designing 
chimeric peptides to integrate two functions simultaneously. In this work, solid binding peptides are 
integrated with antimicrobial peptides. Interdomain interference, or loss of function, is mitigated 
through spacer design. 
 Polypeptide Structure Levels 
The distinction between peptides and proteins, which are both polypeptide chains, is based on length. 
Peptides are polypeptides with less than fifty residues, and proteins are polypeptides have more than 
fifty residues. Domains are subsequences within polypeptide chains that have a functional activity that 
can be demonstrated without the rest of the polypeptide chain. While the topology of polypeptide 
chains is simple in that they are linear chains of amino acids, the interactions between the amino acids 
within the same chain gives rise to a wide variety of structural properties. Some proteins result in soft, 
globular enzymes which catalyze specific chemical reactions through folding dynamics, while other 
proteins form the motors and the structural support of muscle cells to create motion through their 
combination of rigid and dynamic structural properties. As a fundamental concept of molecular biology, 
polypeptide structure has been long studied, but it still holds many unsolved mysteries. One unsolved 
problem is how linker regions in multidomain proteins can add to or subtract from the activity of 
attached domains. 
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To investigate this effect, first, the four levels of polypeptide structure are described. The first level is 
primary structure, which is the amino acid sequence. All three of the other levels relate back to the 
information in the amino acid sequence. The second level is the secondary structure, the hydrogen 
bonding of the polypeptide backbone. These are the general shapes of the polypeptide chains such as α-
helices or β-strands, which leave out descriptions of where the side-chains of residues exist. The tertiary 
structure specifies where both the backbone and side-chain atoms are, either at a given instant in time 
in computational models or as a time-average through experimental measurement. The tertiary 
structure, however, is not the complete description of the polypeptide structure. The quaternary 
structure is how the residues of polypeptide domains interact with the rest of the polypeptide 
sequence. The quaternary structure can also change depending on external interactions. A long-studied 
example of quaternary structure is domain activity changes of hemoglobin based on pH changes and the 
concentration of carbon dioxide.111-114 As polypeptide chains, chimeric peptides also have multiple levels 
of structure which are based on the order and composition of the amino acid sequence. To estimate 
what the secondary and tertiary levels of structure are for candidate amino acid sequences, 
computational structure generation models were developed as customized scripts from PyRosetta, a 
publicly available set of tools.   
 PyRosetta Folding 
The Rosetta project makes building computational protein folding estimates of secondary or tertiary 
structure a modular process.115-117 In fact, Foldit is a game for humans to learn how to fold proteins to 
develop better folding algorithms using the modular protein folding moves built into Rosetta.118, 119 In 
this work, a different branch of the Rosetta project was used. PyRosetta is a Python interface for the 
Rosetta project built on C source code. A custom PyRosetta script was built for this work, given in 
Appendix B.  In developing the custom folding algorithm, changes in conformational space were 
evaluated with the Classic Relax method in PyRosetta. Representative structures are shown in Figure 
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1.4. While the peptide side chains seem to change orientation, almost no backbone movement occurs. 
Therefore, the Classic Relax method appears to be limited to local moves in peptide folding space. 
 
Figure 1.4 Classic relax protocol for three initial starting conformations of a titanium binding peptide 
(AVSPHGVHRSAHGGG). 
 
 Fragment Insertion 
A solution to the limitation of small moves of the backbone conformations in Figure 1.4 is to use the 
fragment insertion methods built into Rosetta. Fragment insertion results in larger backbone 
conformation changes, resulting in a much wider search of the peptide conformational space. Using 
fragment insertion biases the search of the conformational space to conformations of solved protein 
structures. This bias is an advantage when searching for thermodynamically likely peptide folding in a 
short computational time. 
Straight Conformation Random Conformation α-Helix Conformation 
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Figure 1.5 Fragment insertion demonstrates large moves in conformational space compared to the moves 
from the Classic Relax protocol for a titanium binding peptide 
(TMTAPWPPVLDALGVVLSAVFLPVILPVIGKLLNGIL). 
 
Structure-based relationships are integrated into the design of new chimeric peptide sequences as part 
of the  CAMD process in Chapter 4. (Figure 1.3). In Chapter 2, a rough-set theory method not yet explored 
for peptide or protein classification is compared for antimicrobial peptide classification to other methods 
in the field. The sequence-function relationships discovered in Chapter 2 through the developed rough 
set theory method is part of how to design antimicrobial peptides that are effective against any bacterial 
species of interest through iterative cycles of computational analysis and efficacy determination in 
Chapter 3. How these methods fit together is described in Specific Aims. 
 Specific Aims 
The success of implants requires the formation and maintenance of an integrated interface.120-122  
Revision surgeries, the result of some failed implants, are up to 15% of hip replacements and 5% of 
dental implants.123 The prevention of infections, which disrupt integrated interfaces, relies on the 
Fragment insertion structure modified by Classic Relax Protocol 
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application of antibiotics, which brings a major concern due to the rise of bacterial antibiotic-
resistance.124  There is an urgent need for a method to develop new antimicrobial agents as well as an 
improved method for their effective delivery at the implant site.125, 126  
Orientation control of antimicrobial peptides is an essential step for biomolecule activity. This work 
developed a design method for chimeric antimicrobial peptides that can self-assemble and self-orient 
onto implant surfaces in a single step while preserving their antimicrobial activity. Three specific aims to 
address this design challenge are: 1) Develop classification and design methods using rough set theory 
and intelligent search to find novel antibacterial peptides; 2) Develop chimeric peptides by designing 
spacer sequences to effectively display antimicrobial and self-assembling functions onto the Ti and Ti-
Alloys; 3) Verify the approach as an enabling technology by expanding the chimeric AMP design to another 
common biomaterial, i.e. calcium phosphate mineral, and a dental adhesive interface.  
In Aim 1, antibacterial peptides are classified as is shown in Chapter 2. Customized antibacterial peptides 
are designed, in Chapter 3, through computational tools using rough set theory and a genetic algorithm 
to find novel antibacterial peptides. The rough set theory approach60, 127-129 identifies boundaries of key 
chemical properties specific to antibacterial activity through inducted rules.  
Inspired by the fact that spacer sequences play critical roles between functional protein domains, in Aim 
2, chimeric antimicrobial peptides are designed in Chapter 4 with spacer sequences to reduce the 
interference between different peptide domain sequences. The chimeric antimicrobial peptides are first 
demonstrated with titanium implants, the most common biomaterial for implants. The spacer domain 
linking the solid binding peptide and the antimicrobial peptide is engineered through secondary structural 
features of the antimicrobial peptides. 
In Aim 3, the platform developed in Aims 1 and 2 is demonstrated as an enabling technology. Chimeric 
peptides were designed and tested for another common biomaterial, calcium phosphate in Chapter 5.  
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Chimeric peptides of two different kinds were explored for calcium phosphate. Chimeric antimicrobial 
peptides, analogous to titanium, and chimeric mineral forming peptides were designed. The platform is 
also extended in Chapter 5 by the design of chimeric antimicrobial peptides for zirconia surfaces and 
urethane surfaces. A novel application of antimicrobial peptide integration in a dental adhesive system is 
demonstrated in Chapter 6. 
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 Introduction 
Antimicrobial peptides attract considerable interest as novel agents to combat infections. Their long-
time potency across bacteria, viruses and fungi as part of diverse innate immune systems offers a 
solution to overcome the rising concerns from antibiotic resistance. With the rapid increase of 
antimicrobial peptides, peptide selection becomes a challenge. To address this problem, similarity 
analyses of the wide variation of the physicochemical properties of antimicrobial peptides was used to 
describe key properties that distinguish between active and non-active peptide sequences. An iterative 
supervised learning approach was used to identify separate groups of active peptides and inactive 
peptides.  
By generating explicit boundaries, this method defines new categories of active and inactive peptides 
based on their physicochemical properties. Consequently, it describes physicochemical characteristics of 
similarity among active peptides and the physicochemical boundaries between active and inactive 
peptides in a single process. A rough set theory approach is used to build the similarity boundaries; to 
the author’s knowledge, this is the first time that this approach has been used to classify peptides. The 
modified rough set theory method limits the number of values describing a boundary to a user-defined 
limit. This method is optimized for specificity over selectivity. Noting that false positives increase activity 
assays while false negatives only increase computational search time, this method provided a low false 
discovery rate. Published datasets are used to compare this rough set theory method to other published 
classification methods and based on this comparison, high selectivity and comparable sensitivity to 
currently available methods are achieved. 
Rule sets are developed that define physicochemical boundaries which allow us to directly classify the 
active sequences from inactive peptides. Existing classification methods are either order insensitive or 
length-dependent, whereas this method generates the rule sets that combine order-sensitive 
descriptors with length-independent descriptors. The method provides comparable or improved 
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performance to currently available methods.  Discovering the boundaries of physicochemical properties 
may lead to a new understanding of peptide similarity. 
 Background 
In the US, over 23,000 deaths each year are associated with drug-resistant bacterial infections.130 These 
types of infections are central to the projected increase in deaths globally by 2050, which are expect to 
reach 10 million annually.131, 132 The rise of antibiotic-resistant bacteria has prompted increasing interest 
in antimicrobial peptides as a solution to this critical issue.133  
Over 2,800 antimicrobial peptides have been discovered from natural sources in the last decade.65, 134-139 
Antibacterial peptides derived from these natural sequences have shown both broad-spectrum and 
improved activity against targeted bacteria.140-142 Antibacterial peptide-mimics are introduced as 
another source to the existing peptide libraries by incorporating additional backbone chain atoms for 
more structural flexibility and resistance to protease degradation.143-146 Post-translationally modified 
antimicrobial peptides are also being explored by going beyond the chemical properties of the naturally 
occurring amino acids.147, 148   
While many antimicrobial peptides have been discovered at the laboratory bench, computational 
methods have been integrated into this search to find many more candidates. Encrypted antimicrobial 
peptides are an example in which known active peptides are queried against DNA repositories to find 
new antimicrobial peptides.149 Among many methods, grammar-based methods and regular-expression-
based match sequence patterns are used to identify functional similarity.10, 64 Computer-aided molecular 
design78, 150-152 approaches using quantitative sequence activity relationships75, 153-155 (QSAR) predict the 
antibacterial level of peptides given key chemical properties.  Artificial neural networks (ANN) have been 
used both to generate new sequences and to distinguish between active and inactive sequences.10, 89, 156-
158 They are often used in the classification of antimicrobial peptide sequences.136, 159 While ANNs are 
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flexible enough to model many kinds of complex relationships, they lack transparency about how 
classification choices are made. Determining the boundaries of the similar antimicrobial peptide clusters 
remains difficult despite many existing machine learning methods. 
Due to the ongoing need for improved antimicrobial peptide selection and design, many classification 
approaches have been developed with supervised machine learning methods. A recent review by Porto 
et al contrasts two different kinds of sequence representations for antibacterial classification.10 The first 
kind of representation preserves the order of the sequence which tends to lead to length-dependent 
predictions.160 False positives may be produced if the overall chemical property of an antibacterial 
peptide is changed by adding amino acids with contradictory chemical properties. The second kind of 
sequence representation preserves overall sequence properties which tends to lead to order-
insensitivity. False positives may be produced if the order of an active peptide is scrambled.64  
AntiBP161 was one of the first online available services for antibacterial peptide prediction. AntiBP uses a 
sliding window of 15 residues to predict the classification using support vector machines (SVM)162, 
quantitative matrices (QM)163 and artificial neural networks (ANN).164 The strength of this approach is 
that the order of amino acids impacts the prediction. However, the weakness to having a constant 
window of amino acids is that the predictions are peptide-length dependent.160 To overcome the 
peptide length dependence, another sequence representation method was employed as CAMP,65 with 
descriptors that summarized composition, physicochemical properties and structural features of the 
peptides. CAMP uses multiple machine learning approaches for these features such as SVM165, ANN66, 
166, discriminate analysis (DA)167 and random forest (RF).168 However, the descriptor approach is 
insensitive to the sequence order arrangement. For example, full-length sequence descriptors can be 
sensitive to the overall charge of a peptide but not its charge distribution. iAMP-2L67 uses some 
descriptors of correlations between residue positions of peptides, but some of the descriptors are order 
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insensitive.64 This approach is order insensitive to sequence rearrangements that preserve the 
correlation structure from the original peptide.  
The Evolutionary Feature Construction12, 68 (EFC) method, which achieves order-sensitive classification 
combines order sensitivity and length independence by selecting common chemical property sequence 
patterns for antimicrobial peptides. Length-independent classification is achieved with a support-vector 
machine method through physicochemical descriptors selected by FCBF (Fast-Correlation Based Filter 
selection). While this method does combine order-sensitivity and length-independence, it does not 
completely address either of these issues. Order-insensitivity is possible based on the rearrangements of 
amino acids that are indistinguishable by the pattern recognition scheme of compressing twenty amino 
acids into four categories.  
In this work, a novel method addresses order sensitivity by calculating the physicochemical properties of 
subsequences in addition to using descriptors of physicochemical properties for length independence. 
This work, therefore, combines order-sensitivity and length independence as a new approach. These 
descriptors are analyzed using rough set theory (RST). Descriptors that are calculated for both 
physicochemical properties of the full peptide sequences, which are order insensitive, and descriptors of 
constant-length subsequences, which are order sensitive. RST selects combinations of both kinds of 
descriptors into a single rule. Each rule defines its own cluster including the classification of the 
peptide’s activity or inactivity. To the author’s knowledge, RST has not yet been studied to classify 
peptide sequences based on their activity.  
Using a rough set theory approach that combines the algorithm of MLEM2 (modified learning from 
examples module, Version 2) with the algorithm IRIM (Interesting Rule Induction Module), a method is 
developed that investigates the sequence-function relationships.  A high specificity performance by the 
condition-limit number MLEM2 is achieved with the fewest chemical property features among 
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benchmarked methods. This method is tested against publicly available prediction servers CAMP 
(Collection of Antimicrobial Peptides) AMP prediction65, iAMP-2L (antimicrobial peptide prediction two-
level)67, and a motif-searching algorithm EFC (Evolutionary Feature Construction) method12, 68 with and 
without FCBF (Fast-Correlation Based Filter selection). This approach produces physicochemical 
boundaries that create definitions of similarity among antimicrobial peptides and non-antimicrobial 
peptides. 
 Methods 
In this work, a rough set theory classification method is developed to differentiate antibacterial peptides 
from APD2138  (Antimicrobial Peptide Database 2) and randomly selected peptides from the UniProt 
database.169, 170 These benchmark datasets are available online.67, 171 
 Rule Induction by the MLEM2 Algorithm 
The MLEM2 rule induction method60 is a classification method based on a rough set theory approach 
that uses local approximations when the available columns in the data table cannot perfectly separate 
the data. A local approximation is finding the value intervals for data table columns that generate rules 
with a user-set minimum accuracy. This accuracy parameter is called α. MLEM2 was modified to 
combine the polynomial run time growth rate of MLEM2 with the condition-limit number of the IRIM 
(Interesting Rule Induction Method) to find rules with small numbers of conditions in large datasets with 
many attributes. IRIM has an exponential run time growth rate with respect to attribute number. The 
maximum number of conditions was set to eight (8). Conditions are intervals of feature values. Each 
peptide sequence has one value for each feature. Rules are conjunctive expressions of conditions. Rules 
are built from conditions that contain the maximum number of peptide sequence of the desired 
antibacterial label. Ties are broken by the conditions that have the highest percentage of peptide 
sequences with the desired antibacterial label.  Rules are refined by narrowing the interval of an 
included condition or by adding a new condition to the conjunctive expression. Rules are simplified by 
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omitting redundant conditions whose loss still results in a rule with no loss of accuracy. The minimum 
accuracy that a valid rule must have is a user-defined value, α. In this study, α is set to the accuracy of 
the majority class rule, which is to label all peptides with the non-antibacterial class. Figure 2.1 provides 
an overall schematic of the CLN-MLEM2 method. 
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Figure 2.1 CLN-MLEM2 Method. 
CLN-MLEM2 Rule induction process based on rough set theory approach to classify peptides with 
antibacterial activity. 
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 Correlated AAindex1 Property Removal 
The AAindex1 has 544 properties with one value for each of the twenty naturally occurring amino 
acids.80 A database of all properties is available in the R package ‘seqinr’.172 An autocorrelation matrix 
was constructed from these properties to provide pairwise correlation comparisons for all 544 
properties. Properties were filtered using an absolute correlation value cutoff. Properties were 
compared in randomized order. 
 Feature Generation 
Datasets for this classification system are lists of peptide sequences. Each peptide sequence is a list of 
letters representing amino acids in a polypeptide chain. The lengths of peptide sequences vary in the 
dataset. Features for this classification system are single number summaries of the entire peptide 
sequence. Calculations of the summaries are given Table 2.1. 
Table 2.1 Description of summary functions to generate chemical property features as input for the 
MLEM2 method. 
Summary Function Description 
Sum 
∑ 𝑎 , where ai is the amino acid 
chemical property at position i from 1 to 
n, the length of the peptide sequence 
Mean 
∑ , where ai is the amino acid chemical 
property at position i from 1 to n 
Window 3 
max (∑ 𝑎 ), where ai is the amino acid 
chemical property at position i from 1 to 
n-3 
 
The explosion of available antimicrobial peptides brings the new challenge of selecting which 
antimicrobial peptides to use.159, 173-175 With the large increase in the number of available peptides, 
selecting specific peptides to use is aided by finding similarities among peptides. In this work, similarities 
are defined by boundaries between active peptides that also differentiate active peptides from inactive 
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peptides. The rule sets generated have at least one rule for every peptide in the training set, meaning 
that all peptides belong to at least one group.  
The data tables for the peptide training sets include different columns.  Each unique row value is linked 
to a list of peptides which share that value. For example, in case of examining the overall charge of the 
peptide, the column the sum of the overall charge. Each unique charge value, such as +1 would be linked 
to all peptides whose overall charge was +1. Value intervals form sets of peptides that are labeled with 
values in the interval. For overall charge, an interval would be all peptides with charges from +1 to +5. 
This peptide set whose values are included in the value interval is an example of a condition. An 
inducted rule is the set intersection of conditions. (Figure 2.2) Evaluating the performance of the rules 
being generated is done by calculating the Pr, the probability that a peptide covered by the rule has the 
activity assigned by the rule. The Pr is the ratio of the size of the sets of peptides described by the 
intersection of all the conditions in the rule that meet the targeted label to all the peptides described by 
the intersection of the conditions (Equation 2.1). The value of Pr must be at or above α, a user-defined 
cut-off limit for any rule that is part of the output of the method.  
Equation 2.1 
𝑃𝑟 =
⋂ 𝐶
 
⋂ 𝐶
 
 
Figure 2.2 is a Venn diagram separating active and inactive peptides. A rule is the intersection of 
conditions (C1 and C2). Each rule must be selective for either active or inactive peptides. The minimum Pr 
value allowed for a rule is a user-defined parameter α. The selection of conditions that lead to rules is a 
feature selection process that chooses the most relevant conditions to describe the physicochemical 
boundaries. The CLN value is the user-defined condition-limit number which limits the number of 
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conditions in each rule. A rule set is the collection of all rules describing the boundaries for either 
activity or inactivity. 
 
 
 
Figure 2.2 Rough Set Theory Rule Generation.  
 
To create the CLN-MLEM2 method,  features of MLEM2 (modified learning from examples module, 
Version 2) method176, 177 are combined with a feature of the module IRIM (Interesting Rule Induction 
Module) to potentially improve the selectivity and specificity.178 MLEM2 method is modified by adding 
the ability to limit the condition number for each of the rules, a feature of IRIM.  Because the IRIM 
method exhaustively searches all possible rules given the number of conditions, it cannot be used for 
large numbers of conditions or large numbers of peptides because the runtime grows exponentially with 
the number of conditions.  
This modified MLEM2 method uses the heuristics of the MLEM2 method to select condition 
combinations with a run time that grows polynomially in the number of peptides and in the number of 
conditions. This modified method includes a condition-limit number (CLN) which combines the 
polynomially-bound worst-case runtime of MLEM2 with the set number of conditions of IRIM. Because a 
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small number of conditions are selected from the available number of conditions, CLN-MLEM2 is an 
embedded feature selection method.179 It attempts to use the most relevant conditions to describe the 
boundaries. The relevance of a condition is the number of peptides that are described by it in the 
training set. The CLN-MLEM2 method selects rules based on a user-defined minimum accuracy referred 
to as α (0 ≤ α ≤ 1). Using higher values of α generates fewer rules with higher Pr values of training 
accuracy. Using lower values of alpha generates more rules with lower Pr values of training accuracy. 
CLN-MLEM2 generates rules until all peptides in the training set have at least one rule that applies to it. 
The collection of all rules for either active or inactive peptides is called a rule set.  
 Performance Measures 
When measuring the performance of a prediction, there are four possible prediction outcomes for each 
sequence predicted: true positive (TP), false positive (FP), true negative (TN) and false negative (FN). 
True refers to correct classification while false refers to a misclassification. Positive refers to a 
classification of antibacterial and negative refers to a classification of non-antibacterial. Multiple 
performance measures were used to understand how well a classifier can predict positive or negative 
cases. The first is sensitivity, which is the frequency of predicting antibacterial sequences as 
antibacterial.  
Equation 2.2 
𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 =
𝑇𝑃
𝑇𝑃 + 𝐹𝑁
 
The second type is specificity, which is the frequency of predicting non-antibacterial sequences as non-
antibacterial. False discovery rate is its complement, the frequency of predicting non-antibacterial 
sequences as antibacterial. 
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Equation 2.3 
𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 =  
𝑇𝑁
𝑇𝑁 + 𝐹𝑃
= 1 − 𝐹𝑎𝑙𝑠𝑒 𝐷𝑖𝑠𝑐𝑜𝑣𝑒𝑟𝑦 𝑅𝑎𝑡𝑒 
Lastly, a performance measure is used that combines elements of sensitivity and specificity into a single 
measure called the Matthew’s Correlation Coefficient (MCC).  This measure is derived from the Pearson 
correlation coefficient for predictions when classifications are binary.180 Because it is a special case of 
Pearson’s correlation, the maximum value is 1 when the prediction is perfect, 0 when random and -1 
when all predictions are false. 
Equation 2.4 
𝑀𝐶𝐶 =  
𝑇𝑃 ∗ 𝑇𝑁 − 𝐹𝑃 ∗ 𝐹𝑁
(𝑇𝑃 + 𝐹𝑃)(𝑇𝑃 + 𝐹𝑁)(𝑇𝑁 + 𝐹𝑃)(𝑇𝑁 + 𝐹𝑁)
  
 Results 
To begin the condition-limit number MLEM2 (Modified Learning from Experience Module 2) method, 
multiple summaries are generated of the amino acid sequences of the given active and inactive peptides 
by selecting non-correlated amino acid properties in the AAindex180 (Amino Acid index 1). Of the 544 
properties of the AAindex1, many of the properties are highly correlated. The autocorrelation among 
AAindex1 properties with each other is shown in Figure 2.3A. Positive correlation is magenta and 
negative correlation is teal. Non-correlated amino acid property pairs are white. The autocorrelation 
matrix shows that most amino acid properties are highly correlated. How many amino acid properties 
are below a correlation threshold was studied for all other amino acid properties (Figure 2.3B). 60 
repetitions were performed with random initial properties of eliminating properties more correlated 
than a threshold. A very tight trend of how many uncorrelated properties there are for a given cut-off 
value was seen. For further study, a correlation cut-off of 0.65 was selected, which resulted in 74 
properties remaining from the original 544 properties. 
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Figure 2.3 Auto-Correlation and Selection of AAindex1 Properties.  
Combining overall sequence chemical properties with motif properties helped to build sequence 
representation that was sensitive to changes in order or changes in length that effect the peptide 
activity. If only chemical properties are evaluated by the sum or mean of the whole sequence, then the 
rules generated are order insensitive. By considering subsequences of the peptides, then the ordering of 
the chemical properties within the sequence can be used as a feature. Two types of sequence property 
summaries were calculated from the selected amino acid properties in the AAindex1 (Amino Acid index 
1) after removing the correlated amino acid chemical properties. First, the overall property summaries 
were calculated as the mean and average of the properties of the amino acids present in the sequence. 
Secondly, motif properties were calculated as the maximal subsequence sum of a given length of the 
amino acid sequence.  The CLN-MLEM2 method can combine overall sequence properties and motif 
properties within a single rule. Each rule forms a class of either active or inactive peptides. 
Previously studied, publicly available datasets of antimicrobial peptides67, 171 are used to test the 
developed method of finding physicochemical boundaries for antibacterial activity. Table 2.2 shows the 
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inducted rule category with the largest membership of the studied dataset. The rule category is the 
conjunctive expression of each of the conditions up to the user-defined condition-limit number with the 
rule applying to antimicrobial peptides whose property values are within the range of the values given in 
Table 2.2. 
Equation 2.5 
(𝐿𝑜𝑤𝑒𝑟 𝑉𝑎𝑙𝑢𝑒 ≤ 𝑉𝑎𝑙𝑢𝑒 ≤ 𝑈𝑝𝑝𝑒𝑟 𝑉𝑎𝑙𝑢𝑒 ) ⎯⎯⎯⎯ 𝐴𝑛𝑡𝑖𝑏𝑎𝑐𝑡𝑒𝑟𝑖𝑎𝑙 𝐴𝑐𝑡𝑖𝑣𝑖𝑡𝑦 
Table 2.2 has the rough set theory rules found with maximum support from large training dataset. The 
first rule describes antibacterial sequences. The accuracy of this rule is 97.8% (446/456) for the peptides 
that met the conditions from either the dataset from Xiao, et al181 or the dataset from Fernandes, et 
al.171 All sequences that do not match any rule for the applied rule set are classified as non-antibacterial. 
Table 2.2 Maximum Support Rough Set Theory Rules 
Calculation AAindex1 Property Lower Value Upper Value 
Window 3 NAKH900111 31.21 48.66 
Window 3 FINA910104 3.45 5.10 
Window 3 KUMS000101 23.6 28.20 
Sum GEIM800102 12.68 39.90 
Window 3 VASM830102 1.67 2.12 
Window 3 QIAN880139 0.38 0.98 
Sum FAUJ880112 0 3 
Sum CHAM820102 -0.61 19.51 
 
 Rough Set Theory Analysis 
In this work, a data mining approach is taken with rough set theory to understand how to describe 
antibacterial activity in terms of amino acid properties. For defining active and inactive sequences, 
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training sets from the published iAMP-2L dataset were used.67 The positive training set consisted of 
1,274 sequences which originated from APD2138 and the negative training set consisted of 1,440 
sequences which originated from intracellular protein sequences from UniProt. To select from amino 
acid physicochemical properties, the AAindex182 was used from the ‘seqinr’ package in R.172 A correlation 
cut-off of 0.6 was selected, leaving 74 AAindex features from which to select. The overall properties of 
the sequences are described by one of three mathematical operations: sum, mean or window. These 
operations are described in Table 2.1. The CLN-MLEM selected from among 74 AAindex features x 3 
operations = 222 features. CLN-MLEM2 is an embedded feature selection method with the limit of 8 
conditions per rule was set. These AAindex features are listed in Table 2.3. 
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Table 2.3 Description of AAindex features selected by CLN-MLEM2 method.  
Feature Selected AAindex Description 
AURR980118 Normalized positional residue frequency at helix termini C"183 
CHAM820102 Free energy of solution in water, kcal/mole184 
FAUJ880112 Negative charge185 
FINA910104 Helix termination parameter at position j+1186 
GEIM800102 Alpha-helix indices for alpha-proteins187 
GEIM800103 Alpha-helix indices for beta-proteins187  
GEOR030101 Linker propensity from all dataset188 
KUMS000101 Distribution of amino acid residues in the 18 non-redundant families of 
thermophilic proteins189 
NAKH900111 Transmembrane regions of non-mt-proteins190 
QIAN880102 Weights for alpha-helix at the window position of -5191 
QIAN880126 Weights for beta-sheet at the window position of 6191 
QIAN880138 Weights for coil at the window position of 5191 
QIAN880139 Weights for coil at the window position of 6191 
RICJ880115 Relative preference value at C-cap192 
ROBB760107 Information measure for extended without H-bond193 
VASM830101 Relative population of conformational state A194 
VASM830102 Relative population of conformational state C194 
WERD780103 Free energy change of alpha(Ri) to alpha(Rh)195 
YUTK870103 Activation Gibbs energy of unfolding, pH 7.0196 
 
 Training Performance by Rule Coverage 
The accuracy of the rules is the ratio of the support, the number of cases correctly classified by the rules, 
to the coverage, the number of cases to which the rule applies, as shown in Figure 2.4. Below a coverage 
of 30, all rules had 100% training accuracy. For the rules that applied to 100 or more cases, the training 
accuracy was below 100% but above the 95% threshold set for α, the user-set minimum requirement for 
accuracy.  
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Figure 2.4 Training accuracy by rule size. 
 
 Training Performance by Features Selected 
The training accuracy of the rules by the features selected is in Figure 2.5. The accuracy for each of the 
features was divided into rule sets for active peptides (+) or inactive peptides (-). Most of the features in 
Figure 2.5 have 100% accuracy, corresponding to rules with coverage of less than 30 cases. All features 
selected had an average training accuracy greater than 96%.  
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Figure 2.5 The training set accuracy of CLN-MLEM2 rules by features selected. 
The distribution of each of the features among the rules selected is shown in Figure 2.6. The number of 
rules for each of the amino acid properties selected by each calculation made. The rules are an 
embedded feature selection approach. The grid is colored according to the relative times each feature 
was selected. The number of rules each feature occurs in is given in the colored grid for each of the rule 
sets (active or inactive).  
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Figure 2.6 The frequency of selection of features by CLN-MLEM2 rules. 
 Benchmarking CLN-MLEM2 
In this work, the method of using rough set theory to build rules that distinguish between active 
antibacterial peptides from inactive antibacterial peptides is benchmarked against a recently published 
method EFC68, based on motif-recognition, and then against a larger set of methods from publicly 
available prediction servers. The first benchmark test is a ten-fold cross validation on a dataset used in 
previous studies68, 171 with the positive sequences clustered from the APD2 (Antimicrobial Peptide 
Database 2)138 to 115 clusters and the negative sequences from the PDB197 clustered to 116 clusters. 
Each cluster is represented by one sequence. The results are compared with EFC-based methods and 
support vector machines given subsequences of lengths 5 to 8 amino acids. Table 2.4 demonstrates that 
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the developed method has high selectivity and accuracy in comparison to the performance of the SVM 
methods, and comparable selectivity and accuracy in comparison to the EFC method. A trend of 
decreasing Mathew’s Correlation Coefficient (0 for random guessing and 1 for perfect performance) as 
the length of the subsequence increases is seen in Table 2.4.  
Table 2.4 Performance of rough set theory rule induction compared to motif-search in 10-fold cross 
validation. 
Method Sensitivity (%) Specificity (%) MCC 
5-kmer SVM 75.7 75.0 0.54 
6-kmer SVM 74.8 74.1 0.46 
7-kmer SVM 73.0 72.4 0.40 
8-kmer SVM 73.0 72.4 0.36 
EFC-FCBF 87.1 87.2 0.76 
CLN-MLEM2 86.9 86.3 0.75 
 
The CLN-MLEM2 method is further tested against a larger variety of classification methods. The second 
benchmarking test uses the iAMP-2L dataset.67 Like the dataset used for the first benchmark, this 
dataset is derived from the APD2 database. However, instead of choosing a single sequence from each 
cluster, the sequences are narrowed by removing sequences with greater than 40% similarity as 
measured by CD-HIT198 only with cluster of more than 250 sequences. These sequences are reduced to a 
dataset of 848 unique sequences. The negative sequences are from a UniProt search of cytoplasmic 
proteins, also with less than 40% similarity. 2,405 unique sequences are included in the negative 
dataset. 
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Table 2.5 Performance comparison among prediction servers for antimicrobial peptides, a motif-based 
classification method and rough set theory approach. 
Method Sensitivity (%) Specificity (%) MCC 
CAMP SVM 95.8 39.8 0.43 
CAMP RF 97.1 33.5 0.40 
CAMP ANN 89.1 70.9 0.61 
CAMP DA 94.1 49.5 0.49 
iAMP-2L 97.7 92.0 0.90 
EFC-FCBF 92.0 90.0 0.73 
EFC+307-FCBF 
(307 AAindex1 features) 92.4 96.1 0.86 
CLN-MLEM2  
(74 AAindex1 features) 88.0 95.4 0.85 
 
 
 Discussion 
The feature selection process is embedded in the CLN-MLEM2 algorithm. Only 19 of the 74 AAindex 
features (25.7%) are represented in the rules generated. 46 of the possible 222 features (20.7%) are 
represented in the rules generated. While many of the 19 AAindex features in Table 2.3 have previously 
been identified as of interest in relating antimicrobial peptide activity,199, 200 several novel AAindex 
features relating to antibacterial activity have been identified with the CLN-MLEM2 method such as 
QIAN880139 and ROBB760107. 
The training error of the rules, 1 - Pr, increases as the coverage of the rules goes over 100 cases. There is 
a limit in the accuracy of the benchmarking data.  While the positive training set cases have 
experimental evidence demonstrating antibacterial activity, the negative data set does not have direct 
experimental evidence for not having antibacterial activity. So, while the false positive rate is most likely 
very low from the experimental evidence supporting the labels, the false negative rate for the 
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benchmark set is unknown. The rough set theory rules identify candidates for experimental testing 
which are more likely to be false negatives in the negative training set used. 
This work looks at which features have the most impact for finding either antimicrobial peptides or non-
antimicrobial peptides. The sum of GEIM800102, the amino acid frequencies among alpha-helix indices 
for proteins dominated with alpha helix structure, was the most common feature selected for 
generating rules for describing antibacterial peptides appearing in 123 rules.  The window of 
GEIM800102 only appeared in 14 rules. The AAindex feature QIAN880139, weights for coil at the 
window position of 6, had the opposite trend for rules describing active peptides. The window 
calculation was selected for 115 rules, while its sum was only selected for two rules.  
No AAindex feature was used in more than 10 rules across all three calculation types for active peptides. 
ROBB760107, information measure for extended without H-bond, relates to the likelihood of extended 
conformations of the peptides. This AAindex feature was the only one to be selected for more and ten 
rules across all three calculation types for rules describing inactive peptides. This AAindex feature was 
only selected for three rules for active peptides. FINA910104 and YUTK870103 were the only AAindex 
features selected for all three calculation types for active and inactive peptide rules. YUTK870103 relates 
to the additive contributions of amino acids for free energy of folding at pH 7, near physiological 
conditions. FINA910104 relates to amino acid likelihood for being the terminal position of an α-helix. 
The mean of NAKH900111 is the most common feature selected for the inactive peptide rule set, and 
the window of NAKH900111 was often selected to describe active peptides. NAKH90011 relates to the 
frequency of amino acids in membrane proteins that are not found in mitochondria. Therefore, one of 
the key differences between experimentally verified antimicrobial peptides from ADP2 and intracellular 
proteins listed in UniProt is the likelihood that amino acid sequences are stable within cellular 
membranes. For describing active peptides, the mean amino acid frequency is useful, while for 
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describing intracellular proteins, the 3-amino acid window sum is useful. The sum of the charge of the 
amino acid was often important, occurring in 104 rules describing active peptides and in 34 rules 
describing intracellular protein sequences. 
The CLN-MLEM2 method has high specificity and similar accuracy for antibacterial classification as other 
current methods. When using a classification method for the discovery of antimicrobial peptides, the 
specificity of the method is more important than its selectivity.201 The current method prioritizes 
specificity with a low false discovery rate (FDR) by classifying sequences that do not meet any rule in the 
applied rule set as inactive (Figure 2.7). In fact, there is only one method which provides lower FDR 
compared to the CLN-MLEM2 method, EFC+307-FCBF. However, the CLN-MLEM2 method results in 
similar specificity starting with fewer physicochemical properties. The method also acts as an embedded 
feature selection tool by limiting the physicochemical properties in the rules to a user-defined limit.179  
 
Figure 2.7 False discovery rates of antimicrobial peptide classification. 
While the CLN-MLEM2 method has comparable selectivity in classification to current state-of-the-art 
method, the method is among the best in specificity (Table 2.5). The combination evolutionary 
algorithm with chemical properties (EFC+307-FCBF: EFC combined with FCBF (Fast Correlation Based 
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Features) using 307 features) is the only other state-of-the-art method with specificity that is 
comparable to CLN-MLEM2. Similar specificity is achieved using 74 AAindex1 features instead of 307 
AAindex1 features. When removing the length-independent representation from the EFC method (EFC-
FCBF: EFC without FCBF) results in almost no loss of sensitivity, but a loss of 6% in selectivity. Removing 
the order-sensitive representation for EFC in Table 2.2 results in lower sensitivity and selectivity 
performance (MCC = 0.54). While the datasets are different, between Table 2.4 and Table 2.5 results, 
the difference in the individual components of the EFC algorithm compared to the combined algorithm 
shows a dramatic improvement when integrating order-sensitive and length independent sequence 
representations. The CLN-MLEM2 method integrates these two types of representations at its most 
basic level of output, the rule. 
A decrease in selectivity of the classification will cause longer computer search times, while a decrease 
in specificity will increase the number of necessary experimental activity assays. Since the cost of 
experimentally testing peptides is much greater than the computational time of searching for 
antimicrobial peptides, methods that have high specificity are preferred. In addition to the high 
specificity of the CLN-MLEM2 method, the method creates categories of antimicrobial peptides. 
Categorization of peptides aids in the selection and in the design of antimicrobial peptides by providing 
similarity groupings according to physicochemical property boundaries. Peptides that match multiple 
active categories can combine more physicochemical property values associated with activity. 
 Conclusion 
The increase in multidrug resistant bacteria usage has prompted an intense search for agents that can 
be used to treat infectious diseases. There is a growing interest in antimicrobial peptides as novel agents 
to treat infections, and this interest has led to an exponential growth of known antimicrobial peptides. 
However, peptide selection is a challenge with the drastic increase in the number of these peptides 
discovered from natural resources, their modified versions, and computationally designed peptides. 
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Therefore, the CLN-MLEM2 method is developed for generating rule sets to describe the similarity 
among antimicrobial peptides by physicochemical boundaries. This method allows the user to limit the 
number of physicochemical properties used to set the boundaries. Discovering where the boundaries of 
physicochemical properties are among active peptides generates new categories of antimicrobial 
peptides. 
This approach simultaneously groups peptides and classifies them. The rule set performance of CLN-
MLEM2 was benchmarked against other classification methods. Some available classification methods 
are either order insensitive or length-dependent. The rule sets that the developed method generates 
combine order-sensitive descriptors with length-independent descriptors. The CLN-MLEM2 method 
achieves comparable or improved specificity and selectivity to currently available methods with lower 
false discovery rates. The high specificity of this method aids novel antibacterial peptide discovery 
because a low false discovery rate reduces the number of bacterial assays.  
The CLN-MLEM2 algorithm (Figure 2.1) developed in this chapter provides non-linear boundaries of the 
differences between antibacterial and non-antibacterial peptides. In the next chapter, these boundaries 
are used to identify antibacterial peptides customized for ease of peptide synthesis through a novel 
genetic algorithm (Figure 3.3).
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 Peptide Design with Rough Set Theory and a Codon-Based Genetic Algorithm 
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 Introduction 
Over the last two decades, computer-aided molecular design of antimicrobial peptides has mainly 
combined a neural network to learn activity relationships with a genetic algorithm to discover new 
antimicrobial peptides. In this work, a rule-based method was developed, for the first time based on 
rough set theory, for transparent activity relationships. This rough set theory method was combined 
with a codon-based genetic algorithm to design novel antimicrobial peptides which are less than 16 
amino acids, lessen aggregation and have no cysteine residues. The first step, the forward step, to 
discovering novel antimicrobial peptide sequences is to determine the key physicochemical properties a 
peptide needs to be active. The second step, the reverse step, is to search novel peptide sequences to 
customize sequences to meet the design targets and the key physicochemical property values. The 
codon-based genetic algorithm method develop takes advantage of reading frame shifts to increase the 
diversity of novel antimicrobial peptides produced. The codon-based genetic algorithm optimized 
multiple design targets simultaneously. Selected novel antimicrobial peptides were experimentally 
tested for zones of inhibition against S. epidermidis, a key pathogen in implant infections, and verify that 
the method in this work is a successful procedure for developing novel antimicrobial peptides.  
 Background 
As discussed in Section 1.2, antimicrobial peptide research was revolutionized by Merrifield with the 
development of solid phase peptide synthesis (SPPS)69 and some of the first investigations of 
antimicrobial peptides from the Cecropia moth.70-72  That work pioneered rational design concepts for 
antimicrobial peptides, beginning with testing N-terminal and C-terminal analogues202 and enantiomer 
variations.203-206 The modes of action of the peptides were studied with lysosomes as model bacterial 
membranes.205 Shortened antimicrobial peptides were shown to possess activity and adding the 
shortened sequences together into hybrid sequences was also shown to have antimicrobial activity.207-
209 A recent study by Cantisani et al has used rational design concepts with alanine scanning of myxinidin 
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to find new antimicrobial peptides with arginine and tryptophan substitutions for improved activity for 
different kinds of bacteria.73 As discussed before, the rational design of antimicrobial peptides is a 
valuable tool for developing new antimicrobial peptides that are closely related by sequence to existing 
antimicrobial peptides, but the approach limits how broadly peptide sequence space can be explored. 
Concurrent with the development of a generalized approach to synthesize peptides (SPPS), quantitative 
structure-activity relationship (QSAR) models were pioneered by Hansch and Fujita for the toxicity of 
some drugs.74 For an excellent review of QSAR, the reader is referred to a recent review.75 Computer-
aided molecular design (CAMD), as shown in Figure 3.1, relies on a quantitative activity-structure 
relationship (QSAR) model to solve the forward problem of identifying key descriptors that relate 
molecular structure to activity.210-212 CAMD also introduces the reverse problem of using these 
relationships to design novel molecules to meet specific design targets through search.78, 150, 151 Rapid 
peptide development approaches can combine QSAR and search approaches in a CAMD methodology 
with SPPS to iterate between design and testing quickly.78, 150, 151 The development of solutions to the 
forward problem CAMD in the past two decades for antimicrobial peptides has been neural network 
models. In 1998, Patel et al published a single-objective genetic algorithm search with a neural network 
model to describe antibacterial activity.213 In 2009, Cherkasov et al added peptide array methods for an 
increase of the data for the neural network to train.157 Fjell et al provided a follow up on this study in 
2011 with improved cheminformatics descriptors and reported an outstanding 94% true positive rate 
when synthesizing the top-fifty predicted antimicrobial peptides. In 2016, Czyzewski et al extended this 
design approach for antimicrobial peptoid molecules,214 and Wang et al demonstrated this type of 
CAMD model for antimicrobial peptides with unnatural amino acids.215 A limitation of using neural 
networks to determine antibacterial activity is the lack of transparency in terms of how the decisions are 
made. This lack of transparency limits the scientific knowledge gained from these models and prevents 
using additive descriptions of activity to design new peptides. Fernandes et al developed a hybrid neural 
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network-fuzzy inference model.171 The hybrid model includes capabilities of heuristic data 
dimensionality reduction and outlier removal. However, this hybridization does not address the lack of 
transparency of using neural network models. 
 
Figure 3.1 Computer Aided Molecular Design. 
An alternative approach to neural networks for describing antimicrobial peptide activity is a rule-
induction based approach. In 2013, Lira et al used a decision tree model approach for the forward 
problem of CAMD antimicrobial peptides. The decision tree approach addresses the lack of transparency 
of neural networks. However, a decision tree does not allow for a method of finding additive 
descriptions because the branch points of the tree are mutually exclusive. No peptide can be result of 
multiple traversals of the decisions tree. In this work, rough set theory is used for the first time for the 
forward problem in CAMD of antimicrobial peptides. The rough set theory method inducts rules based 
on the relevance of classification labels to feature descriptions. Membership of the peptides relating to 
the rules is not mutually exclusive. A peptide may meet multiple rules for activity or multiple rules for 
inactivity.  
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Feature selection is a critical part of building activity relationships that perform well beyond the training 
datasets. Building activity relationships has three different levels of feature selection integration: filter 
approaches, wrapper approaches and embedded approaches. Filter approaches score the relevance of 
the descriptors to the property or activity of interest without including the performance of the activity 
relationship. Using an analysis of variance between feature values and activity values to rank the 
relevance of features would be an example. However, the interaction between features for a specific 
model is ignored.  Wrapped approaches offer ranking features with a specific activity relationship 
approach to use. Sequential forward selection,216 backward elimination217, 218 and genetic algorithms219, 
220 have been used as accessory algorithms to select features for other algorithms. With embedded 
approaches, the feature selection is completely integrated into the activity-relationship discovery 
algorithm.  Decision trees221, 222 and random forests223, 224 are popular examples. Artificial neural 
networks (ANN) also have embedded feature selection, but they do not provide clear boundaries for 
making decisions like decision trees.   
Rough set theory (RST) has received little interest in CAMD as part of solving the forward problem, even 
though it offers embedded feature selection and clear decision boundaries. A recent study has used RST 
for QSAR feature selection with small-molecule drug models and noted the improved performance to 
wrapper feature selection methods.225 For the first time, RST has been incorporated into a computer-
aided molecular design approach as the solution to the forward problem for designing peptides with 
targeted properties. 
 
For the first time in a CAMD approach, a rough set theory method is combined with a genetic algorithm 
search to tailor antimicrobial peptides for targeted properties. A genetic algorithm is a stochastic 
optimization technique using a fitness function to determine the likelihood of solution components in 
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newly generated solutions. Genetic algorithms are popular for search problems due to their highly 
modular nature and lack of dependence on gradient information.89, 226, 227 A variety of recombination 
operators have been developed in building genetic algorithms. Holland identified selected in this work 
are mutation and crossover. 
For the first time in a genetic algorithm approach to designing peptides, a codon-basis will be used to 
increase the variation of peptide sequences generated for this intelligent search. The codon-based 
genetic algorithm (CB-GA) search completes the reverse problem of CAMD (Figure 3.1). The novel CAMD 
approach developed in this work was demonstrated as functional by designing antimicrobial peptides 
which showed activity against targeted against S. epidermidis and improved the ease of solid-state 
peptide synthesis for shorter sequences.  
 Methods 
 Rule Induction by Rough Set Theory 
Rough set theory127 is a heuristic method for describing the relationships between properties and 
classification labels. Given sequence properties calculated from amino acid chemical properties in the 
AAindex1,80 rough set theory can describe which values of chemical properties separate antibacterial 
peptide sequences from non-antibacterial. The theory describes intervals of known values as conditions. 
Rules are the intersection of the conditions such that the remaining group of sequences is not vague: 
entirely antibacterial or non-antibacterial. Multiple rules are generated until all the sequences are 
described by at least one rule. The CLN-MLEM2 (Condition-Limited Number Modified Learning from 
Experience Module 2) is a method based on the rough set theory approach. Figure 3.2 shows the work 
flow of the rule induction process. CLN-MLEM2 builds categories with rules for antimicrobial peptides 
(Steps 2-3) by antibacterial level through chemical property features built from conditions (Step 1). 
These categories can be updated through incorporation of experimental results for more robust 
categories (Step 4). 
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Figure 3.2 CLN-MLEM2 Algorithm including codon-based genetic algorithm selection and evaluation.  
The rules discovered through rough set theory are used to classify the newly generated sequences for 
each new generation in the genetic algorithm. Once the peptide sequences from the genetic algorithm 
are experimentally characterized, new rule sets are made by adding the experimental results to the 
input peptide sequences. 
 Genetic Algorithm for Finding New Peptide Sequences  
The genetic algorithm in this work begins by ranking known antimicrobial peptide according to a given 
set of design targets as seen in Figure 3.3. The initial step begins with a set of antimicrobial peptides. 
The next step is to rank the peptides according to the design targets. The top 25% of scoring candidates 
60 
 
are selected to mutate and crossover by a DNA codon representation to generate novel peptide 
sequences. While removing the bottom 75% reduces the genetic diversity of future generations, it 
improves the convergence of the solutions to find new sequences with less computation time. The 
diversity lost with the filtering of the top candidates is replaced by recombination operators. 
To minimize the computational time to find new antimicrobial peptide solutions, once the 
recombination operations are finished, the novel sequences are filtered by the antimicrobial peptide 
classifier. Since the best sequences are copied to the next generation, the highest scoring sequence 
across generations is in the final generation. 
 
Figure 3.3 Codon-Based Genetic Algorithm (CB-GA). 
 
The genetic algorithm implementation in this work gains flexibility in the moves it considers by using a 
codon-representation of peptides to direct the selection of sequences related in DNA-space (Figure 3.4). 
The process of peptide sequence conversion to DNA codons is the reverse of the information flow which 
occur in transcription and translation processes in biology.228 The information flow of the processes of 
transcription and translation of mapping nucleic acid sequences to amino acids are applied to the DNA 
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codon representation to recover the peptide sequence following the mutation and crossover events. 
Small moves in the DNA-space might be large moves in the protein sequence space due to reading 
frame shifts, as discussed in Section 1.2. To direct the genetic algorithm toward feasible answers, the 
most successful sequences are copied between generations. Making new candidates instead of 
modifying current candidate sequences builds in a historical property such that the best old sequences 
are propagated to future generations if they are competitive with the newly generated sequences.  
 
Figure 3.4 Schematic of Codon Basis for CB-GA Algorithm 
 Results 
 Novel Antimicrobial Peptide Design 
The reverse problem of CAMD antimicrobial peptide design is solved with the CB-GA method developed 
in this work (Figure 3.3). For the first example, the first generation is selected from known antimicrobial 
peptides in the APD3136 database and sorted by score using the design targets in Table 3.1. These targets 
are selected to improve the ease of synthesis with the FMOC-based SPPS method. The scoring function 
for fitness is the negative weighted average of the distance from the targets. For ease of synthesis, short 
amino acid sequences are targeted. Cysteine residues were avoided in the targets to prevent inter-
peptide bonding through disulfide bonds. Another target was no aggregation hotspots predicted 
through the Aggrescan method.229 The final target was to produce cationic peptide sequences for 
targeting bacterial membranes.64, 156, 230-232 The two classes of bacteria differentiated by Gram’s stain 
both have negative charges displayed on their surfaces.233 Gram negative bacteria, like E. coli, have 
negatively charged lipopolysaccharides (LPS). Gram-positive bacteria like S. epidermidis and S. mutans 
have a peptidoglycan wall with acidic polymers, call teichoic acids radiating outside of the wall. 
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Table 3.1 Design targets for novel antimicrobial peptides for ease of FMOC synthesis. 
Property Target 
Amino Acid Length 7 to 15 
Cysteine Count 0 
Aggrescan Score 0 
Net Positive Charge  +1 to +5  
 
The newly generated sequences are filtered by the high specificity rough set theory classification 
method CLN-MLEM2 so that each completed generation only consists of either known antimicrobial 
peptides from the initial generation or predicted antimicrobial peptides. A violin plot234 of the fitness 
scores, where the center is a boxplot and the shape of the sides is formed from the probability density 
kernel, across selected generations is shown in Figure 3.5.  Advancing generations become more skewed 
in favor of higher fitness scores. 
 
Figure 3.5 Fitness Distributions of Selected Generations. 
 
Translation is the cellular process of nucleic acids becoming polypeptide sequences. To generate novel 
antimicrobial peptide sequences, peptide sequences were reverse-translated to a codon-representation 
to take advantage of reading frames for generating novel sequences. Mutation, as a local search 
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method, was the changing of a single codon through substitution, insertion or deletion. The large search 
changes in sequence space were achieved through crossover by slicing and recombining nucleic acid 
sequences reverse-translated from the peptide sequence candidates. Figure 3.6 shows that using the 
codon-representation increased the variance of the fitness scores generated while reaching similar 
maximum and mean fitness levels. The blue lines represent data for the codon-representation and the 
orange lines represent data without the codon-representation. The solid lines represent the average of 
6 repeated genetic runs over 100 generations. The dotted lines represent the 95% CI using the student t 
test statistic of the repeated runs. In Figure 3.6a, the standard deviation of fitness scores is increased 
with codon representation. The maximum fitness converges independent of codon representation, in 
Figure 3.6b, and in Figure 3.6c the number of predicted antibacterial sequences decreases when using 
the codon representation. The codon-representation mean fitness converges in Figure 3.6d with the 
non-codon-representation mean fitness. Increasing the variance with the codon-representation resulted 
in a reduced number of predicted antibacterial peptides. To the author’s knowledge, this is the first time 
a genetic algorithm to design peptides89, 156, 235-242 has used reading frame shifts for generating novel 
sequences. 
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Figure 3.6 Improved sequence variation through codon-representation.  
 Novel Antimicrobial Peptide Experimental Test 
S. epidermidis, a common pathogen for surgical site infections, was used by my colleague Cate Wisdom 
to evaluate antibacterial activity of the designed peptides on agar plates. The crude peptide synthesized 
by Cate Wisdom was utilized as screening.243-246 The screening test uses the diffusion of the peptides on 
agar plates to evaluate if the peptides can cause of zone of inhibition where the bacteria will not grow. 
Therefore, a large initial concentration of the peptides can be used to evaluate the range of peptide 
concentrations generated through diffusion out into the agar. Ampicillin was used as a positive control 
antibacterial agent.  
Two of the three tested peptides for the top scoring peptides of the final generation of the genetic 
algorithm developed in this work show zones of inhibition against S. epidermidis, as shown in Table 3.2. 
All three of the candidate peptides were within the boundaries described by a CLN-MLEM2 rule 
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category. AMP-1, AMP-2 and AMP-3 agree on residues for five of the seven residue positions. AMP-1 
demonstrates that small sequence changes from AMP-2 can result in a loss of S. epidermidis activity, 
while AMP-3 demonstrates that a small sequence change from AMP-2 does not result in a loss of S. 
epidermidis activity. Applying the CLN-MLEM2 algorithm to the updated data set labeling AMP-1 as 
inactive and AMP-2 and AMP-3 will update the previous rule set which classified AMP-1 as active to be 
less likely to identify false positive peptides.   
Table 3.2 Inhibition zone of S. epidermidis for candidate novel antimicrobial peptides. 
Agent Sequence 
Concentration 
(mM) 
Inhibition Zone 
(cm) 
Ampicillin n/a 0.028 1.6 
ADP3 peptide 1 (crude) DYHHGVRVL 0.377 0.0 
ADP3 peptide 2 (crude) GIHDILKYGKPS 0.407 1.0 
AMP-1 (crude) ESYKKML 0.468 0 
AMP-2 (crude) ESYKRMF 0.431 0.9 
AMP-3 (crude) ESYKHMF 0.439 1.1 
 
Basic Local Alignment Search Tool (BLAST) is a fundamental tool in determining the homology of a 
sequence with other known sequences in databases.247 BLAST uses word search within sequences to find 
likely matches while focusing on words with high sequence complexity, that is a low frequency of 
character repeats. A tblastn search,248 a homology search of the designed peptide sequences against 
known peptides or peptide sequences translated from known nucleic acid sequences in the NCBI 
database, was performed. No significant matches were returned. These peptides do not have homology 
to previously studied peptides or peptide sequences translated from sequenced nucleic acids in the 
NCBI database. 
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 Combining MLEM2 Rule Categories 
To investigate if meeting multiple CLN-MLEM2 rule categories increases the likelihood of activity for 
peptides, the MLEM2 rule category count was added as a design target (Table 3.3).  
Table 3.3 Design targets for novel antimicrobial peptides for combining MLEM2 rule categories. 
Property Target 
Amino Acid Length 7 to 15 
Cysteine Count 0 
Aggrescan Score 0 
Net Positive Charge  +1 to +5  
Matching MLEM2 Rule Count 8-12 
 
Again, the genetic algorithm developed in this work found peptides that were closer to the design 
targets than any of the antimicrobial peptides in the APD3 database. (Figure 3.7). 
 
 
Figure 3.7 Fitness Distributions of Selected Generations. 
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The antibacterial screening with S. epidermidis showed that one of the three antimicrobial peptides 
showed antibacterial activity with a slightly larger inhibition zone than the peptides chosen without the 
multiple MLEM2 rule category design target, as seen in Table 3.4. Hp1404,249 was the highest-ranking 
peptide from the APD3 database according to the design targets in Table 3.3. Hp1404 has known activity 
against gram positive bacteria. The middle of the HP1404 sequence was conserved among novel 
peptides for this genetic algorithm search. Conserved residues are underlined in Table 3.4. The target of 
meeting multiple MLEM2 rules produced search results with more conserved residues than was shown 
in Table 3.2. 
A tblastn search of the designed peptide sequences in Table 3.4 against the NCBI translated nucleotide 
database returned no matches. Therefore, the designed peptides were not found to have high-
homology from translated DNA sequences. Sequences that do have high homology from the translated 
nucleotide database with no previous annotation of antimicrobial activity are referred to as encrypted 
antimicrobial peptides. 250 As seen with examples from Table 3.2, close sequence similarity relationships 
between AMP-4 and AMP-5 resulted in different antibacterial activity against S. epidermidis. New 
MLEM2 rule categories can be generated to separate sequences with these differences.  
Table 3.4 Inhibition zone of S. epidermidis as a screen test of antibacterial activity for combining 
MLEM2 rule categories. 
Agent Sequence Concentration (mM) Inhibition Zone (cm) 
Ampicillin n/a 0.028 1.6 
Hp1404 (crude) GILGKLWEGVKSTF 2.61 2.3 
AMP-4 (crude) ATLGVLWESIRGHR 2.51 0 
AMP-5 (crude) ATLGVLWEGARGHT 2.73 1.2 
AMP-6 (crude) GTLANGWEGVRTNH 2.65 0 
 
68 
 
 Discussion  
 Increasing Variation through Codon Representation 
Genetic algorithms for solving the reverse problem of CAMD have been used for a variety of 
problems.251, 252 Protein or peptide design is a natural application of genetic algorithms since the process 
of genetic evolution designs new biological proteins. Computational protein and peptide design have 
been accomplished through genetic algorithms91-97 before but not all aspects of the genetic system that 
inspired genetic algorithms have been explored in protein and peptide design. A DNA codon was applied 
to the representation of peptides within the genetic algorithm in this work to take advantage of reading 
frame shifts. Generating novel solutions in a genetic algorithm is a balance between viability, finding 
solutions that meet some criteria, and adaptability, finding solutions that meet all criteria. Increasing the 
viability of each generation often involves using small moves in sequence space to avoid the loss of 
viability of large, random moves. Increasing the adaptability relies on the ability to make bigger moves in 
sequence space to preserve genetic diversity among generations. Reading frame shifts in biology are 
large moves which balance viability and adaptability as shown by how biological proteins develop in 
nature. Single-codon mutations in DNA, either deletions or insertions, cause reading frame shifts. 
Reading frame shifts encode transition probabilities for which new amino acids replace the previous 
amino acids. While most-reading frame shifts are nonviable, the viable frame shifts in nature lead to the 
development of new proteins. While using a codon-representation reduces the viability of this method 
by generating less antibacterial sequences (Figure 3.6), the genetic diversity is increased because of the 
increase of the standard deviation of scores. Since the method developed in this work filters out non-
antibacterial sequences, this increased genetic diversity is among predicted antimicrobial peptides. 
 Combining Antibacterial Classes 
Each CLN-MLEM2 rule for antibacterial activity describes a set of physicochemical properties that 
separates a set of antibacterial peptides from all given non-antibacterial peptides in the training set. 
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Some peptides may meet more than one rule for antibacterial activity. These peptides may act in 
multiple ways to achieve antibacterial activity. Measuring the number of CLN-MLEM2 rules a peptide 
meets is a measure of its robustness for having broad spectrum antibacterial activity. 
 Targeting Specific Bacterial Strains 
Multiple peptides were developed with antibacterial activity against S. epidermidis without having labels 
for which peptides were effective against this strain. Several peptides were also found which have no 
activity against S. epidermidis. These negative activity examples are a critical resource to developing 
antibacterial peptides which can preserve or restore balance to microbiomes. A microbiome is the 
complement of bacteria that is vital for the health and wellness of an ecosystem.253 The method 
developed in this work can identify which physicochemical property rules relate to activity against some 
strains over other strains. Just as combining CLN-MLEM2 rules for activity may lead to a broader 
spectrum of activity, combining CLN-MLEM2 rules for inactivity can lead to more targeted antibacterial 
peptides.  
 Conclusions 
To avoid a post-antibiotic era in which bacterial infections become untreatable, a computer-aided 
molecular design (CAMD) method was developed in this work to design antibacterial peptides which can 
be targeted for desired properties and strain specificity. This method found novel antibacterial peptides 
of seven amino acids that are easier to synthesize than antimicrobial peptides in the APD3 database. An 
improvement in antibacterial activity was found when adding together multiple rules for activity from 
the rough set theory method from the previous chapter. For the forward problem of quantifying 
sequence-activity relationships, a rough set theory method (CLN-MLEM2) as a quantitative structure-
activity relationship (QSAR) model for peptides. For the first time, RST has been applied to designing 
peptides or proteins. For the reverse problem of finding novel peptide sequences, the codon-based 
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genetic algorithm developed in this work was applied to discover novel antibacterial sequences against 
S. epidermidis, a key pathogen for implant infections. 
Genetic algorithms favor more fit solutions over less fit solutions in reproduction. The reduced diversity 
of the reproduced solutions may lead to only searching suboptimal parts of the search space. To replace 
diversity that is lost when killing off solutions between generations, recombination operators used in 
this work are mutation and crossover. Other recombination operators from genetics have been studied 
for genetic algorithms such as gene dominance and permutation crossover.254-257 These operators 
attempt to use pattern recognition within generated solutions to recognize blocks of solutions which can 
be recombined for improved solutions. The current work prioritizes the computational efficiency of 
finding new antimicrobial peptides over finding the most optimized solutions, but future work may use 
recombination operators which exploit pattern recognition schemes.   
In Aim 1, new antimicrobial peptides were customized according to ease of synthesis design criteria. Aim 
2 of this work was to create chimeric antimicrobial peptides which can create antibacterial activity 
interfaces. In Chapter 4, titanium-binding antimicrobial peptides are demonstrated and engineered for 
improved antibacterial activity. 
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 Chimeric Spacer Design for Titanium Implant Surfaces 
  
72 
 
 Introduction 
The integration of titanium implants in the host tissue depends on the creation and maintenance of an 
infection-free interface.19, 258 The conventional approach to providing an infection-free environment is 
the systemic delivery of antibiotics.124, 130 This approach results in sub-inhibitory antibiotic 
concentrations throughout the body as the antibiotic is metabolized, leading to further antibiotic drug 
resistance for the bacteria associated with the body. This resistance will lead to reduced efficacy of the 
antibiotic if the bacteria becomes pathogenic for the patient or also for other patients if the resistance is 
genetically transferred. 
Active research in the literature is ongoing about how to deliver antibacterial agents to the titanium 
implant surface to overcome the challenge of spreading bacterial drug resistance.258-261 The two main 
approaches are covalent-chemistry attachment26, 262  and non-specific physical adsorption263-266 of 
antibacterial agents. Both approaches require modification to the titanium surface, preventing the use 
of currently developed implants. Also, none of the current studies for either of these approaches have 
provided orientation control for the applied antibacterial agents.  
Chimeric peptides are an innovative solution that can provide orientation control while using currently 
developed titanium implants.5, 6 In this work, using current implants is achieved through solid binding 
peptide technology. Combinatorial biology protocols run by my colleague Deniz Yucesoy discovered 
solid binding peptide sequences that conforms to titanium surfaces through non-covalent interactions. 
Orientation control was achieved through engineering spacer sequences to improve the functionality of 
the antimicrobial peptide domain of the chimeric peptide through peptide folding analysis.  
 Background 
The reliability of the interface between proteins and material surfaces is often poor due to non-specific 
adsorption and orientation.267, 268 The proteins that adhere to a material surface often have randomized 
orientation. One approach is to develop surfaces which encourage proper protein orientation. Wang et 
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al use co-block polymers to improve the interactions between surfaces and proteins at the nanoscale.269-
272 The surfaces are intended to guide understanding of how protein resistance, that is the lack of 
protein adsorption, can be designed into material surfaces for different kinds of proteins. These design 
rules, once understood, could also lead to the design of nanoscale surfaces which could enhance protein 
binding. However, these surfaces would need to be transferred to currently available devices to have 
the broadest impact. Another approach to loss of protein functionality from randomized orientation is 
to increase the number of immobilized proteins by adsorbing multiple layers. In certain applications, 
such as keratins, multiple layering is advantageous.273 However, multiple layering is not advantageous 
for many protein classes such as enzymes.  Such multiple layering methods lead to reduced specific 
activity of the enzymes on the surface due to a variety of factors. Another example of reduced specific 
activity is antimicrobial peptides. A recent study has used calcium phosphate coatings and titanium 
nanotubes to deliver a dosage of cationic antimicrobial peptides at the implant surface.274 While the 
release profile may help prevent bacteria near the implant site, the delivery system does not facilitate 
the proper display of the antimicrobial peptides so that they reach maximum specific activity on the 
surface.  
Methods are in development to improve the specific activities of peptides and proteins on the surface of 
materials.275-279 The activity of proteins and peptides on the surface of materials depends both on their 
secure attachment to the surface and on preserving their orientation for their function.280-283 Using non-
specific absorption onto the surface can lead to problems with insecure attachment and degraded 
orientation. Physical release systems can address the insecure attachment problem but cannot improve 
the orientation degradation without any additional mechanisms.284-289 Self-assembled monolayers and 
other irreversible bonding techniques290-292 provide secure attachment, but the orientation degradation 
challenge remains. Solid binding peptides are a promising solution to overcome both secure attachment 
and orientation degradation problems as a next-generation physical adsorption technique.5, 6, 33, 48, 275, 293-
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295 For this work, two studies have been published demonstrating chimeric antimicrobial peptides 
functioning on titanium surfaces.6, 293 
 Methods 
 PyRosetta Ensemble 
To build an ensemble, a fragment-insertion based method was used to fold the backbone of the 
structural decoy using Robetta server fragments.296 The fragments are inserted into the backbone if they 
improve the energy score of the decoy. If not, the fragments may be inserted if they are close to 
improving the energy score. This barrier is gradually reduced as an annealing method. Once the 
backbone structure is generated, the Fast Relax protocol is used to determine the lowest energy 
rotamers.119 The process is repeated up to 1,000 times to generate an ensemble for further statistical 
analysis. An example implementation of this procedure is included in Appendix B. 
 Secondary Structure Feature Counts 
Each ensemble of computational structures was generated according to customized PyRosetta scripts 
such as the script included in Appendix B. Each structural decoy within a structural ensemble was 
analyzed by the Dictionary of Secondary Structure in Proteins (DSSP) program297 to identify secondary 
structure features with in the sequence. The feature counts of every DSSP analysis for a single decoy 
was tabulated into a single text file in the LERS format. The feature counts were divided by the number 
of structural decoys generated to calculate the structural feature frequencies.  
 Results 
 Chimeric Titanium Antimicrobial Peptides Reduced Efficacy 
The chimeric peptide antibacterial activity is dependent on the interaction of the solid-binding domain 
and the antimicrobial peptide domain, data is provided in Table 4.1.6  These activity experiments were 
performed by my colleague Deniz Yucesoy. For example, the S. mutans minimum inhibitory 
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concentration increased over four times for AMP1 when the titanium binding peptide TIBPS1 was 
added, and over nine times when titanium binding peptide TIBSP2 was added.  
Table 4.1 Minimum inhibitory concentrations for chimeric antimicrobial peptides with solid binding 
peptides for titanium and a GGG spacer.  
Peptide E. coli MIC (μM) S. epidermidis MIC (μM) S. mutans MIC (μM) 
AMP1 9.45 4.72 37.81 
AMP2 21.08 0.66 10.54 
TiBPS1-AMP1 9.58 4.78 153.25 
TiBPS2-AMP1 21.0 5.23 336.5 
TiBPS1-AMP2 80.8 2.52 80.8 
TiBPS3-AMP2 167.4 5.23 83.7 
TiBPS4-AMP2 167.6 5.22 83.8 
 
The folding dynamics of the antimicrobial peptide domain may change in the chimeric peptide 
compared to the single domain. To learn which secondary structure features in the antimicrobial 
peptides are the most relevant to antibacterial activity, a rough set theory analysis of computationally 
predicted structures for single-domain antimicrobial peptides and chimeric antimicrobial peptides was 
performed with MLEM2, as diagramed in Figure 4.1. 
 
Figure 4.1. Schematic of rule induction process by MLEM2 for discovering structure-function relationships 
for chimeric antimicrobial peptides. 
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The MLEM2 analysis showed that the most relevant differences observed among computational 
structure predictions were helices. Table 4.2 describes the secondary structure features associated with 
low and high levels of antibacterial activity shown in Table 4.1. Three different pathogens were 
evaluated by my colleague Deniz Yucesoy for the activity against the seven peptide sequences in Table 
4.1. E. coli was selected for its role in urinary device infections, S. epidermidis for its role in orthopedic 
implant infections and S. mutans for its for in dental implant infections.  
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Table 4.2. MLEM2 generated rules describing secondary structure and chimeric antimicrobial peptide 
activity. 
Alpha Helix Property Pathogen 
MIC Interval 
(μM) 
Correction Cases / Applicable 
Cases 
4-a.a.-right-handed helix &  
5-a.a.-helix 
E. coli 9.45-21 164/179 
4-a.a.-right-handed helix &  
5-a.a.-helix 
S. epidermidis 4.72-5.23 164/179 
4-a.a.-right-handed helix &  
5-a.a.-helix 
S. mutans 10.54-37.81 151/179 
8-a.a.-helix & 
6 or 8-a.a.-right-handed helix 
S. mutans 336.5 8/11 
 
Figure 4.2 shows the helical formations which are most relevant to the peptide folding of the most 
active sequences against the pathogens listed in Table 4.2. 200 different structural decoys were 
generated for each of the seven peptide sequences to discover the most relevant secondary structures 
to antibacterial inhibition in Table 4.1. 
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Figure 4.2. Aligned secondary structure decoys for 5-a.a.-helix rules generated by MLEM2 algorithm. 
Figure 4.3 shows the structures that were observed for the peptides with higher inhibitory 
concentrations in Table 4.1. These structural trends shown in Figure 4.2 and 4.3 are structure-function 
relationships of activity for chimeric peptide sequences. The structures shown in Figure 4.3 were used to 
build improved chimeric antimicrobial peptide function through the design of a new spacer. 
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Figure 4.3. Aligned secondary structure decoys of 8-a.a.-helix rule generated by MLEM2. 
 
 Designing New Chimeric Peptide Spacer for Improved Antimicrobial Activity 
Different chimeric peptide sequence combinations of the same antimicrobial peptide and different solid-
binding peptides resulted in different computationally predicted secondary structure frequencies. 
Different spacer domains were investigated to see if they would also change the computationally 
predicted secondary structure frequencies.  The GGG linking domain used for the sequences in Table 4.1 
was changed to GSGGG due to serine/glycine combinations in peptide display systems. Computer-
generated structures of these sequences are in Figure 4.4. 
In Figure 4.4, the lowest energy structures modeled in solution for (a) TiBP-Spacer3-AMP chimeric 
peptide; (b) TiBP-Spacer5-AMP chimeric peptide; (c) Spacer3 (GGG); (d) Spacer5 (GSGGG); (e) AMP; (f) 
TiBP. The peptide backbone is represented as a ribbon to show secondary structure for peptides with 
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side chains represented by full atoms. TiBP domains, spacer domain and AMP domains are designated 
with blue-, black- and red-shading, respectively. 
 
 
Figure 4.4. Improved spacer for antibacterial activity against S. mutans 
The secondary structure frequencies were calculated for TiBP-Spacer3-AMP and TiBP-Spacer5-AMP, and 
a shift was observed for features that were the most relevant for high antimicrobial activity against S. 
mutans and S. epidermidis for peptide sequences in Table 4.1. TiBP-Spacer3-AMP is the same sequence 
as TiBPS1-AMP1 in Table 4.1. Table 4.3 gives the secondary structure frequency comparison between 
these two sequences. The secondary structure function relationship predicts that TiBP-Spacer5-AMP 
possesses a secondary structure more associated with antimicrobial activity than the secondary 
structure of the TiBP-Spacer3-AMP. 
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Table 4.3. PyRosetta method of peptide structure prediction frequencies of four and five amino acid 
alpha helices in computational generated structures.  
Peptide 4 aa α-helix Frequency (%) 5 aa α-helix Frequency (%) 
TiBP-Spacer3-AMP 
(RPRENRGRERGL-GGG-KLLKKLLKLLKKL) 
10.4 5.6 
TiBP-Spacer5-AMP 
(RPRENRGRERGL-GSGGG-KLLKKLLKLLKKL) 
17.6 8.0 
 
Along with a shift in secondary structural features seen in Table 4.3, a shift in antibacterial activity was 
observed in Table 4.4. The TiBP-Spacer5-AMP had a minimum inhibitory concentration much closer to 
the antimicrobial peptide domain alone than the MIC of the TiBP-Spacer3-AMP. This example shows 
that spacer design in chimeric peptides can help close the antibacterial activity gap between the activity 
of the single domain peptide and the chimeric peptide which adds the additional functionality of coating 
the titanium surface through solid binding peptide technology. 
 
Table 4.4 MIC of TiBP-Spacer5-AMP, TiBP-Spacer3-AMP and AMP 
Peptide S. mutans MIC (μM) S. epidermidis MIC (μM) 
AMP 38 4 
TiBP-Spacer3-AMP 153 5 
TiBP-Spacer5-AMP 50 8 
 
 Discussion 
Because chimeric antimicrobial peptides are polypeptide chains, they have multiple levels of structure. 
This work has shown that small changes in the primary level of structure has led to detectable 
differences in modeled secondary structure through the customized PyRosetta script built for this work. 
The secondary structure features of antimicrobial peptides such as helices has been shown to be related 
to their antibacterial function.298-300 This work relates the modeled secondary structure features to the 
observed antibacterial activity of antimicrobial peptides and chimeric antimicrobial peptides. For 
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chimeric peptides, some loss of activity was observed. A novel spacer was shown to improve the activity 
of the chimeric peptide. 
 Conclusions 
A structure description tool (PyRosetta Peptide Folding Method, Appendix B) was developed for 
evaluating structure-function relationships and the effect of the spacer sequences of chimeric peptides 
on the titanium surface. Specific secondary structure features were discovered through a data mining 
technique (CLN-MLEM2, Figure 2.1) to find spacers which increase the frequencies of secondary 
structures related to antibacterial activity.  The second aim of designing chimeric antimicrobial peptides 
for the titanium implant surface was achieved. The third aim of this work to explored multiple types of 
implant surfaces to apply antibacterial activity. In the next chapter, chimeric antimicrobial peptides are 
designed for new materials: calcium phosphate, zirconia and urethane polymers.  
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 Chimeric Antimicrobial Peptides across Multiple Materials 
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 Introduction 
The second aim of this work is to engineer the interface between implant surfaces and the host tissue 
for titanium surfaces with chimeric peptides in the previous chapter. The third aim of this work is to 
design chimeric antimicrobial peptides for multiple materials. Calcium phosphate, zirconia and urethane 
polymers are provided as case studies. 
Within both disciplines of material science and molecular biology, the interface between biological 
molecules and engineered material surfaces is among the most active research areas. Investigations in 
this area are applicable to a wide range of problems such as biological sensors, industrial processing of 
biological feedstocks, and medical device interfaces.  
 Background 
In Chapter 4, the most common metal in biomaterial implants was selected for chimeric antimicrobial 
peptide development (titanium). In this chapter, common biomaterials of different types were selected 
for chimeric antimicrobial peptide design. A mineral (calcium phosphate), a ceramic (zirconia) and a 
polymer surface (acrylic urethane) have been selected for developing chimeric antimicrobial peptides.  
Material Surfaces 
Calcium phosphate is the main mineral component of hard tissues. The main mineral phases of calcium 
phosphate are amorphous calcium phosphate (ACP), octacalcium phosphate (OCP) and hydroxyapatite 
(HAP).301  Like titanium, calcium phosphate is widely used as a biomaterial in orthopedics and dental 
applications.302 Calcium phosphate is used as an implant coating because of its osteoinductivity across a 
variety of mineral phases.44, 47, 302-306 Therefore, due to the risk of surgical site infections, the protection of 
the calcium phosphate surface against drug-resistant bacteria must go beyond what prophylactic systemic 
antibiotics provide.5, 19, 305  
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In Tamerler’s group’s previous work, many calcium phosphate binding peptides have been selected 
through combinatorial biology protocols. In 2008, a library of peptides was selected against 
hydroxyapatite.307 From this study, HABP1 was identified as a strong binding peptide can direct the 
formation of octacalcium phosphate from the ion stage of mineralization. In 2012, the library of over 100 
hydroxyapatite binding peptides from the 2008 study was used to calculate which subsequences of 
amelogenin, a protein used in forming hydroxyapatite mineral phase in tooth enamel, likely bind to 
hydroxyapatite38 through sequence similarity bioinformatics methods.38 Three separate subsequences of 
amelogenin were identified as likely to bind to hydroxyapatite (ADP1, ADP2, and ADP4). The range of 
dissociation constants for amelogenin subsequences identified as likely to bind to hydroxyapatite was in 
the low micromolar range. The dissociation constant of HABP1 is also in the low micromolar range. The 
calcium phosphate solid binding peptides have comparable binding kinetics to the titanium solid binding 
peptides used in Chapter 4.6, 48 
In dentistry, titanium and zirconia are most commonly used for connection between the implant and the 
mandible or the maxilla. Therefore, the bony integration of the implant is critical to avoiding implant 
failure in challenging cases with comorbidities that reduce bone healing such as diabetes and 
osteoporosis. In this work, the primary approach for an antibacterial barrier is to develop chimeric 
antimicrobial peptides at interface. The secondary approach is to provide a mechanical barrier to 
bacteria and pH buffering capacity by mineralizing the implant interface with a calcium phosphate 
mineral phase. The solubility of the formed mineral depends on the ratios of these phases,308, 309 which 
are tunable based on the capping properties of the peptide-mediated mineral formation process.307, 310-
313   
Amelogenin is a protein secreted by ameloblasts in the formation of tooth enamel.314, 315 The distinct 
roles of amelogenin-subsequence peptides in the formation of hydroxyapatite in enamel was elegantly 
described in a 2012 study.311 With this recent study, two functions were differentiated: the nucleation of 
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calcium phosphate particles and the formed morphologies. This study was used as inspiration for 
combining fast formation kinetics with octacalcium phosphate-forming morphology. Characterization of 
calcium consumption rate of HABP1 in the bio-enabled mineralization assay was published by 
Gungormus et al in 2008.307 The calcium consumption rate of amelogenin derived peptide 1 (ADP1) was 
published by Gungormus et al in 2012.311 
Zirconia, or zirconium dioxide, has three phases: monoclinic, tetragonal and cubic. Ceramic material 
properties are dependent on the mixture of these phases. The mixture is controlled by alloying different 
oxides.316 Zirconia has been used in many new uses in medicine and dentistry in the past decade.317 
Example include orthopedic hip implants, endosseous dental implants and all-ceramic crowns.  
Polymer surfaces in biomedical devices are common among many device types and categories. Coatings 
of medical devices are an important opportunity to create and maintain infection-free interfaces. 
Polyurethanes are versatile family of polymers in many medical devices such as pacemaker lead 
insultation, vascular prostheses and breast implants. Grafting polyurethane with poly(acrylic acid) can 
change the hydrophilic and lubricating properties of the polymer surface.318 Acrylic urethanes were 
selected to demonstrate the feasibility of using chimeric antimicrobial peptides to create antibacterial 
surfaces on urethane surfaces, specifically, and polymer surfaces, generally.  
Computational Structure Characterization Methods 
To achieve chimeric peptide sequences that retain the functions of the component domains, interdomain 
interference must be minimized. Structural modeling of chimeric peptides provides an approach to 
estimate when domains are folding similarly in the chimeric peptide or much differently. Computational 
structure modelling of proteins can be achieved through a wide variety of tools such as Rosetta, Amber, 
CHARMM, GROMACS and others.117, 319-321 These tools allow for the modeling of structural changes in a 
domain due to sequence changes external to the domain. In this work, structures were modelled through 
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a PyRosetta script in Appendix B. This method uses a Rosetta approach to generate computational 
structure decoys with less computational work than molecular dynamics (MD) approaches. The reduced 
computational time compared to MD allows for screening more peptides in the design process. 
The study of allostery,114, 322-325 how different binding events regulate the functionality of proteins, gives 
insight into a possible solution to the reduced performance of combining antimicrobial peptides with solid 
binding peptide seen in Table 4.1. Inspiration from the linking domains of multi-domain proteins was used 
to design spacers for chimeric peptides. Within a single polypeptide chain, the combination of a solid 
binding peptide and a displayed functional domain enables functional nanoscale interfaces between 
inorganic materials and biological systems.5, 6, 41, 48, 293 While the solid-binding peptide allows for the self-
assembly of the chimeric peptide onto the inorganic surface through molecular recognition,30, 326 it is the 
linking sequence, or spacer, between the solid binding domain and the displayed domain that allows for 
self-organization of the antimicrobial peptide to retain its antibacterial activity. 
The potential of spacer design is shown through the growing literature of the complex allosteric effects 
observed in biologically evolved proteins discovered both through structure determination techniques 
such as NMR and CD and through computational structure modeling techniques such as molecular 
dynamics and coarse grain models.323, 327, 328 
Spacer Sequence Design 
The design of linking domains in proteins has been studied for more than 25 years.329-331 A recent review 
compared linker design for naturally occurring, multi-domain proteins and those which are empirically 
designed.332 Empirical linkers are further divided into flexible, rigid and in vivo cleavable. Two databases 
of naturally occurring linkers with designing tools were discussed. LINKER takes in queries with multiple 
inputs, including length and proteases to avoid. 333  In this review, the development of databases of 
empirical linkers are discussed, concluding that a need exists for new search algorithms for linkers.332  
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This need is addressed in this work for new search algorithms by developing a codon-based genetic 
algorithm to find short peptide sequences of targeted length according to user specifications (Figure 5). 
In addition to the limitations noted by the reviewers, the design of the linking domains is intended for 
fusion proteins, making the use of the designs for combining peptide domains high risk. A method for 
mitigating this risk is to estimate the structure folding consequences of the choice of spacer domain in 
chimeric peptides according to the procedures in this chapter. 
While many designs of linking domains in proteins exist in the literature and in databases, methods for 
designing spacer sequences for chimeric solid-binding peptide have not been reported. To design 
peptide sequences, a computer aided molecular design (CAMD) approach was developed for this work. 
A genetic algorithm was used (Figure 3.3) to consistently improve the spacer-induced structural 
features, as seen in Figure 5.1. The spacer design method begins with design targets and initial 
sequences to investigate. The candidate spacer sequences are scored by the distance from the design 
targets, then filtered by MLEM2 rules from the method in Section 2.3.1. Further customization is 
accomplished through adding target properties to the single-objective of the genetic algorithm. 
Structure preservation is evaluated for the active domains desired for the application through spacer 
frequency error (SFE). The lower the SFE, the closer the frequencies of the secondary structures are 
between the single domain decoys and the chimeric peptide domain decoys. The resulting spacer 
sequences are used to build chimeric peptide sequences with the newly designed spacers linking the 
given pair of domains. 
The design of chimeric peptides for mineralization is approached by characterize the folding of solid 
binding peptides through three different methods. The first method is to characterize the peptide 
folding, both experimentally and computationally, for secondary structural features. The second 
approach is to characterize the peptide folding by protonation state distribution. The third approach is 
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to characterize the peptide folding through the surface area distributions. This work explores these 
characterization methods to serve as design targets for chimeric peptides. 
 Methods 
 Chimeric Spacer Design Method 
The initial sequences studied here are from short peptide sequences based on flexibility and secondary 
structural ideals. The new candidate spacer sequences are generated through the genetic algorithm 
developed in this work (Figure 3.3). As part of the genetic algorithm, the spacer sequences are filtered 
by MLEM2 rules generated through the rough set theory method in Figure 2.1. Spacers are further 
customized with new design constraints. The overall methodology is detailed in Figure 5.1. 
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Figure 5.1 Process schematic for chimeric spacer engineering design. 
 
 Secondary Structure and Spacer Frequency Error 
Ensembles of up to 1,000 structural decoys were generated for candidate chimeric peptide sequences 
and the single domain sequences. Each structural decoy was analyzed by the DSSP program297 to identify 
secondary structure with in the sequence. The results of every DSSP analysis of single decoys are 
tabulated into a single text file, as in Chapter 4 methods (Section 4.3.2). This method differs from the 
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Chapter 4 method by including the residue position in the description of the secondary structural 
feature. For the residue position calculation, at each residue position each unique symbol (B, E, G, H, I, S 
and T) was summed for the ensemble, then divided by the number of decoys generated in the 
ensemble. To estimate the difference in the folding between the chimeric domain and the single 
domain, the frequencies at each residue position are summed in the spacer frequency error (SFE). This 
error was calculated as the sum of the absolute value of the differences between the feature 
frequencies of the chimeric residues from the single domain residues at each residue position. 
Equation 5.1 
𝑆𝐹𝐸 = |𝑓  − 𝑓  | 
 
 Circular Dichroism 
Circular dichroism (CD) is a method for experimentally observing the differential absorption of polarized 
light across a spectrum in molecules.334 This technique is widely used for the characterization to 
secondary structure in peptides and proteins.335-339 Depending on the electron density of the carbonyl 
bond in the polypeptide backbone, circularly polarized light is absorbed differently. The secondary 
structure folding patterns of peptides and proteins can be inferred through CD decomposition analysis. 
CD Pro is a set of tools built for this purpose.340 
The CD spectra were recorded with a CD spectrometer (JASCO, J-815) at room temperature, using a 1.0 
mm cuvette. Each peptide sample was dissolved at 0.2 mg/mL in 100 mM Tris (pH 7.4) with and without 
TFE at 4°C for overnight. CD spectra were acquired from 190 to 260 nm at a scanning speed of 60 
nm/min and were averaged from three runs per each sample. The secondary structure Far-UV CD 
spectra were processed with the tools of CD Pro.340 The mean residue absorbance was processed with 
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CRDATA.exe to create the input file for SELCON3.exe, CDSSTR.exe and CONTILL.exe. For each set of data, 
the reference set selected was SMP50. The fractions of secondary structure (Regular Helix, Distorted 
Helix, Regular Sheet, Distorted Sheet, Turns and Unordered) were averaged for all three CD Pro tools 
(SELCON3, CDSSTR, and CONTILL). This decomposition of secondary structure is used to compare with 
the PyRosetta computational structure estimation method (Section 5.3.2). 
 Results 
 Calcium Phosphate Surfaces 
The chimeric antimicrobial peptide approach on titanium from Chapter 4 is being extended in Chapter 5 
to calcium phosphate, zirconia and urethane polymer surfaces to demonstrate that the chimeric 
antimicrobial peptide technology is applicable to different types of biomaterials.  
Structure-Function Relationship for Chimeric Antimicrobial Peptide 
My colleague Hilal Yazici performed the synthesis of three peptides (cHABP1, HHC-36 and cHABP1-GGG-
HHC-36). These peptides were chosen to build a chimeric antimicrobial peptide for calcium phosphate 
surfaces. cHABP1 is a solid binding peptide for calcium phosphate,307, 341 HHC-36 is an antimicrobial 
peptide with known activity against multi-drug resistant bacteria,157  and the chimeric peptide cHABP1-
GGG-HHC-36 is a chimeric peptide analogous to the titanium chimeric peptides in Table 4.1 in Chapter 4. 
Hilal Yazici also performed activity characterization with these three peptides against two strains of 
bacteria common in areas of surgical site infections, E. coli and S. mutans. In Figure 5.2, two different 
pathogens were evaluated by the optical density of well volumes at 600 nanometers (OD600). The optical 
density measurement quantifies the scattering of the solution and is a measure of the quantity of bacteria 
present. As shown in Figure 5.2, (A) shows the relative growth of E. coli with various concentrations the 
studied peptides, and (B) shows the relative growth of S. mutans with various concentrations of the 
studied peptides. 
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Figure 5.2. Bacterial turbidity (OD600) as a function of hydroxyapatite binding chimeric peptide concentration 
and its component domains.  
 
Table 5.1 displays the sequences of the peptides and their minimum inhibitory concentration. MIC values 
against some E. coli strains for HHC-36 have been previously reported, ranging from 2.5 µM – 5.4 μM.157, 
342 As in Chapter 4, the MIC values for the chimeric antimicrobial peptides are higher than the MIC values 
for the antimicrobial peptide domain alone, indicating some loss of activity. 
Table 5.1. Antimicrobial activity of peptides for the calcium phosphate surface. 
Peptide Name Sequence S. mutans IC50 E. coli IC50 
cHABP1 CMLPHHGAC 128 μg/mL 48 μg/mL 
HHC-36 KRWWKWWRR 3 μg/mL 12 μg/mL 
cHABP1-GGG-HHC36 CMLPHHGACGGGKRWWKWWRR 16 μg/mL 18 μg/mL 
 
A secondary structure study on these peptides was performed using the PyRosetta script discussed in 
Appendix B.81, 343 The secondary structure frequencies were graphed in R. The α-helix formation frequency 
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trends positively with antibacterial activity level: the highest for HHC-36, lower for cHABP1-GGG-HHC36 
and the lowest for cHABP1, as shown in Figure 5.3. The structure generation data analysis for these three 
peptides reinforces the trend of increasing α-helical structure frequency with increased antibacterial 
activity. 
 
Figure 5.3. Helical structure frequencies for hydroxyapatite binding chimeric peptide and its components 
The trend of α-helix length to antibacterial activity among these three peptides combines the results 
shown in Table 5.1 with Figure 5.3. For an analysis that relates many kinds of secondary structure 
features to antibacterial activity, the MLEM2 algorithm, as discussed in Chapter 2, is used. 500 structure 
decoys for each sequence generated from the PyRosetta script method (Appendix B) were reviewed 
with the MLEM2 algorithm. Six secondary structure rules were discovered to be specific between the 
peptides cHABP1, HHC-36 and cHABP1-GGG-HHC36, and these are shown in Table 5.2. 
  
α-helix Length 
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Table 5.2 Inducted rules by MLEM2 for secondary structure features of chimeric hydroxyapatite 
binding peptide and its component domains. 
Rule Secondary Structure Feature Sequence 
Feature Frequency 
for Sequence 
Feature Frequency 
for Other 
Sequences 
1 4-a.a.-α helix & 
2-a.a.-turn 
HHC-36 (KRWWKWWRR) 40/500 4/1000 
2 6-a.a.-α helix HHC-36 (KRWWKWWRR) 35/500 0/1000 
3 5-a.a.-α helix & 
2-a.a.-turn 
HHC-36 (KRWWKWWRR) 37/500 0/1000 
4 4-a.a.-bend & 
2-a.a.-bend 
cHABP1-CCC-HHC36 
(CMLPHHGAC 
GGGKRWWKWWRR) 
43/500 0/1000 
5 4-a.a.-bend & 
2-a.a.-bend 
cHABP1-CCC-HHC36 
(CMLPHHGAC 
GGGKRWWKWWRR) 
49/500 0/1000 
6 2-a.a.-turn cHABP1 (CMLPHHGAC) 85/500 14/1000 
 
Figure 5.4 shows the distinguishing secondary structure features for each of the three peptides. 
Secondary Structure Features 1-3 are unique to HHC-36, while Secondary Structure Features 4 and 5 are 
unique to cHABP1-CCC-HHC36. Secondary Structure Feature 6 is unique to cHABP1.  
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Figure 5.4 Characteristic structures fitting each of the inducted rules in Table 5.2 for HABP-AMP and its 
component domains.  
Peptide Characterization for Mineralization Design  
In this work, a secondary approach for infection-free interfaces is to mineralize the interface from 
calcium and phosphate ion sources. HABP1 was identified as a mineral forming peptide by Tamerler’s 
group.307 Three separate approaches for characterizing the interfacial properties of this peptide in two 
forms are presented compared to a non-mineral forming peptide. The first approach is to characterize 
the secondary structure of the peptide through CD analysis and computational structure generation. The 
second approach is to characterize the distribution of protonation state likelihoods with intrinsic pKa 
analysis. The third approach is to characterize the surface area distribution change due to a hydrophobic 
or a hydrophilic side chain substitution. 
Secondary Structure Characterization of Mineralization Peptide 
The secondary structure folding patterns of HABP1 are characterized, in both linear and constrained 
forms, through experimental measurement and computational structure generation methods. The 
folding patterns serve as design guides to know when peptide structure is changing with spacer 
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engineering for chimeric peptide applications. Figure 5.5 shows the folding characterization with (A) 
referring to the CD spectrum of each of the peptides in Tris buffer at pH 7.4 and (B) referring to the CD 
Pro decomposition of secondary structures as an average of three methods (SELCON, CONTILL, CDSSTR).  
 
Figure 5.5 Structure characterization of linear HABP1, HABP2, constrained HABP1 and constrained HABP2 
through circular dichroism analysis.  
The folding of the peptides near mineral surfaces can be inferred using a kosmotropic (water-ordering) 
agent. In this work, 2,2,2-trifluoroethanl (TFE) was selected.307 The TFE environment results in a more 
ordered secondary structure of linear HABP1, as seen in Figure 5.6. However, changes in TFE 
concentrations for cHABP1 TFE had little effect on its CD spectrum.307 In Figure 5.6, linear HABP1 
changes more in response to changes in TFE than cHABP1. The trend of increasing TFE concentration for 
linear HABP1 shows increasing similarity of secondary structure decomposition to constrained HABP 
(Figure 5.6B). This observation supports that there may be similarities between the folding of HABP1 on 
the mineral surface and the folding of cHABP1 on the mineral surface. 
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Figure 5.6. Solvent engineering study with 2,2,2-trifluoroethanol (TFE) for HABP1. 
Computational Secondary Structure Patterns 
Flexibility is the structural entropy of the peptide ensemble. Secondary structures represent a small 
percentage of possible structural states, and thus are low entropy states. The flexibility of the peptide 
sequences is shown by secondary structure frequencies by residue position.  
In this work, the folding properties of HABP1, HABP2, cHABP1 and cHABP2 are explored through 
computational structure decoy ensembles using the PyRosetta method (Appendix B). These ensembles 
are used to estimate the flexibility of the peptide by estimating the frequencies of structures at a given 
residue position, as seen Figure 5.7 for HABP1 and HABP2 in linear and constrained forms.  
The changes in peptide folding due to the disulfide bond difference between linear and constrained 
forms of HABP1 and HABP2 can be seen in Figure 5.7. The constraint of the disulfide bond and increase 
in peptide length from 7 to 9 amino acids reduces the frequency of right handed residue decoys for 
leucine at residue position 2 and proline at residue position 3 for HABP1 (Figure 5.7A) compared to 
cHABP1 (Figure 5.7B). The constrained HABP2 peptide shows some changes to the dominate orientation 
for P, G and F (Residues 3-5 in cHABP2) compared to linear HABP2. These differentiated secondary 
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structure features provide design targets for study in spacer design within the cHABP1 sequence to tune 
the interactions between the varied geometries of the faces of forming calcium phosphate mineral. 
 
Figure 5.7 Estimation of Flexibility Study by computer-generated structures to estimate folding frequencies 
across the residues of the HABP1 sequences; A) HABP1, B) Constrained HABP1, C) HABP2, D) Constrained 
HABP2. 
Protonation State Distribution of Mineralization Peptide 
The second approach to characterize the mineralization peptide interface is the estimation of the pKa, 
the pH at which the frequency of two adjacent protonation states of a peptide are equal. The estimation 
is the intrinsic pKa which estimates the peptide pKa from a folded structure. This value is calculated using 
Propka 3.1344 as a function of the generated structural ensembles, as seen in Figure 5.8.  
. 
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Figure 5.8 Computational Intrinsic pKa Study to estimate effect of disulfide bond on peptide structure 
between linear peptides (A) HABP1 and (B) HABP2 and constrained peptides (C) cHABP1 and (D) cHABP2. 
The solid black line in Figure 5.8 indicates that the bioenabled mineralization assay occurs at pH 7.4 
which is the normal physiological pH. The dotted lines indicate one or two logarithmic units away from 
the pH of the assay. Species with pKa values within the first dotted line have 10% or more of their 
protonation states changed. The green dotted line are species with deprotonated states at pH 7.4, and 
the red dotted line are species with protonated states. Species between the dotted lines are 1% to 10% 
changed with higher pH values indicating deprotonation. Species outside of the dotted lines have less 
than 1% of the species with a changed protonation state. The terminals of cHABP1 and cHABP2 have 
slightly wider ranges of pKa values compared to HABP1 and HABP2. 
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Surface Area Distribution as a Function of Side Chain Substitution 
The third approach to characterize the mineralization peptide interface is the surface area distribution. 
To determine how the surface area affects the mineralization process, this work calculates the surface 
area changes of linear HABP1 for side chain substitutions. First, an alanine scanning study shows the 
surface area for a substitution of alanine along the peptide sequence in Figure 5.9. The position 
substitution with the maximum hydrophilic surface area was HABP1-M1A. 
 
Figure 5.9. Surface area changes of ensembles of structural decoys due to substitution of alanine at a single 
position.  
Alanine has a hydrophobic side chain. Substituting histidine at each residue position is used to explore 
hydrophilic side chain substitutions as a contrast. Figure 5.10 shows the clustering of surface area by 
sequence mutation. The position substitution with the maximum hydrophilic surface area was HABP1-
A7H.  
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Figure 5.10 Surface area changes of ensembles of structural decoys due to substitution of histidine at a 
single position.  
 
Fast and Slow Mineral-Formation Kinetic Domains in a Single Chimeric Peptide 
A chimeric peptide designed for mineralization control can combine the functions of distinct peptide 
domains. One example is to combine peptides that have slow and fast kinetics to investigate if the 
mineral morphology seen with the slow kinetic peptide can be sped up by the fast-kinetic peptide 
without changing the mineral morphology. Table 5.3 shows the sequences for spacer evaluation and the 
two peptides selected, one for its fast kinetics (ADP1)311 and one for its formed mineral morphology 
(HABP1).307  
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Table 5.3: Initial Spacer Sequences as a Modeling Basis for Spacer Design Method 
Peptide Name Peptide Sequence 
ADP1 HTLQPHHHIPVV 
HABP1 MLPHHGA 
ADP1-Rigid Spacer-HABP HTLQPHHHIPVV PAPAP MLPHHGA 
ADP1-ADP8 Spacer-HABP HTLQPHHHIPVV GPVAPQQPG MLPHHGA 
ADP1-Soluble AH1 Spacer-HABP HTLQPHHHIPVV KGSVLSA MLPHHGA 
ADP1-Soluble AH2 Spacer-HABP HTLQPHHHIPVV PKSALQEL MLPHHGA 
ADP1-Hydrophobic AH1 Spacer-HABP HTLQPHHHIPVV GLALLGWG MLPHHGA 
ADP1-Hydrophobic AH2 Spacer-HABP HTLQPHHHIPVV LGWLSAV MLPHHGA 
ADP1-Pi Helix 1 Spacer-HABP HTLQPHHHIPVV WLMNYFWPL MLPHHGA 
ADP1-Pi Helix 2 Spacer-HABP HTLQPHHHIPVV YLMNYLLPY MLPHHGA 
ADP1-Original Linker-HABP HTLQPHHHIPVV GGG MLPHHGA 
ADP1-Flexible Spacer-HABP HTLQPHHHIPVV GGGSGGG MLPHHGA 
 
Figure 5.11 shows a structural decoy of one of the chimeric peptides. Structure ensembles were built for 
each peptide in Table 5.3 to compare the structural frequencies. The spacer frequency error (SFE) was 
calculated as the sum of the absolute value of the frequency differences between the single domain and 
the same sequence in the chimeric peptide. The SFE results are grouped by functional domain and 
ranked by median SFE. The boxplots represent repetitions of building structural ensembles. Three 
repeats were made for all sequences in Table 5.3.  
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Figure 5.11 Structure decoy of chimeric peptide combining fast mineralization kinetics with octacalcium 
phosphate mineral-forming morphology generated in PyRosetta. 
In Figure 5.12, The feature frequencies are calculated by DSSP and averaged by category (helix, beta 
sheet, turn/bend and right/left orientation). Each category is scaled to level the contribution from each 
category to the error score. The box plots represent repetitions of generating sets of 1,000 
computational structures with the same Robetta fragment files (N=3). 
 
Figure 5.12: Summed error of chimeric peptides compared to ADP1 peptide alone of feature frequencies at 
each residue position.  
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In Figure 5.13, the feature frequencies were calculated by DSSP and averaged by category (helix, beta 
sheet, turn/bend and right/left orientation). Each category was scaled to level the contribution from 
each category to the error score. The box plots represent repetitions of generating sets of 1,000 
computational structures with the same Robetta fragment files (N=3). 
 
Figure 5.13: Summed error of chimeric peptides compared to HABP1 peptide alone of feature frequencies at 
each residue position.  
 Zirconia Surfaces 
For the chimeric antimicrobial peptide concept, changing the surface for antibacterial activity requires 
changing the solid-binding peptide and customizing the spacer for each pairing of a solid binding peptide 
and an antimicrobial peptide. The computer-aided molecular design (CAMD) approach is used for 
designing chimeric peptide spacers for antimicrobial peptides. The forward problem of quantitative 
relationships are structure-function relationships discovered through the MLEM2 method (Figure 2.1).60, 
345 Structure ensembles of 1,000 energy minimized structures are formed for low, medium and high 
antibacterial activity antimicrobial peptides using PyRosetta tools.81, 343 Secondary structure feature rules 
for high antibacterial activity are shown in Table 5.4. The MLEM2 inducted rules in this table were 
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calculated by combining the data tables from which rules in Table 4.2 and Table 5.2 are generated. The 
chimeric peptides are for targeting two surfaces, titanium and calcium phosphate. The antimicrobial 
peptides are AMP1 and AMP2 from Yucesoy et al.6 
Table 5.4. Selected secondary structure feature rules from the MLEM2 method relating to high 
antibacterial activity from data mining structure ensembles. 
Secondary Structure 
Feature Pathogen Antibacterial Activity Ensemble Frequency 
12-a.a.-α helix E. coli High 4.2% 
11-a.a.-α helix E. coli High 3.3% 
5-a.a.-α helix E. coli / S. mutans High 2.2% 
 
As shown in Figure 5.1, the chimeric spacer design process begins with spacer sequences of different 
putative secondary structures. The initial basis is to start with evaluating the structural frequencies of 
different kinds of spacers: flexible, putative π helices, and putative α helices, both hydrophobic and 
hydrophilic. To find chimeric peptides which have high antibacterial activity, the 5-aa α-Helix frequency 
was calculated as a function of spacer sequence. The average among the chimeric peptides with each of 
the two antimicrobial peptide domains, AMP1 (LKLLKKLLKLLKKL) and AMP2 (KWKRWWWWR), and each 
of two zirconia-binding domains, ZrBP (RPRENRGRERF) and ZrBPM1 (RPREQRGRER). These average 
frequencies are in Table 5.5. 
  
107 
 
Table 5.5. 5-a.a. α helix frequencies for the initial generation of chimeric spacers. 
Spacer Sequence 5-aa α-Helix Frequency 
π-Helix 1 Spacer  WLMNYFWPL 5.4% 
π-Helix 2 Spacer YLMNYLLPY 5.0% 
Soluble α-Helix Spacer 2 PKSALQEL 4.3% 
Original Spacer GGG 4.0% 
Flexible Spacer GGGSGGG 3.9% 
Hydrophobic α-Helix Spacer 1 GLALLGWG 3.8% 
Hydrophobic α-Helix Spacer 2 LGVVLSAV 2.5% 
Polyalanine Spacer AAAAAAA 0.1% 
Soluble α-Helix Spacer 1 KGSVLSAD 0.0% 
 
The crossover and mutation operators are applied to the top half of the initial generation to populate 
the second generation. The secondary structure feature frequency was averaged across four separate 
chimeric peptide sequences: ZrBPS1-Spacer-AMP1, ZrBPS1-Spacer-AMP2, ZrBPS2-Spacer-AMP1 and 
ZrBPS2-Spacer-AMP2. The crossover and mutation operators are applied to the top half of the initial 
generation to populate the second generation. The resulting average 5-aa α helix frequencies of three 
second generation spacers is in Table 5.6. A structural decoy with the 5-aa α helix occurrences labeled 
for the IGVVISAV spacer is in Figure 5.14.  
Table 5.6 Second generation of spacers derived from initial generation of spacers in Table 5.5. 
Spacer Sequence 5-aa α Helix Frequency 
L1I & L5I Soluble AH2 IGVVISAV 7.3% 
Soluble AH2 x π Helix 2 KGSVYLLPY 7.1% 
π Helix 1 x Soluble AH2 WLMNLSAD 5.9% 
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Figure 5.14. Structural decoy showing two 5-aa α helices in a chimeric peptide (ZrBP-IGVVISAV-AMP1) with a 
second-generation spacer domain (IGVVISAV). 
 Urethane Polymer Surfaces 
This case study seeks to design a chimeric antimicrobial peptide for a urethane polymer surface.346 The 
secondary structure features as a function of residue position are shown for a solid binding peptide, 
PUABP1 (GRAVRRSIRRRV),347 and antimicrobial peptide AMP1 (LKLLKKLLKLLKKL), and a chimeric peptide 
PUABP1-GSGGG-AMP1 in Figures 5.15-5.17. PUABP1-GSGGG-AMP1 (GRAVRRSIRRRV GSGGG 
LKLLKKLLKLLKKL) is designed as a chimeric antimicrobial peptide to coat urethane polymeric materials 
with antimicrobial activity. The structures are generated according to the PyRosetta method (4.3.1) and 
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analyzed according to the position-specific secondary structure method (5.3.2).
 
Figure 5.15. Secondary structure feature frequency by residue position of PUABP1. 
 
Figure 5.16 Secondary structure feature frequency by residue position of AMP1. 
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Figure 5.17 Secondary structure feature frequency by residue position of PUABP1-GSGGG-AMP1. 
The spacer design scheme for preserving as much of the predicted secondary structure as possible 
minimizes the differences between the predictions of the chimeric peptide domain and the single 
domain. The Manhattan distance was used to define the differences between the individual domain 
frequencies and the chimeric domain as the spacer frequency error (SFE), which is defined in Equation 
5.1 in Section 5.3.2. 
SFE is calculated by feature category (helical features, beta sheet features, bends and turns, and 
left/right orientation). These features are normalized and the summed to calculate the overall spacer 
frequency error as described in Section 5.3.2. These calculations are plotted for repetitions of structure 
generations of 1,000 decoys Figure 5.19-5.20). The solid binding peptide candidates PUABP1 and 
PUABP2 both have GSGGG as a highly ranked spacer for either antimicrobial peptide tested. GSGGG is 
the top spacer for both antimicrobial peptides for PUABP1 and for the top spacer for PUABP2 and AMPa. 
The top scoring spacer for PUABP2 and AMP1 was Soluble Alpha Helix 1 (KGSVLSAD). These rankings 
may be further improved by reducing the variation of SFE estimates by incorporating more structure 
decoy sets or by incorporation of larger structure decoy sets whose statistical frequencies of secondary 
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structures converge. The wide boxplot bars in Figures 5.18-5.19 have estimates of SFE that vary enough 
to lead to uncertainty into the proper ranking of the spacers because of the overlapping boxplot ranges. 
In Figure 5.18, the chimeric peptides are ranked by the median SFE. The box plots are repetitions of the 
SFE, created by generating 1,000 structure decoys and generating the secondary structure frequencies 
(N=6). PUABP1 (GRAVRRSIRRRV) and PUABP2 (AIRGIRGIRGIR) are the candidate solid-binding peptide 
domains. AMP1 (LKLLKKLLKLLKKL) and AMPa (KWKLWKKIEKWGQGIGAVLKWLTTWL) are the candidate 
antimicrobial peptide domains. 
 
Figure 5.18 Spacer frequency error (SFE) for selected chimeric peptides with AMPa 
(KWKLWKKIEKWGQGIGAVLKWLTTWL).  
In Figure 5.19, the chimeric peptides are ranked by the median SFE. The box plots are repetitions of the 
SFE by generating 1,000 structure decoys and generating the secondary structure frequencies (N=6). 
PUABP1 (GRAVRRSIRRRV) and PUABP2 (AIRGIRGIRGIR) are the candidate solid-binding peptide domains. 
AMP1 (LKLLKKLLKLLKKL) and AMPa (KWKLWKKIEKWGQGIGAVLKWLTTWL) are the candidate 
antimicrobial peptide domains. 
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Figure 5.19 Spacer frequency error (SFE) for selected chimeric peptides with AMP1 (LKLLKKLLKLLKKL).  
The candidate spacers are ranked according to the preservation of secondary structures in single domain 
sequences compared to the chimeric domain sequences. The spacer frequency error is spacer 
dependent. Future work is needed to determine the number of structure decoy sets or the number of 
structure decoys in a set to get convergence of these frequency calculations.  
 Discussion 
 Calcium Phosphate Surfaces 
In this work, chimeric peptide technology was designed for three different kinds of surfaces: mineral, 
ceramic and polymer. The mineral selected is calcium phosphate. Chimeric antimicrobial peptide designs 
were supplemented with a secondary antibacterial strategy of a formed mineral barrier. Three different 
properties of the mineralization peptides were explored as design targets for chimeric peptide designs.  
Chimeric Antimicrobial Peptide 
The secondary structural features in Table 5.2 can be used to design new chimeric antimicrobial peptide 
spacers that close the gap in activity between HHC-36 and cHABP1-GGG-HHC36 in Table 5.1 using the 
methods described in Chapter 4. As part of closing the gap, secondary structure design structures are 
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found to be helpful in the spacer design in Chapter 4. This work in Chapter 5 discovers the secondary 
structural features to target for chimeric antimicrobial peptides for calcium phosphate surfaces. 
Mineralization Peptide Protonation State Distribution 
Mineralization is a secondary antibacterial barrier approach. The protonation state effects the attraction 
or repulsion of the mineralization peptide to ions and mineral components in the mineral formation 
process. If the pKa of a side chain or terminus changes, the distribution of the protonation state of the 
peptide will change at a stable pH. This change will be larger the closer the pKa value is to the given pH. 
This work calculates the intrinsic pKa distributions of a mineralization peptide due to the variation of 
folding in the structural decoys generated. This work has provided protonation state distributions for 
which to target chimeric peptide design. 
The shielding effect of larger peptide sequences may provide new trends in the intrinsic pKa values. For 
these short peptides, no interior is shielded from solvent; the entire peptide sequence is the exterior 
surface. For larger peptides with interior ionizable amino acids, larger variations of intrinsic pKa values 
are expected. Large variations of pKa values have been measured in many proteins, including 
Staphylococcal Nuclease.348 
Mineralization Peptide Surface Area Distribution by Substitution 
The surface area distribution of a mineralization peptide is compared to mutants which either have a 
hydrophobic residue substitution of alanine or a hydrophilic residue substitution with histidine. The 
mutant with the largest hydrophobic surface area was HABP1-M1A, and the mutant with the maximum 
hydrophilic surface area was HABP1-A7H. 
Slow and Fast Mineralization Kinetics in a Chimeric Peptide 
Different mineralization mechanisms are designed to be combined by adding together slow and fast 
mineralization kinetics in a single chimeric peptide. Amelogenin has demonstrated that this target is 
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achievable. The chimeric peptide combines an amelogenin subsequence ADP1 with fast mineralization 
kinetics with the slow-formation kinetics of HABP1 selected from combinatorial biology protocols. To 
maintain the original folding of both domains with in the chimeric peptide, SFE was calculated. Low SFE 
values indicate secondary structure features that closely match the secondary structure features in the 
single mineralization peptide. This work estimates the SFE to provide guidance in ranking candidate 
spacers. The results of the spacer error rankings do not agree between domains in that the same spacer 
did not result in the minimum error for both domains. 
 Zirconia Surfaces 
Chimeric antimicrobial peptides are designed with novel spacers through the genetic algorithm 
approach in Figure 5.1. The design targets for the secondary structure feature were calculated from 
combining the data bales of titanium and calcium phosphate chimeric antimicrobial peptides. The initial 
generation of spacers were selected for variety of secondary structures. Some of these initial spacers 
increased the targeted secondary structures compared to the GGG spacer. A second generation of 
spacers were formed through recombination operators of mutation and crossover to produce a spacer 
which improved on the initial generation for the targeted secondary structure. 
 Urethane Polymer Surfaces 
Chimeric antimicrobial peptides are designed for polyurethane acrylic surfaces with a new approach to 
describing structural features. A limitation of the previous approach in Chapter 4.3.2 was to count 
structure features independent of where they occurred along the chimeric sequence. The secondary 
structures with a specific side chain type at a specific residue position would not be separated from the 
same structure at a different residue position. New types of structure-function relationships can be 
investigated by accounting for the positions of the secondary structure within the sequence. The 
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position-based secondary structure feature differences are summarized by the SFE. An initial generation 
of spacers were evaluated according to the SFE. 
This work has shown two methods of using structure-function relationships to design spacer sequences 
between peptide domains. The first method uses the existence of secondary structure of a specific 
length and the second method uses the existence of a secondary structure feature at a specified 
position within the sequence to determine the structure description. 
 Conclusions 
Despite the design of linking domains in protein and peptides being a long-studied topic in the literature, 
there does not exist a universally applicable method of design for peptide domain interactions. For this 
work, a structure description tool was developed as a customized script (PyRosetta Peptide Folding 
Method, Appendix B) for evaluating structure-function relationships and the effect of the spacer 
sequences of chimeric peptides. This structure generation tool may be combined with data mining 
techniques (CLN-MLEM2, Figure 2.1) and a genetic algorithm search (codon-based genetic algorithm, 
Figure 3.3) to engineer spacers which optimize the frequencies of secondary structure in the connected 
domains of the chimeric peptides. This work explores four different types of materials: metals, minerals, 
ceramics and polymers. The chimeric solid binding peptide concept is a platform technology. 
In Aim 1, a novel method for customizing the design of antimicrobial peptides was developed through 
solving the forward problem of computer-aided molecular design (CAMD) in Chapter 2 and the reverse 
problem of CAMD in Chapter 3. The second aim of this work, in Chapter 4, was to engineer chimeric 
peptides to improve the formation and maintenance of an infection-free interface between titanium 
implant surfaces and the host tissue. In Chapter 5, chimeric antimicrobial peptides were demonstrated 
as a platform technology across calcium phosphate, zirconia and urethane polymer surfaces. In Chapter 
6, this platform was further explored through the integration into a dental adhesive system.  
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 Engineered Antimicrobial Peptide Enhances Dental Adhesive 
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 Introduction 
Due, in part, to aesthetic appeal, dental composites are overtaking amalgam for the repair of posterior 
teeth. However, this transition from amalgam to composite is not without consequences. The clinical 
lifetime of dental composites is a half to a third that of amalgam. The result for dentists is that more 
than half of dental practice time is spent on dental composite repairs and replacements, and the result 
for patients is increasing tooth loss whenever composites are repaired or replaced. The most common 
cause of dental failure are secondary carries due to oral bacteria invading the adhesive/dentin interface. 
Therefore, the interface between the remaining tooth and dental composite is a weak interface.  
In this work, an engineered antibacterial primer adhesive is developed that is hydrophilic to completely 
wet the demineralized dentin layer as part of an integrated dental composite system. While commercial 
dental adhesives with antibacterial properties are available using quaternary amines, toxicity to dental 
tissues and oral bacterial resistance are concerns. These concerns are addressed by coupling an 
antimicrobial peptide, inspired by the many native oral antimicrobial peptides in saliva, to the primer 
adhesive. The folding of the engineered antimicrobial peptide was characterized using a kosmotropic 
agent. The dental adhesive material system developed in this work shows antibacterial activity against S. 
mutans UA159 antimicrobial peptide. This work provides a path to conjugate the antimicrobial peptide 
to the primer adhesive polymer for longer term availability of antimicrobial activity. 
 Background 
Traditionally, direct dental restorations for posterior teeth were made from a silver-tin alloy known as 
dental amalgam. Composite restorations are overtaking amalgam as the most popular material for 
posterior teeth. These restorations are often very stable materials, but they have reduced average 
clinical lifetimes. These reduced lifetimes are due to bacteria degrading the adhesive/dentin interface. 
The current reported longevity for composite restorations is 7.8 years as compared to 12.8 years for 
amalgam.349  
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Clinical data suggest that over half of all dental restorations are replacements for failed restorations.350 
Recurrent caries are the largest contributor (36.5%) followed by restoration loss (19.6%) and unknown 
reason (17.7%).351 While many reviews stress patient factors in the approach to recurrent caries352, 
material engineering can also address the prevention of recurrent caries. Biodegradation by bacteria of 
the adhesive bond interface is considered a critical contributor to secondary loss of adhesion, 
microleakage and decay.353 This interface is the weakest link in the composite restoration.350 Therefore, 
adhesives with antibacterial interfaces should provide protection against bacteria. 
 
 
Figure 6.1 Dental primer adhesive system for antimicrobial barrier to prevent bacterial degradation 
Antimicrobial approaches are being investigated to improve the lifetimes of composite restorations. One 
option is to add metallic ions to build an antibacterial adhesive/dentin interface.354 A limitation of this 
method, as with amalgam, is the reduced aesthetic appearance of the dental restoration. Discoloration 
due to metallic ions may be mistaken for tooth infection or decay. Small amounts of chlorhexidine 
gluconate (CHX) have also been used.355 However, long-term exposure to CHX has known adverse 
effects such as mouth discoloration, mucosal irritation and desquamation of the gums.356 A method of 
more directly targeting the enzymes that S. mutans uses to break down adhesive is to mix in 
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dextranomer microspheres to competitively remove the enzymes.357 While removing the enzyme would 
prolong the life of the adhesive, this approach would also store the enzyme for eventual release. 
Antimicrobial peptides are a nature-inspired approach to antibacterial activity. In the oral environment, 
many different antimicrobial peptides are present.358-360 A recent review has catalogued which 
antimicrobial peptides have been evaluated for use in the oral environment against which pathogens.361 
None of these studies, however, attempted to integrate the antimicrobial peptide into a dental adhesive 
system. A recent study has incorporated nisin, a peptide food preservative, in a dental adhesive mixture 
at 1% without significantly lowering the bond strength of the adhesive.362 At a mixture of 3% or 5% nisin, 
the bond strength was reduced. While inhibition of S. mutans was shown within the material, no zone of 
inhibition surrounding the mixture was observed.  
To address the critical problem of bacterial degradation at the adhesive/dentin interface, a dental 
adhesive system is developed in this work with multiple mechanisms for resisting bacterial degradation 
and inhibiting bacterial growth near the interface.  An amine-functionalized dental adhesive system 
builds on Spencer’s group previous work to address the challenges of the hydration difference between 
the dental adhesive and the demineralized dentin.363-365 The major components in dental adhesives 
include monofunctional monomers, such as 2-hydroxyethylmethacrylate (HEMA), and difunctional 
monomers, such as bisphenol A-glycidyl methacrylate (BisGMA) and triethylene glycol dimethacrylate 
(TEGDMA).366, 367 HEMA is a common component of most dental adhesives, due to its unique solubility in 
both hydrophilic and hydrophobic environments.368 Difunctional monomers are used in adhesive to 
enhance the properties of the polymers to withstand the rigors of the oral environment.369, 370 TEGDMA 
functions as a crosslinker and shows a relatively high degree of conversion.369 Polymers bearing a 
phosphorylcholine group have been studied as biocompatible materials,371-373 and 2-
methacryloyloxyethyl phosphorylcholine (MPC) has been successfully used as a monomer for 
preparation of such biomaterials371, 372, 374-376 and in dental adhesives.377-381 Adding MPC was shown to 
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improve the neutralization performance without the degradation of the adhesive. A secondary strategy 
for including buffering capacity in the dental adhesive is to add a form of lysine, an amino acid with a 
weak base side chain. A commercial food preservative and a natural antimicrobial agent,382, 383 ε-
polylysine is added to the dental adhesive primer formulation. Finally, an engineered derivative of an 
antimicrobial peptide with known activity against S. mutans, GH12 was coupled to the dental adhesive 
system. This work demonstrates that the addition of the ε-polylysine and engineered antimicrobial 
peptide components results in bacterial inhibition near the dental adhesive material. CHX was used as a 
positive control for the bacterial inhibition experiments in this work. Because of the recognized 
limitations of CHX in the mouth, this work develops a dental adhesive system with an antimicrobial 
peptide to provide antibacterial activity. 
 Methods 
 Inhibitory Concentration Assays 
The inhibitory assays were conducted by Sheng-Xue Xie. This work follows the standard broth 
microdilution method, according to the recommendations of the Clinical and Laboratory Standards 
Institute (CLSI).384-386 Briefly, two-fold serial dilutions of compounds are prepared with sterile deionized 
water to achieve concentrations ranging from 2500 to 4.9 μg/ml in a volume of 20.0 μl. After these 
dilutions, 80.0 μl of BHI broth and 100.0 μl of bacterial culture containing 1.0 x 106 CFU/ml are added. 
Thus, each well contains final peptide concentrations ranging from 0.5 to 250 μg/ml in a final volume of 
200 μl and a final bacterial concentration of 5.0 X 105 CFU/ml.  
For control samples for positive antibacterial activity, microwells containing chlorhexidine digluconate 
(CHX) with concentrations ranging from 0.04 to 20 μg/ml were also combined with BHI broth and 
bacterial culture. The blank well contains 20 μl of H2O and 180 μl of medium without cells. The 96-well 
plate is incubated in the presence of 5% CO2 at 37°C overnight. The MIC value is defined as the lowest 
peptide, CHX and ε-polylysine concentration corresponding to total inhibition. The metabolic activity of 
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bacteria is indicated by alamar blue.387 The activity is tracked by conversion of resazurin to the 
fluorescent molecule, resorufin. Upon adding bacteria, the reduction of resazurin produces a bright red 
color. 
 Circular Dichroism 
This method is similar to the CD method previously discussed in Section 5.3.3. The CD spectra are 
recorded with a CD spectrometer (JASCO, J-815) at room temperature, using a 1.0 mm cuvette. Each 
peptide sample was dissolved at 0.2 mg/mL in 10 mM potassium phosphate containing 100 mM 
(NH4)2SO4 (pH 7.4) with and without TFE at -4°C for overnight. CD spectra were acquired from 185 to 300 
nm at a scanning speed of 60 nm/min and were averaged from three runs per each sample. The 
secondary structure Far-UV CD spectra were processed with the tools of CD Pro.340 The mean residue 
ellipticity of each sample was converted to mean residue absorbance. The mean residue absorbance 
was processed with CRDATA.exe to create the input file for SELCON3.exe, CDSSTR.exe and CONTILL.exe. 
For each set of data, the reference set selected was SMP50. The fractions of secondary structure 
(Regular Helix, Distorted Helix, Regular Sheet, Distorted Sheet, Turns and Unordered) were averaged 
over all three CD Pro tools (SELCON3, CDSSTR, and CONTILL). These fractions can be compared to the 
statistical estimates of across residue positions from the computational structure flexibility method. 
 Computational Structure Flexibility 
Ensembles of structure decoys are generated with PyRosetta tools using a script developed for folding 
peptides in Appendix B.6, 293 Briefly, fragments of lengths of 3 and 9 were inserted from a Robetta 
database of structures indexed from the Protein Databank. Side chains were positioned according to the 
Fast Relax Protocol. The percentages of each secondary structure defined in the DSSP program is 
calculated at each peptide residue for each structure decoy. The combined percentages of the ensemble 
123 
 
are compared with the circular dichroism decomposition values from CD Pro tools to determine the 
agreement of feature composition for the entire sequence. 
 Adhesive Disc Preparation 
The dental adhesive discs are synthesized and prepared by Linyong Song. Disc specimens are prepared by 
injecting the resin into a standard aluminum hermetic lid (Tzero®, P/N:901600.901) and covering them 
with a glass cover (22 mm×30 mm, Fisherfinest®) to prevent oxygen exposure. The specimens are light-
cured for 40 s at 23±2 °C with a commercial visible-light-polymerization unit (Spectrum®, Dentsply, 
Milford, DE) at an intensity of 550 mW/cm2. The polymerized disc specimens are stored in the dark at 
23±2 °C for at least 48 h. Then, the disc specimens are prewashed by soaking in water for 5 days to remove 
the unreacted components before antimicrobial testing. The components for the adhesive disc are shown 
in Table 6.1.  
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Table 6.1 Commercial analogue components and ε-Polylysine Primer components. 
Component Commercial Analogue (wt%) ε-Polylysine (wt%) 
HEMA 64 59 
TEGDMA 15 15 
MPC 5 5 
ε-Polylysine / 5 
Water 14 14 
Photo-Initiators 2 2 
Total   100 100 
Photo-Initiators: CQ 0.5 wt%, EDMAB 0.5 wt%, and DPIHP 1.0 wt%. 
After post-curing, each group primer discs were leached out in a large volume of water (250 ml) for 4 
days and monitored by HPLC. The water was changed 3-4 times during the leaching out phase. 
 Antimicrobial Activity Assays of Adhesive Discs with Peptide Coupling  
In-solution antimicrobial activity of peptide-treated resin discs is assessed in this work by Sheng-Xue Xie. 
For these studies, each disc is soaked overnight in 100 µl sterile deionized water, peptide, or CHX 
solution at 4℃. The soaked discs are rinsed 4 times with 100 µl of H2O, with excess H2O on the disc 
surface gently removed by blotting with Kimwipes. Each soaked and rinsed disc are carefully transferred 
to a microwell of a 96-well plate. 20 μl H2O, 80 μl of BHI broth and 100 μl of BHI broth containing 1x106 
CFU/ml S. mutans UA159 cells are added to each well. The final bacterial concentration in each well is 
5.0 X 105 CFU/ml. 385 S. mutans UA159 bacteria without any disc present serves as the positive control 
and the negative control was 20 μl of 63 μg/ml CHX solution instead of H2O. The blank well contains 20 
μl of H2O and 180 μl of media without cells. The 96-well plate is incubated in the presence of 5% CO2 at 
37°C overnight.  
The metabolic activity of bacteria is indicated by alamar blue.387 Samples are incubated for 1-4 hours 
before fluorescence is taken.  
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 Results 
 Inhibitory Concentrations 
To incorporate antimicrobial functionality to the dental adhesive system in this work, an antimicrobial 
peptide with known activity against S. mutans was synthesized and characterized by my colleague 
Sheng-Xue Xie. Table 5.2 shows the GH12 peptide sequence386 and its modifications in this work. In the 
literature, the MIC value of GH12 with an amide at the C-terminus was around 6.7 μg/ml.386  
Table 6.2 Properties of GH12 peptides, modifications and ε-polylysine 
Peptide Sequence S. mutans IC50 (μg/ml) S. mutans MIC (μg/ml) 
GH12 GLLWHLLHHLLH 11.55 31.3 
GH12-M1 K_GGGSG_GLLWHLLHHLLH 17.05 31.3 
GH12-M2 GLLWHLLHHLLH_GSGGG_K 12.75 31.3 
ε-Polylysine (ε-Lysine)n 71.27 125 
 
GH12-M1 is designed with the spacer domain on the N-terminus side of the antimicrobial peptide. 
GH12-M2 is designed with the spacer and a single lysine residue on the C-terminus side. IC50 
concentrations of GH12 and GH12-M2 were 11.55 and 12.75 μg/ml, as seen in Table 6.2. The IC50 
concentration of GH12-M1 was 17.05 μg/ml, an increase compared to GH12.  Due to the lower IC50 
concentration, GH12-M2 was selected for further antibacterial studies with the dental adhesive discs. 
IC50 values of designed peptides, ε-polylysine, and CHX are shown in Figure 6.2.  
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Figure 6.2 Antibacterial activity of CHX, antimicrobial peptides and ε-polylysine. 
 CD Spectra and CD Deconvolution 
TFE was used as a kosmotropic agent to simulate ordered water near the bacterial membrane. The 
circular dichroism spectrum was relatively flat for GH12 without TFE in ammonium sulfate and 
potassium phosphate buffer at pH 7.4, with a negative peak near 230 nm, as shown in Figure 6.3. The CD 
spectrum for GH12-M2 was also relatively flat with a negative peak near 235 nm. Adding 10% TFE 
resulted in flattening the spectra for both peptides while increasing the MRE near 185 nm. Increasing 
the TFE to 20% showed a large difference in the CD spectrum between the peptides. The GH12-M2 
peptide at 20% TFE shows the characteristic large positive peak near 190 nm and negative peaks near 
205 and 225 nm, representative of helical secondary structure formation. The GH12 peptide does not 
show this behavior at 20% TFE, but both peptides show this behavior at 40% TFE and above 
concentrations. 
In Figure 6.3, A) represents the mean residue ellipticity (MRE) of far-UV CD Spectra for GH12 and GH12-
M2 with varying levels of 2,2,2-trifluoroethanol (TFE) and B) represents circular dichroism spectra 
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deconvolution through CD Pro analysis. The percentages given in the figure indicate the amount of TFE 
in the solution. 
 
Figure 6.3 Secondary structure characterization by circular dichroism of GH12 and GH12-M2. 
With no TFE present, GH12 and GH12-M2 have similar secondary structure fractions. The regular helix 
structure is slightly larger (3% vs 0%) for the GH12 peptide. With 10% TFE in the buffer solution, the 
result is a similar distribution of secondary structure fractions with the GH12 reducing the regular helix 
so that all the categories are within 1%-2%. At 20% TFE, a large difference between the secondary 
structure fractions for GH12 and GH12-M2 was observed in the original CD spectra results. GH12-M2 
has much more regular helix and distorted helix (38%) than GH12 (4%). The regular sheet and distorted 
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sheet are higher for GH12 (44%) versus GH12-M2 (15%). At high TFE concentrations (>20%), the two 
peptides stabilize in the fractions of their CD deconvolution. GH12 has a larger turn fraction (21%-23%) 
and smaller helix fraction (37%-38%) than GH12-M2 for turns (16%-17%) and helix fraction (42%-43%).  
 Computational Structure Flexibility 
In this work, secondary structures of peptide sequences are predicted when generating structure decoys 
through PyRosetta. In Figure 6.4, the GH12 lowest energy score structure decoy generated via the 
PyRosetta method is shown in A. GH12 flexibility analysis of percentages of secondary structures 
occurring in the PyRosetta-generated decoys by residue calculated by DSSP is shown in B. GH12-M2 
lowest energy structure is shown in C. GH12-M2 flexibility analysis of secondary structure of decoys by 
residue using PyRosetta and DSSP are shown in D.  The green ribbon indicates the GH12 residues, and 
the purple ribbon indicates the modification for GH12-M2. Figure 6.4C shows a helix in the polypeptide 
backbone ribbon for the lowest energy score decoy. The distribution of secondary structure features as 
a function of sequence residue for GH12 is shown in Figure 6.4A. Darker colors denote higher 
frequencies of the feature labeled at the right-hand side. The residue positions with the highest 
occurrence of alpha helix are residues 3-7 (LWHLL). The residues with the highest predicted three-helix 
are residues 3-5 (LWH). The first residue and the last two residues cannot be labeled with secondary 
structure features because the definition of the features used by DSSP uses multiple adjacent residues 
to label structures. Bends (which are not helices) peaked at residues 5, 9 and 10. Turns (which are not 
bends or helices) peaked at residues 2 and 3. The bottom two rows are defined by the direction in which 
the polypeptide backbone rotates. For about 80% of the decoys, the leucine at residue 2 is turned right. 
From residue 3 to 6 about 70% of decoys are turned right, while for residues 7-10 about 60% of the 
decoys are turned right. 
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Figure 6.4 Analysis of secondary structure features predicted through PyRosetta method and quantified 
through DSSP. 
Figure 6.4B shows the lowest energy decoy for GH12-M2. No α-helical secondary structure was 
predicted for this decoy. The M2 spacer (GSGGGK) does induce a change in the flexibility, as seen by 
comparing residues 2-10 from GH12 with residues 2-10 from GH12-M2. Even though no helix is 
predicted in the lowest energy score decoy, a 310-helix is predicted for about 10-20% of decoys for 
residues 2-7. A structure estimation approach that only finds a few low energy structures may have 
missed this secondary structural feature. 
This work investigates the differences in secondary structural features that occur by adding the spacer 
sequence on GH12 resulting in GH12-M2 to understand what feature differences lead to similar 
antibacterial activity for future chimeric peptide design. The percentages of alpha helix drop below 10% 
for any residue of GH12-M2, while the percentages of alpha helix are above 10% for residues 3-7 for 
GH12. Flexibility features of bends are predicted in residues 14 and 16 in about 50% of the decoys. The 
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right and left percentages seem to be like the GH12 percentages, with a 50%/50% split for the spacer 
residues. These noted structural differences lead to no change in the measured MIC values between 
GH12 and GH12-M2 in Table 6.2, and a small change in IC50 values. 
 Antibacterial Activity of Treated Discs 
Coupling the GH12-M2 engineered antimicrobial peptide to the dental adhesive discs built in this work 
showed antibacterial activity against S. mutans UA159 if the ε-polylysine additive was also included, as 
shown in Figure 6.5. The minimum effective initial concentration for the peptide to use with the 
coupling process is between 6.25 and 12.5 times the MIC. Sheng-Xue Xie’s coupling process is to soak 
the disc overnight in a solution of peptide with the indicated concentration. The discs are rinsed with 
water to remove excess solution on the outside of the disc. The discs are incubated with S. mutans 
bacteria to determine viability. 
 With ε-polylysine in the dental adhesive discs and neither GH12-M2 or CHX, no inhibition was detected, 
as shown in Figure 6B for 0x concentration. Without ε-polylysine, the coupling of the GH12-M2 did not 
result in detected antibacterial activity against S. mutans UA159 using an initial concentration of peptide 
that was up to 50 times the measured MIC (data not shown). Adding CHX to the dental primer adhesive 
system resulted in antibacterial activity with or without ε-polylysine. The minimum effective initial 
concentrations of CHX was the same multiplication factor of the MIC as GH12-M2.  
In Figure 6.5A, the schematic of the primer adhesive disc samples starting with a commercial analogue. 
The two test conditions are to add ε-polylysine to the disc formulation or to couple GH12-M2 
antimicrobial peptide by soaking.  When both conditions are met, bacterial inhibition is seen. As a 
positive control for antimicrobial activity, chlorhexidine gluconate was added at a multiple of its 
measured MIC value. In Figure 6.5B, S. mutans UA159 viability is shown based on alamar blue 
conversion for dental adhesive discs using the conditions indicated in Figure 6.5A. 
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Figure 6.5 Inhibitory activity of GH12-M2 with the ε-polylysine added to the disc formulation. 
 Discussion 
An antimicrobial peptide for the oral environment was engineered for the interface of the adhesive and 
the remaining tooth structure. GH12 was selected because of its known activity against S. mutans, a key 
bacterium for dental caries. GH12 was also selected for its lack of lysine to aid the conjugation of the 
antimicrobial peptide to the carboxyl functional group (-COOH) of the primer adhesive. This work shows 
that the antimicrobial peptide can remain active in this environment with an ε-polylysine additive to the 
dental adhesive material. While further study is needed to confirm why the ε-polylysine additive is 
necessary for the antimicrobial peptide to provide inhibition, the most likely reasons the additive plays 
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an essential role in the antimicrobial peptide function is change in hydropathy and the change of 
porosity of the adhesive discs. The adhesive is more hydrophilic and may have larger pore size when ε-
polylysine is present. The antimicrobial peptide must have a concentration near the MIC surrounding 
the adhesive disc to inhibit the growth of bacteria. Since this did not occur without the presence of the 
ε-polylysine, this work concludes that the diffusion of the antimicrobial peptide through the material 
was too limited to see activity. CHX was effective with the same trend with and without ε-polylysine, 
and thus was able to diffuse through the material to reach its MIC surrounding the adhesive disc. This is 
evidence for CHX diffusing more easily than GH12-M2 out of the material. 
The lack of lysine in GH12 allows for the placement of an added lysine at a terminal of the peptide when 
adding a spacer sequence. Thus, the conjugation reaction avoids attaching the monomer to the middle 
of the peptide, likely changing its folding patterns and reducing its activity. The lysine at the terminal is 
attached to the GH12 peptide through the spacer which was shown in Chapter 4 to improve the folding 
of a chimeric titanium antimicrobial peptide.293  
The next design choice was which terminal of the peptide to use, the N-terminal or C-terminal. The 
activity of each of the two peptides was evaluated against S. mutans UA159. The N-terminal 
modification (GH12-M1) has an increased IC50 which shows reduced activity compared to the 
unmodified peptide, as seen in Figure 6.2. The C-terminal modification (GH12-M2) showed a small 
increase in the IC50.  
The difference in flexibility between GH12 and GH12-M2 was evaluated according to the fragment 
insertion method used by PyRosetta to understand structural difference that lead to similar antibacterial 
activity. The decoy generation method is stochastic, and therefore cannot predict if the lowest energy 
structures possible are found. However, the lowest energy structure may differ from the native 
structure.388, 389 The parallel optimization of many decoys at once may also provide insight into the 
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distribution of the ensemble of structures sampled by peptides in solution. Peptides are not static when 
floating in solution, but they are quite dynamic angstrom-to-nanometer scale fuzzy masses constantly in 
motion.334  
The computational folding model and the circular dichroism measurements have conflicting results for 
the buffer-only measurements but agree as the TFE amount in the solution increases. The 
computational folding model predicts helical structures, while the deconvolution of the CD spectra by 
CD Pro predicts mainly beta-sheet structures for buffer-only conditions. However, the deconvolution 
method predicts large increases in the helical structures with increasing amounts of 2,2,2-
trifluoroethanol (TFE) in the solution. TFE is a known kosmotropic agent, increasing the order of the 
water near the surface of biomolecules.390 TFE has long been used in the crystallization of proteins.391, 392 
Therefore, increasing the TFE concentration likely puts the peptide into a more ordered, structured 
state. The computational folding model is biased toward native, ordered structures because it uses 
fragments from experimentally determined structures, often crystallized structures. Therefore, 
fragment-insertion structures generated using these kinds of fragments are more likely to be more 
representative of peptide or protein structures associated with kosmotropic agents such as glucose and 
TFE than with chaotropic agents such as urea and guanidinium chloride. The water near bacterial 
surfaces is likely also highly ordered according to the biomolecules on the bacterial membrane.393 Since 
the structure generation method developed in this work searches portions of the structural space with 
ordered fragments, it provides structures which more likely to be relevant for structure-function 
relationships for how the peptide interacts with the bacterial surface. 
 Conclusion 
An antimicrobial peptide GH12-M2 was engineered from GH12, an antimicrobial peptide with known 
activity against S. mutans, for future conjugation to a dental adhesive to enhance its antibacterial 
properties. This work coupled GH12-M2 to a dental adhesive by a soaking method to evaluate the 
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remaining antibacterial activity. The engineered peptide was structurally characterized to obtain a path 
for structure-function relationships by measuring folding the peptide with a kosmotropic agent through 
circular dichroism and by using a computational structure generation folding method biased toward 
ordered-water states. 
Commercial analogue coupled with the engineered peptide not inhibit against S. mutans UA159 up to an 
initial concentration of 1560 μg/ml (50 times MIC). However, when ε-polylysine was added to the dental 
adhesive as a component, the engineered peptide completely inhibited the growth of S. mutans for 
initial concentrations at or above 390 μg/ml (12.5 times MIC). CHX showed a similar trend inhibiting the 
growth of S. mutans with or without ε-polylysine in the dental adhesive discs. CHX inhibited the growth 
of S. mutans at 7.8 μg/ml (12.5 times MIC). Because CHX has a variety of limitations for oral use, an 
antimicrobial peptide (GH12-M2) is engineered for integrating into a dental adhesive. 
Antimicrobial peptides, such as GH12, can be integrated into dental adhesives at the interface between 
the remaining tooth structure and the composite restoration if the peptides can be engineered to be 
attached to the dental adhesive and remain active. This interface is currently vulnerable to bacterial 
attack, resulting in shorter clinical lifetimes for composite restorations compared to dental amalgam for 
posterior restorations. Chapter 4 provides examples of chimeric peptides which can non-covalently 
attach to titanium surfaces but have reduced activity. Engineering GH12 with principles in Chapters 4 
and 5 is expected to result in an antimicrobial peptide that can attach within the dental adhesive and 
remain active. 
In Aim 1, computer-aided molecular design (CAMD) was used to customize antimicrobial peptides for 
the ease of synthesis. In Chapter 4, chimeric peptides were engineered for infection-free interfaces at 
titanium implant surfaces. Chimeric antimicrobial peptides were shown as a platform across several 
materials in Chapter 5. In this chapter, the coupling of an antimicrobial peptide was achieved in a dental 
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adhesive leading toward conjugating the antimicrobial peptide within the adhesive. Chimeric 
antimicrobial peptides show promise for creating antibacterial interfaces through solid binding peptides 
and through conjugation approaches. 
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 Conclusions and Future Directions 
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Biomimetics, the study of biological systems to advance engineering principles, recognizes that 
biological systems utilize nanoscale interfaces between biomolecules and inorganic materials. The 
structure of biologically-made materials results from orientation control at multiple scales to form 
nanometer-sized minerals with many levels of hierarchical structure to form bone. In current synthetic 
materials engineering, high energy costs are required to form materials through melting, such as glass, 
because of the lack of orientation control, such as in the protein-mediated formation of silicon dioxide 
spicules in siliceous sponges. In medicine, drugs are often delivered systemically when the active agent 
is meant for targeted areas, such as in preventing medical implant infections. This project advances the 
engineered interfaces between active peptides and inorganic materials through building computational 
analysis tools to understand sequence-function and structure-function relationships to aid in novel 
peptide design. 
The first tool built for this work was a classification method to distinguish active and inactive peptides 
based on physicochemical boundaries, CLN-MLEM2. This tool is built using the principles of rough set 
theory. This novel extension combines the polynomial worst-case run time of MLEM2 with the feature 
number limit of the IRIM method. Comparing to other antimicrobial peptide classification methods, CLN-
MLEM2 achieves good selectivity and state-of-the-art specificity. This supervised learning method may 
be used on other molecule types besides peptides, such as polymers and small molecule drugs.   
Because a set theory approach was used in this work to describe antibacterial activity, selective targets 
of antibacterial activity can be expressed through the grouping of antibacterial activity labels against one 
bacterial species and inactivity against another bacterial species. For example, if different sets of 
antimicrobial peptides are effective against E. coli than S. mutans, such as the bacteriocins these 
bacteria produce, then the CLN-MLEM2 method can make boundaries to customize new antimicrobial 
peptides that are selectively active against either E. coli or S. mutans. As a future direction, the 
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selectivity approach allows engineering bacterial environments into balanced systems among bacterial 
strains. 
This work has not exhausted the peptide functionalities that can be explored with this approach. In the 
future, many other different sequence-function relationships can be discovered. A speed improvement 
of CLN-MLEM2 is to compute the maximum relevance condition in parallel when multiple cores are 
available.  Using the current implementation in Python 2.7, many different parallelization packages, like 
pp (parallelpython.com), can be implemented starting with the code produced for this work. 
The next tool built for this work was a codon-based genetic algorithm method to create new sequences 
that fit the classification boundaries identified with the rough set theory tool also developed for this 
work. The codon-based genetic algorithm is a single-objective optimization that addresses multiple 
target properties simultaneously. While this genetic algorithm did not find peptide sequences that met 
all design targets, the algorithm was effective at finding customized antimicrobial peptides with 
detectable activity against S. epidermidis that were closer to the design targets than any sequence in the 
initial generation. The genetic algorithm was necessary to find the solutions in this work because in the 
first trial, the output peptides with seven residues had little sequence similarity with the most fit 
sequence in the original generation. In the second trial, the output peptides had higher sequence 
similarity, but only half of the fourteen residues were conserved. For seven non-conserved residues with 
twenty possible amino acids each from either trial, there are  ∑ 20 = 1.35 x 109 possible sequences, 
if the residues may also be deleted from the sequence. If which amino acids are conserved is not known, 
there are 3,432 ways to choose 7 out of 14 amino acids, making the number of possibilities 4.62 x 1012. If 
how many residues to conserve is not known before hand, there are ∑ 20 = 1.72 x 1018 possible 
sequences. Enumerating 1018 sequences, i.e. a million-billion sequences, is infeasible. This analysis also 
ignores non-canonical amino acids. The target lengths of seven to fifteen amino acids used in Chapter 3 
are short sequence examples for peptide design. Longer sequences up to around 50 amino acids 
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exponentially increase the number of sequences to consider. Peptide design space is too large to 
enumerate. Metaheuristic approaches, like genetic algorithms are a good fit for this design space. 
In future work, more parameter optimization is considered. The selection rate has currently been tested 
between 10% to 25% of the population of each generation. The number of the sequences in each 
generation is not further capped. To reduce the computation time of the genetic algorithm, only unique 
sequences are selected for new generations. The fitness of the sequence is accounted for in the 
probability of being selected by a recombination operator. To avoid losing fit sequences, sequences 
from the previous generation are considered for selection along with the newly generated sequences. 
The increased presence of highly fit sequence is incorporated by using recombination operators to select 
more fit sequences more often. Mutation rates of up to 50% and crossover rates up to 30% have been 
explored. The codon-based representation is another technique used to improve the genetic diversity of 
the solutions considered by the genetic algorithm, which was confirmed to improve the diversity of the 
solutions in Figure 3.6. 
Other metaheuristic methods besides genetic algorithms may also be considered in future work. Tabu 
search could be implemented with an edit distance function to avoid generating repetitive solutions. 
Other metaheuristics based on natural metaphors have had some success such as ant colony, particle 
swarm optimization, and directed evolutionary algorithms. Physics-based metaphors include simulated 
annealing, stochastic fractal search and other non-linear physics approaches.  
Further development of codon-based genetic algorithm would be to incorporate other recombination 
operators based on genetics concepts, from such as allele dominance and chromosome translocation. 
These concepts will give new insight of how to make efficient, large changes in sequences while 
converging to solutions quickly. Evolutionary biology has demonstrated many adaptations of protein and 
peptide sequences for new purposes. A recent study has shown how apply concept of B-cell evolution in 
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adaptive immunity to understanding how to direct the evolution of functional sequences.394 
Understanding the mechanisms of nucleic acid sequence evolution will lead to more informed peptide 
and protein design approaches.  
Finally, a peptide structure generation script was built for this work by incorporating algorithms from 
PyRosetta. This integrates with the rough set theory tool to form a method for generating relevant 
features to discover structure-function relationships. The peptide folding tool built using PyRosetta gives 
insight into the thermodynamic likelihood of peptide folded structures. This method is biased toward 
generating ordered structures, which occur more often when kosmotropic agents are present or at 
certain kinds of material interfaces. In Chapter 4, the chimeric peptide folding change due to the spacer 
sequence showed that this structure generation method is a useful approach for peptide spacer design. 
In future work, combining the peptide folding tool with coarse-folding models can enable the improved 
prediction of larger peptide sequences. Another future direction for this structure generation method 
would be to validate the folding predictions through empirical information from NMR, X-ray 
crystallography, CD and other structure determination tools. 
This work has begun applying the above tools to the design of an antimicrobial peptide for integration 
into a dental adhesive. It has demonstrated the successful integration of an antimicrobial peptide, 
coupled within the dental adhesive. This integration is a novel approach for the development of dental 
adhesives because it provides inhibitory activity near the dental adhesive without discoloration effects. 
The appearance of infection is difficult to distinguish from discoloration. To further develop this 
approach, one could design spacers for antimicrobial peptides conjugated with polymers, using the 
approaches discussed in Chapters 4 and 5. A genetic algorithm approach to spacer design for 
antimicrobial peptides would be evaluated without a secondary domain. The candidate spacers with the 
minimum spacer frequency error could be evaluated for antibacterial activity and compared to the 
antimicrobial peptide alone. 
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The structure-function relationships present in biological systems provide clear evidence that peptides 
and proteins can have well-integrated interfaces with inorganic materials. Hard tissues, such as bones 
and teeth, are organ-level examples. As the field at the intersection of molecular biology and materials 
science becomes increasingly able to characterize and to understand how peptides can build novel 
interfaces for engineering materials, a path can be built toward artificial hierarchical structures with 
integrated interfaces at multiple levels.
143 
 
 
 
 
 
 
 
 
 
 References 
  
144 
 
1. Anderson DJ, Podgorny K, Berríos-Torres SI, Bratzler DW, Dellinger EP, Greene L, Nyquist A-C, 
Saiman L, Yokoe DS, Maragakis LL. Strategies to prevent surgical site infections in acute care hospitals: 
2014 update. Infection Control & Hospital Epidemiology. 2014;35(06) 
2. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee 
arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89(4) 
3. Anuforom O, Wallace GR, Piddock LV. The immune response and antibacterial therapy. Med 
Microbiol Immunol. 2015;204(2) 
4. Yang JH, Bhargava P, Mccloskey D, Mao N, Palsson BO, Collins JJ. Antibiotic-induced changes to 
the host metabolic environment inhibit drug efficacy and alter immune function. Cell Host & Microbe. 
2017;22(6) 
5. Yazici H, O'neill MB, Kacar T, Wilson BR, Oren EE, Sarikaya M, Tamerler C. Engineered chimeric 
peptides as antimicrobial surface coating agents toward infection-free implants. ACS Appl Mater 
Interfaces. 2016;8(8) 
6. Yucesoy DT, Hnilova M, Boone K, Arnold PM, Snead ML, Tamerler C. Chimeric peptides as 
implant functionalization agents for titanium alloy implants with antimicrobial properties. JOM. 
2015;67(4) 
7. Roux D, Danilchanka O, Guillard T, Cattoir V, Aschard H, Fu Y, Angoulvant F, Messika J, Ricard JD, 
Mekalanos JJ, Lory S, Pier GB, Skurnik D. Fitness cost of antibiotic susceptibility during bacterial 
infection. Sci Transl Med. 2015;7(297) 
8. Hawkey PM. Multidrug-resistant Gram-negative bacteria: a product of globalization. J Hosp 
Infect. 2015;89(4) 
9. Ayhan DH, Tamer YT, Akbar M, Greenberg DE, Toprak E. A synthetic knob for modulating 
antibiotic resistance. Biophys J. 2016;110(3) 
10. Porto WF, Pires AS, Franco OL. Computational tools for exploring sequence databases as a 
resource for antimicrobial peptides. Biotechnol Adv. 2017;35(3) 
11. Chernysh S, Gordya N, Suborova T. Insect antimicrobial peptide complexes prevent resistance 
development in bacteria. PLoS One. 2015;10(7) 
12. Veltri D, Kamath U, Shehu A. Improving recognition of antimicrobial peptides and target 
selectivity through machine learning and genetic programming. IEEE/ACM Trans Comput Biol Bioinform. 
2017;14(2) 
13. Peschel A, Sahl HG. The co-evolution of host cationic antimicrobial peptides and microbial 
resistance. Nat Rev Microbiol. 2006;4(7) 
14. Li LL, Qi GB, Yu F, Liu SJ, Wang H. An adaptive biointerface from self-assembled functional 
peptides for tissue engineering. Adv Mater. 2015;27(20) 
15. Mccloskey AP, Gilmore BF, Laverty G. Evolution of antimicrobial peptides to self-assembled 
peptides for biomaterial applications. Pathogens. 2014;3(4) 
16. Chen R, Willcox MD, Ho KK, Smyth D, Kumar N. Antimicrobial peptide melimine coating for 
titanium and its in vivo antibacterial activity in rodent subcutaneous infection models. Biomaterials. 
2016;85 
17. Ozcelik B, Chen R, Glattauer V, Kumar N, Willcox MP, Thissen H. Crosslinked platform coatings 
incorporating bioactive signals for the control of biointerfacial interactions. Macromol Biosci. 2017;17(4) 
18. Yu K, Lo JC, Yan M, Yang X, Brooks DE, Hancock RE, Lange D, Kizhakkedathu JN. Anti-adhesive 
antimicrobial peptide coating prevents catheter associated infection in a mouse urinary infection model. 
Biomaterials. 2017;116 
19. Raphel J, Holodniy M, Goodman SB, Heilshorn SC. Multifunctional coatings to simultaneously 
promote osseointegration and prevent infection of orthopaedic implants. Biomaterials. 2016;84 
20. Bosco R, Van Den Beucken J, Leeuwenburgh S, Jansen J. Surface engineering for bone implants: 
A trend from passive to active surfaces. Coatings. 2012;2(3) 
145 
 
21. Nejadnik MR, Yang X, Bongio M, Alghamdi HS, Van Den Beucken JJ, Huysmans MC, Jansen JA, 
Hilborn J, Ossipov D, Leeuwenburgh SC. Self-healing hybrid nanocomposites consisting of 
bisphosphonated hyaluronan and calcium phosphate nanoparticles. Biomaterials. 2014;35(25) 
22. Heinz H, Pramanik C, Heinz O, Ding Y, Mishra RK, Marchon D, Flatt RJ, Estrela-Lopis I, Llop J, 
Moya S, Ziolo RF. Nanoparticle decoration with surfactants: Molecular interactions, assembly, and 
applications. Surface Science Reports. 2017 
23. Gimenez-Marques M, Hidalgo T, Serre C, Horcajada P. Nanostructured metal-organic 
frameworks and their bio-related applications. Coordination Chem Rev. 2016;307 
24. Yang X, Yang M, Pang B, Vara M, Xia Y. Gold nanomaterials at work in biomedicine. Chem Rev. 
2015;115(19) 
25. Wang Q, Wei S, Wu J, Zou X, Sieggreen O, Liu Y, Xi C, Brooks CL, Chen Z. Interfacial behaviors of 
antimicrobial peptide Cecropin P1 immobilized on different self-assembled monolayers. The Journal of 
Physical Chemistry C. 2015;119(39) 
26. Costa F, Carvalho IF, Montelaro RC, Gomes P, Martins MC. Covalent immobilization of 
antimicrobial peptides (AMPs) onto biomaterial surfaces. Acta Biomater. 2011;7(4) 
27. Simchi A, Tamjid E, Pishbin F, Boccaccini AR. Recent progress in inorganic and composite 
coatings with bactericidal capability for orthopaedic applications. Nanomedicine. 2011;7(1) 
28. Popat KC, Eltgroth M, Latempa TJ, Grimes CA, Desai TA. Titania nanotubes: a novel platform for 
drug-eluting coatings for medical implants? Small. 2007;3(11) 
29. Ma M, Kazemzadeh-Narbat M, Hui Y, Lu S, Ding C, Chen DD, Hancock RE, Wang R. Local delivery 
of antimicrobial peptides using self-organized TiO2 nanotube arrays for peri-implant infections. J Biomed 
Mater Res A. 2012;100(2) 
30. Sarikaya M, Tamerler C, Schwartz DT, Baneyx F. Materials assembly and formation using 
engineered polypeptides. Annual Review of Materials Research. 2004;34(1) 
31. Tamerler C, Khatayevich D, Gungormus M, Kacar T, Oren EE, Hnilova M, Sarikaya M. Molecular 
biomimetics: GEPI-based biological routes to technology. Biopolymers. 2010;94(1) 
32. Sarikaya M, Tamerler C, Jen AKY, Schulten K, Baneyx F. Molecular biomimetics: nanotechnology 
through biology. Nat Mater. 2003;2(9) 
33. Care A, Bergquist PL, Sunna A. Solid-binding peptides: smart tools for nanobiotechnology. 
Trends Biotechnol. 2015;33(5) 
34. Seker UO, Wilson B, Kulp JL, Evans JS, Tamerler C, Sarikaya M. Thermodynamics of engineered 
gold binding peptides: establishing the structure-activity relationships. Biomacromolecules. 2014;15(7) 
35. Corni S, Hnilova M, Tamerler C, Sarikaya M. Conformational behavior of genetically-engineered 
dodecapeptides as a determinant of binding affinity for gold. Journal of Physical Chemistry C. 
2013;117(33) 
36. Oren EE, Notman R, Kim IW, Evans JS, Walsh TR, Samudrala R, Tamerler C, Sarikaya M. Probing 
the molecular mechanisms of quartz-binding peptides. Langmuir. 2010;26(13) 
37. Notman R, Oren EE, Tamerler C, Sarikaya M, Samudrala R, Walsh TR. Solution study of 
engineered quartz binding peptides using replica exchange molecular dynamics. Biomacromolecules. 
2010;11 
38. Oren EE, Tamerler C, Sahin D, Hnilova M, Seker UO, Sarikaya M, Samudrala R. A novel 
knowledge-based approach to design inorganic-binding peptides. Bioinformatics. 2007;23(21) 
39. Adams BL, Finch AS, Hurley MM, Sarkes DA, Stratis-Cullum DN. Genetically engineered peptides 
for inorganics: study of an unconstrained bacterial display technology and bulk aluminum alloy. Adv 
Mater. 2013;25(33) 
40. Briggs BD, Knecht MR. Nanotechnology meets biology: Peptide-based methods for the 
fabrication of functional materials. Journal of Physical Chemistry Letters. 2012;3(3) 
146 
 
41. Zhou Y, Snead ML, Tamerler C. Bio-inspired hard-to-soft interface for implant integration to 
bone. Nanomedicine. 2015;11(2) 
42. Hassert R, Beck-Sickinger AG. Tuning peptide affinity for biofunctionalized surfaces. Eur J Pharm 
Biopharm. 2013;85(1) 
43. Salou L, Hoornaert A, Louarn G, Layrolle P. Enhanced osseointegration of titanium implants with 
nanostructured surfaces: An experimental study in rabbits. Acta Biomater. 2015;11 
44. Philippart A, Boccaccini AR, Fleck C, Schubert DW, Roether JA. Toughening and functionalization 
of bioactive ceramic and glass bone scaffolds by biopolymer coatings and infiltration: A review of the 
last 5 years. Expert Rev Med Devices. 2015;12(1) 
45. Jiang S, Pan H, Chen Y, Xu X, Tang R. Amorphous calcium phosphate phase-mediated crystal 
nucleation kinetics and pathway. Faraday Discuss. 2015;179(0) 
46. Santander S, Alcaine C, Lyahyai J, Perez MA, Rodellar C, Doblare M, Ochoa I. In vitro 
osteoinduction of human mesenchymal stem cells in biomimetic surface modified titanium alloy 
implants. Dent Mater J. 2014;33(3) 
47. Surmenev RA, Surmeneva MA, Ivanova AA. Significance of calcium phosphate coatings for the 
enhancement of new bone osteogenesis--A review. Acta Biomater. 2014;10(2) 
48. Yazici H, Fong H, Wilson B, Oren EE, Amos FA, Zhang H, Evans JS, Snead ML, Sarikaya M, 
Tamerler C. Biological response on a titanium implant-grade surface functionalized with modular 
peptides. Acta Biomater. 2013;9(2) 
49. Tamerler C, Sarikaya M. Genetically designed peptide-based molecular materials. ACS Nano. 
2009;3(7) 
50. Sarikaya M, Tamerler C. Biohesion: Coupling synthetic and biological entities using genetically 
engineered peptides. Abstracts of Papers of the American Chemical Society. 2009;237 
51. Kacar T, Ray J, Gungormus M, Oren EE, Tamerler C, Sarikaya M. Quartz binding peptides as 
molecular linkers for co-assembling nanoentities on multifunctional micropatterned substrates. 
Abstracts of Papers of the American Chemical Society. 2009;237 
52. Zimmerman JM, Eliezer N, Simha R. The characterization of amino acid sequences in proteins by 
statistical methods. J Theor Biol. 1968;21(2) 
53. Dawson D, Brock D, Mayo O. The biochemical genetics of man. Brock, DJH, Mayo, O(eds). 1972 
54. Garel JP, Filliol D, Mandel P. Partition coefficients of amino acids, nucleobases, nucleosides and 
nucleotides in a saline solvent system. J Chromatogr. 1973;78(2) 
55. Renfrew PD, Choi EJ, Bonneau R, Kuhlman B. Incorporation of noncanonical amino acids into 
Rosetta and use in computational protein-peptide interface design. PLoS One. 2012;7(3) 
56. Ullman JD. NP-complete scheduling problems. Journal of Computer and System sciences. 
1975;10(3) 
57. Cocco S, Monasson R. Trajectories in phase diagrams, growth processes, and computational 
complexity: How search algorithms solve the 3-satisfiability problem. Physical review letters. 2001;86(8) 
58. Thangavel K, Pethalakshmi A. Dimensionality reduction based on rough set theory: A review. 
Applied Soft Computing. 2009;9(1) 
59. Yao Y, Wong SM, Lin TY. A review of rough set models.  Rough sets and data mining: Springer; 
1997. 
60. Grzymala-Busse JW, Rzasa W. A local version of the MLEM2 algorithm for rule induction. 
Fundamenta Informaticae. 2010;100(1-4) 
61. Swiniarski RW, Skowron A. Rough set methods in feature selection and recognition. Pattern 
Recognition Letters. 2003;24(6) 
62. Lindsey TS. Interesting rule induction module: Adding support for unknown attribute values: 
University of Kansas; 2016. 
147 
 
63. Lata S, Mishra NK, Raghava GP. AntiBP2: improved version of antibacterial peptide prediction. 
BMC Bioinformatics. 2010;11 Suppl 1(1) 
64. Loose C, Jensen K, Rigoutsos I, Stephanopoulos G. A linguistic model for the rational design of 
antimicrobial peptides. Nature. 2006;443(7113) 
65. Thomas S, Karnik S, Barai RS, Jayaraman VK, Idicula-Thomas S. CAMP: A useful resource for 
research on antimicrobial peptides. Nucleic Acids Res. 2010;38(Database issue) 
66. Waghu FH, Gopi L, Barai RS, Ramteke P, Nizami B, Idicula-Thomas S. CAMP: Collection of 
sequences and structures of antimicrobial peptides. Nucleic Acids Res. 2014;42(Database issue) 
67. Xiao X, Wang P, Lin W-Z, Jia J-H, Chou K-C. iAMP-2L: A two-level multi-label classifier for 
identifying antimicrobial peptides and their functional types. Anal Biochem. 2013;436(2) 
68. Veltri D, Kamath U, Shehu A, editors. A novel method to improve recognition of antimicrobial 
peptides through distal sequence-based features. IEEE International Conference on Bioinformatics and 
Biomedicine; 2014 2-5 Nov. 2014. 
69. Mitchell AR. Bruce Merrifield and solid-phase peptide synthesis: A historical assessment. 
Biopolymers. 2008;90(3) 
70. Fink J, Merrifield RB, Boman A, Boman HG. The chemical synthesis of Cecropin D and an analog 
with enhanced antibacterial activity. Journal of Biological Chemistry. 1989;264(11) 
71. Andreu D, Merrifield RB, Steiner H, Boman HG. Solid-phase synthesis of Cecropin A and related 
peptides. Proc Natl Acad Sci U S A. 1983;80(21) 
72. Merrifield RB, Vizioli LD, Boman HG. Synthesis of the antibacterial peptide Cecropin A (1-33). 
Biochemistry. 1982;21(20) 
73. Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, 
Galdiero M, Galdiero S. Structural insights into and activity analysis of the antimicrobial peptide 
myxinidin. Antimicrob Agents Chemother. 2014;58(9) 
74. Hansch C, Fujita T. Rho-Sigma-Pi analysis, method for correlation of biological activity and 
chemical structure. J Am Chem Soc. 1964;86(8) 
75. Cherkasov A, Muratov EN, Fourches D, Varnek A, Baskin, Ii, Cronin M, Dearden J, Gramatica P, 
Martin YC, Todeschini R, Consonni V, Kuz'min VE, Cramer R, Benigni R, Yang C, Rathman J, Terfloth L, 
Gasteiger J, Richard A, Tropsha A. QSAR modeling: where have you been? Where are you going to? J 
Med Chem. 2014;57(12) 
76. Gani R, Nielsen B, Fredenslund A. A group contribution approach to computer-aided molecular 
design. AIChE Journal. 1991;37(9) 
77. Sundaram A, Venkatasubramanian V. Parametric sensitivity and search-space characterization 
studies of genetic algorithms for computer-aided polymer design. Journal of Chemical Information and 
Computer Sciences. 1998;38(6) 
78. Lin B, Chavali S, Camarda K, Miller DC. Computer-aided molecular design using Tabu search. 
Computers & Chemical Engineering. 2005;29(2) 
79. Boone K, Abedin F, Anwar MR, Camarda KV. Molecular design in the pharmaceutical industries. 
In: Martín M, Eden MR, Chemmangattuvalappil NG, editors. Tools for Chemical Product Design. 
Computer Aided Chemical Engineering. 39: Elsevier; 2016. 
80. Kawashima S, Pokarowski P, Pokarowska M, Kolinski A, Katayama T, Kanehisa M. AAindex: 
amino acid index database, progress report 2008. Nucleic Acids Res. 2008;36(Database issue) 
81. Chaudhury S, Lyskov S, Gray JJ. PyRosetta: A script-based interface for implementing molecular 
modeling algorithms using Rosetta. Bioinformatics. 2010;26(5) 
82. Rios LM, Sahinidis NV. Derivative-free optimization: a review of algorithms and comparison of 
software implementations. Journal of Global Optimization. 2013;56(3) 
83. Dennis J, Torczon V, editors. Derivative-free pattern search methods for multidisciplinary design 
problems. 5th Symposium on Multidisciplinary Analysis and Optimization; 1994. 
148 
 
84. Hooke R, Jeeves TA. ``Direct Search'' solution of numerical and statistical problems. J of ACM. 
1961;8(2) 
85. Nelder JA, Mead R. A Simplex-Method for Function Minimization. Computer Journal. 1965;7(4) 
86. Holland J. Adaptation in natural and artificial systems: an introductory analysis with application 
to biology. Control and artificial intelligence. 1975 
87. Kirkpatrick S, Gelatt CD, Jr., Vecchi MP. Optimization by simulated annealing. Science. 
1983;220(4598) 
88. Glover F, Laguna M. Tabu search.  Handbook of combinatorial optimization: Springer; 1998. 
89. Fjell CD, Jenssen H, Cheung WA, Hancock RE, Cherkasov A. Optimization of antibacterial 
peptides by genetic algorithms and cheminformatics. Chem Biol Drug Des. 2011;77(1) 
90. Eiben AE, Hinterding R, Michalewicz Z. Parameter control in evolutionary algorithms. Ieee 
Transactions on Evolutionary Computation. 1999;3(2) 
91. Jones G, Willett P, Glen RC, Leach AR, Taylor R. Development and validation of a genetic 
algorithm for flexible docking. J Mol Biol. 1997;267(3) 
92. Lazar GA, Desjarlais JR, Handel TM. De novo design of the hydrophobic core of ubiquitin. Protein 
Science. 1997;6(6) 
93. Krivov GG, Shapovalov MV, Dunbrack RL, Jr. Improved prediction of protein side-chain 
conformations with SCWRL4. Proteins. 2009;77(4) 
94. Desjarlais JR, Handel TM. De novo design of the hydrophobic cores of proteins. Protein Science. 
1995;4(10) 
95. Yeh CT, Brunette TJ, Baker D, Mcintosh-Smith S, Parmeggiani F. Elfin: An algorithm for the 
computational design of custom three-dimensional structures from modular repeat protein building 
blocks. J Struct Biol. 2018;201(2) 
96. Movahedi M, Zare-Mirakabad F, Arab SS. Evaluating the accuracy of protein design using native 
secondary sub-structures. BMC Bioinformatics. 2016;17(1) 
97. Brunk E, Perez MaS, Athri P, Rothlisberger U. Genetic-algorithm-based optimization of a peptidic 
scaffold for sequestration and hydration of CO2. Chemphyschem. 2016;17(23) 
98. Jeschke G. Ensemble models of proteins and protein domains based on distance distribution 
restraints. Proteins. 2016;84(4) 
99. Tompa P, Varadi M. Predicting the predictive power of IDP ensembles. Structure. 2014;22(2) 
100. Luo Y, Ma B, Nussinov R, Wei G. Structural insight into tau protein's paradox of intrinsically 
disordered behavior, self-acetylation activity, and aggregation. Journal of Physical Chemistry Letters. 
2014;5(17) 
101. Uversky VN. Unusual biophysics of intrinsically disordered proteins. Biochim Biophys Acta. 
2013;1834(5) 
102. Levine ZA, Larini L, Lapointe NE, Feinstein SC, Shea JE. Regulation and aggregation of intrinsically 
disordered peptides. Proc Natl Acad Sci U S A. 2015;112(9) 
103. Uversky VN. A protein-chameleon: Conformational plasticity of alpha-synuclein, a disordered 
protein involved in neurodegenerative disorders. J Biomol Struct Dyn. 2003;21(2) 
104. Thévenet P, Rey J, Moroy G, Tuffery P. De novo peptide structure prediction: An overview.  
Computational Peptidology: Springer; 2015. 
105. Patwardhan SV, Emami FS, Berry RJ, Jones SE, Naik RR, Deschaume O, Heinz H, Perry CC. 
Chemistry of aqueous silica nanoparticle surfaces and the mechanism of selective peptide adsorption. J 
Am Chem Soc. 2012;134(14) 
106. Christen M, Hunenberger PH, Bakowies D, Baron R, Burgi R, Geerke DP, Heinz TN, Kastenholz 
MA, Krautler V, Oostenbrink C, Peter C, Trzesniak D, Van Gunsteren WF. The GROMOS software for 
biomolecular simulation: GROMOS05. Journal of Computational Chemistry. 2005;26(16) 
149 
 
107. Lin TJ, Heinz H. Accurate force field parameters and pH resolved surface models for 
hydroxyapatite to understand structure, mechanics, hydration, and biological interfaces. Journal of 
Physical Chemistry C. 2016;120(9) 
108. Briggs BD, Bedford NM, Seifert S, Koerner H, Ramezani-Dakhel H, Heinz H, Naik RR, Frenkel AI, 
Knecht MR. Atomic-scale identification of Pd leaching in nanoparticle catalyzed C-C coupling: Effects of 
particle surface disorder. Chem Sci. 2015;6(11) 
109. Shen Y, Maupetit J, Derreumaux P, Tuffery P. Improved PEP-FOLD approach for peptide and 
miniprotein structure prediction. J Chem Theory Comput. 2014;10(10) 
110. Lamiable A, Thevenet P, Rey J, Vavrusa M, Derreumaux P, Tuffery P. PEP-FOLD3: Faster de novo 
structure prediction for linear peptides in solution and in complex. Nucleic Acids Res. 2016;44(W1) 
111. Tsubaki M, Srivastava RB, Yu NT. Resonance Raman investigation of carbon monoxide bonding in 
(carbon monoxy) hemoglobin and-myoglobin: detection of iron-carbon monoxide stretching and iron-
carbon-oxygen bending vibrations and influence of the quaternary structure change. Biochemistry. 
1982;21(6) 
112. Lukin JA, Kontaxis G, Simplaceanu V, Yuan Y, Bax A, Ho C. Quaternary structure of hemoglobin in 
solution. Proc Natl Acad Sci U S A. 2003;100(2) 
113. Silva MM, Rogers PH, Arnone A. A third quaternary structure of human hemoglobin A at 1.7-A 
resolution. Journal of Biological Chemistry. 1992;267(24) 
114. Nussinov R, Tsai CJ. Allostery without a conformational change? Revisiting the paradigm. Curr 
Opin Struct Biol. 2015;30 
115. Lindert S, Meiler J, Mccammon JA. Iterative molecular dynamics-Rosetta protein structure 
refinement protocol to improve model quality. J Chem Theory Comput. 2013;9(8) 
116. Simoncini D, Berenger F, Shrestha R, Zhang KY. A probabilistic fragment-based protein structure 
prediction algorithm. PLoS One. 2012;7(7) 
117. Leaver-Fay A, Tyka M, Lewis SM, Lange OF, Thompson J, Jacak R, Kaufman K, Renfrew PD, Smith 
CA, Sheffler W, Davis IW, Cooper S, Treuille A, Mandell DJ, Richter F, Ban YE, Fleishman SJ, Corn JE, Kim 
DE, Lyskov S, Berrondo M, Mentzer S, Popovic Z, Havranek JJ, Karanicolas J, Das R, Meiler J, Kortemme T, 
Gray JJ, Kuhlman B, Baker D, Bradley P. ROSETTA3: An object-oriented software suite for the simulation 
and design of macromolecules. Methods Enzymol. 2011;487 
118. Khoury GA, Liwo A, Khatib F, Zhou H, Chopra G, Bacardit J, Bortot LO, Faccioli RA, Deng X, He Y, 
Krupa P, Li J, Mozolewska MA, Sieradzan AK, Smadbeck J, Wirecki T, Cooper S, Flatten J, Xu K, Baker D, 
Cheng J, Delbem AC, Floudas CA, Keasar C, Levitt M, Popovic Z, Scheraga HA, Skolnick J, Crivelli SN, Foldit 
P. WeFold: a coopetition for protein structure prediction. Proteins. 2014;82(9) 
119. Khatib F, Cooper S, Tyka MD, Xu K, Makedon I, Popovic Z, Baker D, Players F. Algorithm discovery 
by protein folding game players. Proc Natl Acad Sci U S A. 2011;108(47) 
120. Rodriguez Sanchez F, Rodriguez Andres C, Arteagoitia I. Which antibiotic regimen prevents 
implant failure or infection after dental implant surgery? A systematic review and meta-analysis. J 
Craniomaxillofac Surg. 2018;46(4) 
121. Wang JT, Wang AY, Psarros C, Da Cruz M. Rates of revision and device failure in cochlear implant 
surgery: a 30-year experience. Laryngoscope. 2014;124(10) 
122. Wang DA, Varghese S, Sharma B, Strehin I, Fermanian S, Gorham J, Fairbrother DH, Cascio B, 
Elisseeff JH. Multifunctional chondroitin sulphate for cartilage tissue-biomaterial integration. Nat Mater. 
2007;6(5) 
123. Sadoghi P, Liebensteiner M, Agreiter M, Leithner A, Bohler N, Labek G. Revision surgery after 
total joint arthroplasty: A complication-based analysis using worldwide arthroplasty registers. J 
Arthroplasty. 2013;28(8) 
124. Aminov R. History of antimicrobial drug discovery: Major classes and health impact. Biochem 
Pharmacol. 2017;133 
150 
 
125. Belanger CR, Mansour SC, Pletzer D, Hancock REW. Alternative strategies for the study and 
treatment of clinical bacterial biofilms. Emerging Topics in Life Sciences. 2017 
126. Bechinger B, Gorr SU. Antimicrobial peptides: Mechanisms of action and resistance. J Dent Res. 
2017;96(3) 
127. Pawlak Z. Rough set theory and its applications to data analysis. Cybernetics and Systems. 
1998;29(7) 
128. Clark PG, Grzymala-Busse JW, Rzasa W. A comparison of two MLEM2 rule induction algorithms 
extended to probabilistic approximations. Journal of Intelligent Information Systems. 2015 
129. Cohagan C, Grzymala-Busse JW, Hippe ZS, editors. Mining inconsistent data with the bagged 
MLEM2 rule induction algorithm. IEEE Conference on Granular Computing; 2010: IEEE. 
130. Ventola CL. The antibiotic resistance crisis: Part 1: Causes and threats. P T. 2015;40(4) 
131. Mishra B, Reiling S, Zarena D, Wang G. Host defense antimicrobial peptides as antibiotics: Design 
and application strategies. Curr Opin Chem Biol. 2017;38 
132. O’neill J. Tackling drug-resistant infections globally: final report and recommendations. Review 
on Antimicrobial Resistance 2016. 2016 
133. Al-Tawfiq JA, Laxminarayan R, Mendelson M. How should we respond to the emergence of 
plasmid-mediated colistin resistance in humans and animals? Int J Infect Dis. 2017;54 
134. Fan L, Sun J, Zhou M, Zhou J, Lao X, Zheng H, Xu H. DRAMP: a comprehensive data repository of 
antimicrobial peptides. Sci Rep. 2016;6 
135. Di Luca M, Maccari G, Maisetta G, Batoni G. BaAMPs: the database of biofilm-active 
antimicrobial peptides. Biofouling. 2015;31(2) 
136. Wang G, Li X, Wang Z. APD3: The antimicrobial peptide database as a tool for research and 
education. Nucleic Acids Res. 2016;44(D1) 
137. Zhao X, Wu H, Lu H, Li G, Huang Q. LAMP: A database linking antimicrobial peptides. PLoS One. 
2013;8(6) 
138. Wang G, Li X, Wang Z. APD2: The updated antimicrobial peptide database and its application in 
peptide design. Nucleic Acids Res. 2009;37(Database issue) 
139. Wang J, Dong X, Yu Q, Baker SN, Li H, Larm NE, Baker GA, Chen L, Tan J, Chen M. Incorporation 
of antibacterial agent derived deep eutectic solvent into an active dental composite. Dent Mater. 
2017;33(12) 
140. Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS. Rational design of alpha-helical 
antimicrobial peptides with enhanced activities and specificity/therapeutic index. Journal of Biological 
Chemistry. 2005;280(13) 
141. Jodoin J, Hincke MT. Histone H5 is a potent antimicrobial agent and a template for novel 
antimicrobial peptides. Sci Rep. 2018;8(1) 
142. Tajbakhsh M, Karimi A, Tohidpour A, Abbasi N, Fallah F, Akhavan MM. The antimicrobial 
potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant 
Staphylococcus aureus. J Microbiol. 2018;56(2) 
143. Vasudev PG, Chatterjee S, Shamala N, Balaram P. Structural chemistry of peptides containing 
backbone expanded amino acid residues: Conformational features of beta, gamma, and hybrid peptides. 
Chem Rev. 2011;111(2) 
144. Sang P, Shi Y, Teng P, Cao A, Xu H, Li Q, Cai J. Antimicrobial AApeptides. Curr Top Med Chem. 
2017;17(11) 
145. Seebach D, Beck AK, Bierbaum DJ. The world of beta- and gamma-peptides comprised of 
homologated proteinogenic amino acids and other components. Chem Biodivers. 2004;1(8) 
146. Porter EA, Weisblum B, Gellman SH. Mimicry of host-defense peptides by unnatural oligomers: 
antimicrobial beta-peptides. J Am Chem Soc. 2002;124(25) 
151 
 
147. Knerr PJ, Van Der Donk WA. Discovery, biosynthesis, and engineering of lantipeptides. In: 
Kornberg RD, editor. Annual review of biochemistry. Vol 81,2012. 
148. Brogden NK, Brogden KA. Will new generations of modified antimicrobial peptides improve their 
potential as pharmaceuticals? Int J Antimicrob Agents. 2011;38(3) 
149. Candido-Ferreira IL, Kronenberger T, Sayegh RSR, Batista IDC, Da Silva PI. Evidence of an 
antimicrobial peptide signature encrypted in HECT E3 ubiquitin ligases. Frontiers in Immunology. 2017;7 
150. Boone K, Abedin F, Anwar MR, Camarda KV. Molecular design in the pharmaceutical industries. 
Computer Aided Chemical Engineering. 2017;39 
151. Ng LY, Chong FK, Chemmangattuvalappil NG. Challenges and opportunities in computer-aided 
molecular design. Computers & Chemical Engineering. 2015;81 
152. Roughton BC, Christian B, White J, Camarda KV, Gani R. Simultaneous design of ionic liquid 
entrainers and energy efficient azeotropic separation processes. Computers & Chemical Engineering. 
2012;42 
153. Riera-Fernandez P, Martin-Romalde R, Prado-Prado FJ, Escobar M, Munteanu CR, Concu R, 
Duardo-Sanchez A, Gonzalez-Diaz H. From QSAR models of drugs to complex networks: State-of-art 
review and introduction of new Markov-spectral moments indices. Curr Top Med Chem. 2012;12(8) 
154. Prado-Prado FJ, Uriarte E, Borges F, Gonzalez-Diaz H. Multi- target spectral moments for QSAR 
and Complex Networks study of antibacterial drugs. Eur J Med Chem. 2009;44(11) 
155. Du Q-S, Huang R-B, Chou K-C. Recent advances in QSAR and their applications in predicting the 
activities of chemical molecules, peptides and proteins for drug design. Current Protein and Peptide 
Science. 2008;9(3) 
156. Fjell CD, Hiss JA, Hancock RE, Schneider G. Designing antimicrobial peptides: Form follows 
function. Nat Rev Drug Discov. 2011;11(1) 
157. Cherkasov A, Hilpert K, Jenssen H, Fjell CD, Waldbrook M, Mullaly SC, Volkmer R, Hancock RE. 
Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum 
of highly antibiotic-resistant superbugs. ACS Chem Biol. 2009;4(1) 
158. Claro B, Bastos M, Garcia-Fandino R. Design and applications of cyclic peptides.  Peptide 
Applications in Biomedicine, Biotechnology and Bioengineering: Elsevier; 2018. 
159. Muller AT, Kaymaz AC, Gabernet G, Posselt G, Wessler S, Hiss JA, Schneider G. Sparse neural 
network models of antimicrobial peptide-activity relationships. Mol Inform. 2016;35(11-12) 
160. Gabere MN, Noble WS. Empirical comparison of web-based antimicrobial peptide prediction 
tools. Bioinformatics. 2017;33(13) 
161. Lata S, Sharma BK, Raghava GP. Analysis and prediction of antibacterial peptides. BMC 
Bioinformatics. 2007;8 
162. Bhasin M, Raghava GP. SVM based method for predicting HLA-DRB1*0401 binding peptides in 
an antigen sequence. Bioinformatics. 2004;20(3) 
163. Bhasin M, Raghava GP. Prediction of CTL epitopes using QM, SVM and ANN techniques. Vaccine. 
2004;22(23-24) 
164. Saha S, Raghava G. Prediction of continuous B-cell epitopes in an antigen using recurrent neural 
network. Proteins: Structure, Function, and Bioinformatics. 2006;65(1) 
165. Karatzoglou A, Smola A, Hornik K, Zeileis A. Kernlab-An S4 package for kernel methods in R. 
Journal of Statistical Software. 2004;11(9) 
166. Venerables W, Ripley B. Modern applied statistics with S. Springer; 2002. 
167. Norušis MJ. SPSS/PC+ advanced statistics V2. 0: for the IBM PC/XT/AT and PS/2: SPSS 
Incorporated; 1988. 
168. Liaw A, Wiener M. Classification and regression by randomForest. R News. 2002;2(3) 
169. Magrane M, Uniprot C. UniProt Knowledgebase: A hub of integrated protein data. Database 
(Oxford). 2011;2011 
152 
 
170. Bairoch A, Apweiler R, Wu CH, Barker WC, Boeckmann B, Ferro S, Gasteiger E, Huang H, Lopez R, 
Magrane M, Martin MJ, Natale DA, O'donovan C, Redaschi N, Yeh LS. The universal protein resource 
(UniProt). Nucleic Acids Res. 2005;33(Database issue) 
171. Fernandes FC, Rigden DJ, Franco OL. Prediction of antimicrobial peptides based on the adaptive 
neuro-fuzzy inference system application. Biopolymers. 2012;98(4) 
172. Charif D, Lobry JR. SeqinR 1.0-2: A contributed package to the R project for statistical computing 
devoted to biological sequences retrieval and analysis.  Structural approaches to sequence evolution: 
Springer; 2007. 
173. Yu D, Sheng Z, Xu X, Li J, Yang H, Liu Z, Rees HH, Lai R. A novel antimicrobial peptide from 
salivary glands of the hard tick, Ixodes sinensis. Peptides. 2006;27(1) 
174. Wang G, Watson KM, Peterkofsky A, Buckheit RW, Jr. Identification of novel human 
immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database. 
Antimicrob Agents Chemother. 2010;54(3) 
175. Menousek J, Mishra B, Hanke ML, Heim CE, Kielian T, Wang G. Database screening and in vivo 
efficacy of antimicrobial peptides against methicillin-resistant Staphylococcus aureus USA300. Int J 
Antimicrob Agents. 2012;39(5) 
176. Grzymala-Busse JW, Rzasa W. A Local Version of the MLEM2 Algorithm for Rule Induction. 
Fundamenta Informaticae. 2010;100(1) 
177. Clark PG, Gao C, Grzymala-Busse JW, editors. Complexity of rule sets induced by two versions of 
the MLEM2 rule induction algorithm. International Conference on Artificial Intelligence and Soft 
Computing; 2017: Springer. 
178. Grzymala-Busse JW, Hamilton J, Hippe ZS. Diagnosis of melanoma using IRIM, a data mining 
system. In: Rutkowski L, Siekmann JH, Tadeusiewicz R, Zadeh LA, editors. International Conference on 
Artificial Intelligence and Soft Computing. Berlin, Heidelberg: Springer Berlin Heidelberg; 2004. 
179. Austin ND, Sahinidis NV, Trahan DW. Computer-aided molecular design: An introduction and 
review of tools, applications, and solution techniques. Chemical Engineering Research and Design. 
2016;116 
180. Baldi P, Brunak S, Chauvin Y, Andersen CA, Nielsen H. Assessing the accuracy of prediction 
algorithms for classification: An overview. Bioinformatics. 2000;16(5) 
181. Xiao X, Wang P, Lin WZ, Jia JH, Chou KC. iAMP-2L: a two-level multi-label classifier for identifying 
antimicrobial peptides and their functional types. Anal Biochem. 2013;436(2) 
182. Kawashima S, Kanehisa M. AAindex: amino acid index database. Nucleic Acids Res. 2000;28(1) 
183. Aurora R, Rose GD. Helix capping. Protein Science. 1998;7(1) 
184. Charton M, Charton BI. The structural dependence of amino acid hydrophobicity parameters. J 
Theor Biol. 1982;99(4) 
185. Fauchere JL, Charton M, Kier LB, Verloop A, Pliska V. Amino acid side chain parameters for 
correlation studies in biology and pharmacology. Int J Pept Protein Res. 1988;32(4) 
186. Finkelstein AV, Badretdinov AY, Ptitsyn OB. Physical reasons for secondary structure stability: 
alpha-helices in short peptides. Proteins. 1991;10(4) 
187. Geisow MJ, Roberts RD. Amino acid preferences for secondary structure vary with protein class. 
International Journal of Biological Macromolecules. 1980;2(6) 
188. George RA, Heringa J. SnapDRAGON: a method to delineate protein structural domains from 
sequence data. J of Mol Biol. 2002;316(3) 
189. Kumar S, Tsai CJ, Nussinov R. Factors enhancing protein thermostability. Protein Eng. 2000;13(3) 
190. Nakashima H, Nishikawa K, Ooi T. Distinct character in hydrophobicity of amino acid 
compositions of mitochondrial proteins. Proteins. 1990;8(2) 
191. Qian N, Sejnowski TJ. Predicting the secondary structure of globular proteins using neural 
network models. J Mol Biol. 1988;202(4) 
153 
 
192. Richardson JS, Richardson DC. Amino acid preferences for specific locations at the ends of alpha 
helices. Science. 1988;240(4859) 
193. Robson B, Suzuki E. Conformational properties of amino acid residues in globular proteins. J Mol 
Biol. 1976;107(3) 
194. Vasquez M, Nemethy G, Scheraga HA. Computed conformational states of the 20 naturally 
occurring amino acid residues and of the prototype residue α-aminobutyric acid. Macromolecules. 
1983;16(7) 
195. Wertz DH, Scheraga HA. Influence of water on protein structure. An analysis of the preferences 
of amino acid residues for the inside or outside and for specific conformations in a protein molecule. 
Macromolecules. 1978;11(1) 
196. Yutani K, Ogasahara K, Tsujita T, Sugino Y. Dependence of conformational stability on 
hydrophobicity of the amino acid residue in a series of variant proteins substituted at a unique position 
of tryptophan synthase alpha subunit. PNAS. 1987;84(13) 
197. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The 
protein data bank. Nucleic Acids Research. 2000;28(1) 
198. Li W, Godzik A. Cd-hit: A fast program for clustering and comparing large sets of protein or 
nucleotide sequences. Bioinformatics. 2006;22(13) 
199. Georgiev AG. Interpretable numerical descriptors of amino acid space. Journal of Computational 
Biology. 2009;16(5) 
200. Veltri DP. A computational and statistical tramework for screening novel antimicrobial peptides: 
George Mason University; 2015. 
201. Porto WF, Pires AS, Franco OL. Antimicrobial activity predictors benchmarking analysis using 
shuffled and designed synthetic peptides. J Theor Biol. 2017;426 
202. Andreu D, Merrifield RB, Steiner H, Boman HG. N-terminal analogs of Cecropin-A - synthesis, 
antibacterial activity and conformational properties. Biochemistry. 1985;24(7) 
203. Wade D, Boman A, Wahlin B, Drain CM, Andreu D, Boman HG, Merrifield RB. All-D amino acid-
containing channel-forming antibiotic peptides. Proc Natl Acad Sci U S A. 1990;87(12) 
204. Merrifield EL, Mitchell SA, Ubach J, Boman HG, Andreu D, Merrifield RB. D-enantiomers of 15-
residue Cecropin A-melittin hybrids. Int J Pept Protein Res. 1995;46(3-4) 
205. Steiner H, Andreu D, Merrifield RB. Binding and action of cecropin and cecropin analogs - 
antibacterial peptides from insects. Biochim Biophys Acta. 1988;939(2) 
206. Juvvadi P, Vunnam S, Merrifield RB. Synthetic melittin, its enantio, retro, and retroenantio 
isomers, and selected chimeric analogs: Their antibacterial, hemolytic, and lipid bilayer action. J Am 
Chem Soc. 1996;118(38) 
207. Juvvadi P, Vunnam S, Yoo B, Merrifield RB. Structure-activity studies of normal and retro pig 
cecropin-melittin hybrids. J Pept Res. 1999;53(3) 
208. Andreu D, Ubach J, Boman A, Wahlin B, Wade D, Merrifield RB, Boman HG. Shortened Cecropin 
A-melittin hybrids. Significant size reduction retains potent antibiotic activity. FEBS Lett. 1992;296(2) 
209. Juvvadi P, Vunnam S, Merrifield EL, Boman HG, Merrifield RB. Hydrophobic effects on 
antibacterial and channel-forming properties of Cecropin A-melittin hybrids. Journal of Peptide Science. 
1996;2(4) 
210. Yousefinejad S, Hemmateenejad B. Chemometrics tools in QSAR/QSPR studies: A historical 
perspective. Chemometrics and Intelligent Laboratory Systems. 2015;149 
211. Xu L, Fu HY, Yin QB, Fan Y, Goodarzi M, She YB. Interpretable linear and nonlinear quantitative 
structure-selectivity relationship (QSSR) modeling of a biomimetic catalytic system by particle swarm 
optimization based sparse regression. Chemometrics and Intelligent Laboratory Systems. 2016;159 
212. Pirhadi S, Shiri F, Ghasemi JB. Multivariate statistical analysis methods in QSAR. RSC Advances. 
2015;5(127) 
154 
 
213. Patel S, Stott IP, Bhakoo M, Elliott P. Patenting computer-designed peptides. Journal of 
Computer-Aided Molecular Design. 1998;12(6) 
214. Czyzewski AM, Jenssen H, Fjell CD, Waldbrook M, Chongsiriwatana NP, Yuen E, Hancock RE, 
Barron AE. In Vivo, In Vitro, and In Silico Characterization of Peptoids as Antimicrobial Agents. PLoS One. 
2016;11(2) 
215. Wang Y, Yang YJ, Chen YN, Zhao HY, Zhang S. Computer-aided design, structural dynamics 
analysis, and in vitro susceptibility test of antibacterial peptides incorporating unnatural amino acids 
against microbial infections. Comput Methods Programs Biomed. 2016;134 
216. Araujo SC, Maltarollo VG, Silva DC, Gertrudes JC, Honorio KM. ALK-5 Inhibition: A Molecular 
Interpretation of the Main Physicochemical Properties Related to Bioactive Ligands. Journal of the 
Brazilian Chemical Society. 2015;26(9) 
217. Xu L, Zhang WJ. Comparison of different methods for variable selection. Analytica Chimica Acta. 
2001;446(1-2) 
218. So SS, Karplus M. Genetic neural networks for quantitative structure-activity relationships: 
improvements and application of benzodiazepine affinity for benzodiazepine/GABAA receptors. J Med 
Chem. 1996;39(26) 
219. So SS, Karplus M. Evolutionary optimization in quantitative structure-activity relationship: an 
application of genetic neural networks. J Med Chem. 1996;39(7) 
220. Kubinyi H. Variable selection in QSAR studies. 1. An evolutionary algorithm. Quantitative 
Structure-Activity Relationships. 1994;13(3) 
221. Tong W, Xie Q, Hong H, Shi L, Fang H, Perkins R. Assessment of prediction confidence and 
domain extrapolation of two structure-activity relationship models for predicting estrogen receptor 
binding activity. Environ Health Perspect. 2004;112(12) 
222. Bruce CL, Melville JL, Pickett SD, Hirst JD. Contemporary QSAR classifiers compared. J Chem Inf 
Model. 2007;47(1) 
223. Svetnik V, Liaw A, Tong C, Culberson JC, Sheridan RP, Feuston BP. Random forest: a classification 
and regression tool for compound classification and QSAR modeling. J Chem Inf Comput Sci. 2003;43(6) 
224. Palmer DS, O'boyle NM, Glen RC, Mitchell JB. Random forest models to predict aqueous 
solubility. J Chem Inf Model. 2007;47(1) 
225. Maji P, Paul S. Rough sets for selection of molecular descriptors to predict biological activity of 
molecules. IEEE Transactions on Systems Man and Cybernetics Part C-Applications and Reviews. 
2010;40(6) 
226. Shehu A, Jong KD. Evolutionary algorithms for protein structure modeling. Annual Conference 
on Genetic and Evolutionary Computation; Madrid, Spain. 2756569: ACM; 2015. 
227. Jain A, Castelli IE, Hautier G, Bailey DH, Jacobsen KW. Performance of genetic algorithms in 
search for water splitting perovskites. Journal of Materials Science. 2013;48(19) 
228. Crick F. Central dogma of molecular biology. Nature. 1970;227(5258) 
229. Conchillo-Sole O, De Groot NS, Aviles FX, Vendrell J, Daura X, Ventura S. AGGRESCAN: a server 
for the prediction and evaluation of "hot spots" of aggregation in polypeptides. BMC Bioinformatics. 
2007;8(1) 
230. Han HM, Gopal R, Park Y. Design and membrane-disruption mechanism of charge-enriched 
AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties. Amino Acids. 
2016;48(2) 
231. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev 
Microbiol. 2005;3(3) 
232. Scott MG, Hancock RE. Cationic antimicrobial peptides and their multifunctional role in the 
immune system. Crit Rev Immunol. 2002;20 
233. Tille P. Bailey & Scott's Diagnostic Microbiology-E-Book: Elsevier Health Sciences; 2015. 
155 
 
234. Hintze JL, Nelson RD. Violin plots: A box plot-density trace synergism. The American Statistician. 
1998;52(2) 
235. Opuu V, Silvert M, Simonson T. Computational design of fully overlapping coding schemes for 
protein pairs and triplets. Sci Rep. 2017;7(1) 
236. Lorenzo-Ginori JV, Rodriguez-Fuentes A, Abalo RG, Rodriguez RS. Digital signal processing in the 
analysis of genomic sequences. Current Bioinformatics. 2009;4(1) 
237. Giannerini S, Gonzalez DL, Rosa R. DNA, dichotomic classes and frame synchronization: A quasi-
crystal framework. Philos Trans A Math Phys Eng Sci. 2012;370(1969) 
238. Lebre S, Gascuel O. The combinatorics of overlapping genes. J Theor Biol. 2017;415 
239. Patel S, Stott IP, Bhakoo M, Elliott P. Patenting computer-designed peptides. J Comput Aided 
Mol Des. 1998;12(6) 
240. Jones DT. De novo protein design using pairwise potentials and a genetic algorithm. Protein 
Science. 1994;3(4) 
241. D'costa VM, King CE, Kalan L, Morar M, Sung WWL, Schwarz C, Froese D, Zazula G, Calmels F, 
Debruyne R, Golding GB, Poinar HN, Wright GD. Antibiotic resistance is ancient. Nature. 2011;477(7365) 
242. Maximova T, Plaku E, Shehu A, editors. Computing transition paths in multiple-basin proteins 
with a probabilistic roadmap algorithm guided by structure data. IEEE International Conference on 
Bioinformatics and Biomedicine; 2015 9-12 Nov. 2015. 
243. Lopez-Perez PM, Grimsey E, Bourne L, Mikut R, Hilpert K. Screening and optimizing antimicrobial 
peptides by using SPOT-synthesis. Front Chem. 2017;5 
244. Borquaye LS, Darko G, Ocansey E, Ankomah E. Antimicrobial and antioxidant properties of the 
crude peptide extracts of Galatea paradoxa and Patella rustica. SpringerPlus. 2015;4 
245. Bluhm ME, Knappe D, Hoffmann R. Structure-activity relationship study using peptide arrays to 
optimize Api137 for an increased antimicrobial activity against Pseudomonas aeruginosa. Eur J Med 
Chem. 2015;103 
246. Minervini F, Algaron F, Rizzello CG, Fox PF, Monnet V, Gobbetti M. Angiotensin I-converting-
enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed 
caseins of milk from six species. Appl Environ Microbiol. 2003;69(9) 
247. Mount DW. Using the basic local alignment search tool (BLAST). Cold Spring Harbor Protocols. 
2007;2007(7) 
248. Mcginnis S, Madden TL. BLAST: At the core of a powerful and diverse set of sequence analysis 
tools. Nucleic Acids Research. 2004;32(Suppl 2) 
249. Li Z, Xu X, Meng L, Zhang Q, Cao L, Li W, Wu Y, Cao Z. Hp1404, a new antimicrobial peptide from 
the scorpion Heterometrus petersii. PLoS One. 2014;9(5) 
250. Brand GD, Magalhães MT, Tinoco ML, Aragão FJ, Nicoli J, Kelly SM, Cooper A, Bloch Jr C. Probing 
protein sequences as sources for encrypted antimicrobial peptides. PLoS One. 2012;7(9) 
251. Korichi M, Gerbaud V, Floquet P, Meniai AH, Nacef S, Joulia X. Computer aided aroma design I-
Molecular knowledge framework. Chemical Engineering and Processing. 2008;47(11) 
252. Karami Y, Khakzad H, Arab S, Fathy M, Shirazi H, editors. Protein structure prediction using bio-
inspired algorithm: A review. Artificial Intelligence and Signal Processing (AISP), 2012 16th CSI 
International Symposium on; 2012 2-3 May 2012. 
253. Goldwater PN. Gut microbiota and immunity: Possible role in sudden infant death syndrome. 
Front Immunol. 2015;6 
254. Holland JH. Adaptation in natural and artificial systems: an introductory analysis with 
applications to biology, control, and artificial intelligence: MIT press; 1992. 
255. Oliver I, Smith D, Holland JR, editors. Study of permutation crossover operators on the traveling 
salesman problem. Genetic algorithms and their applications: proceedings of the second International 
156 
 
Conference on Genetic Algorithms: July 28-31, 1987 at the Massachusetts Institute of Technology, 
Cambridge, MA; 1987: Hillsdale, NJ: L. Erlhaum Associates, 1987. 
256. Parsons RJ, Forrest S, Burks C. Genetic algorithms, operators, and DNA fragment assembly. 
Machine Learning. 1995;21(1-2) 
257. Islam SM, Das S, Ghosh S, Roy S, Suganthan PN. An adaptive differential evolution algorithm 
with novel mutation and crossover strategies for global numerical optimization. IEEE Trans Syst Man 
Cybern B Cybern. 2012;42(2) 
258. Cheng H, Yue K, Kazemzadeh-Narbat M, Liu Y, Khalilpour A, Li B, Zhang YS, Annabi N, 
Khademhosseini A. Mussel-inspired multifunctional hydrogel coating for prevention of infections and 
enhanced osteogenesis. ACS Appl Mater Interfaces. 2017;9(13) 
259. Dobson AJ, Purves J, Kamysz W, Rolff J. Comparing selection on S. Aureus between antimicrobial 
peptides and common antibiotics. PLoS One. 2013;8(10) 
260. Hickok NJ, Shapiro IM. Immobilized antibiotics to prevent orthopaedic implant infections. Adv 
Drug Deliv Rev. 2012;64(12) 
261. Onaizi SA, Leong SS. Tethering antimicrobial peptides: current status and potential challenges. 
Biotechnol Adv. 2011;29(1) 
262. Hilpert K, Elliott M, Jenssen H, Kindrachuk J, Fjell CD, Korner J, Winkler DF, Weaver LL, Henklein 
P, Ulrich AS, Chiang SH, Farmer SW, Pante N, Volkmer R, Hancock RE. Screening and characterization of 
surface-tethered cationic peptides for antimicrobial activity. Chem Biol. 2009;16(1) 
263. Polivkova M, Hubacek T, Staszek M, Svorcik V, Siegel J. Antimicrobial treatment of polymeric 
medical devices by silver nanomaterials and related technology. Int J Mol Sci. 2017;18(2) 
264. Cyphert EL, Von Recum HA. Emerging technologies for long-term antimicrobial device coatings: 
advantages and limitations. Exp Biol Med. 2017;242(8) 
265. Bauer S, Schmuki P, Von Der Mark K, Park J. Engineering biocompatible implant surfaces: Part I: 
Materials and surfaces. Progress in Materials Science. 2013;58(3) 
266. Tamerler C. Surfaces and their interfaces meet biology at the bio-interface. JOM. 2015;67(11) 
267. Luo QY, Lin Y, Peng J, Liu SL, Zhang ZL, Tian ZQ, Pang DW. Evaluation of nonspecific interactions 
between quantum dots and proteins. Phys Chem Chem Phys. 2014;16(17) 
268. Fu YY, Guan EL, Liang JG, Ren GL, Chen L. Probing the effect of Ag2S auantum dots on human 
serum albumin using spectral techniques. Journal of Nanomaterials. 2017 
269. Wang K, Chen Y, Gong X, Xia J, Zhao J, Shen L. A mobile precursor determines protein resistance 
on nanostructured surfaces. Phys Chem Chem Phys. 2018;20(18) 
270. Shen L, Zhu XY. Evidence of a mobile precursor state in nonspecific protein adsorption. 
Langmuir. 2011;27(11) 
271. Shen L, Zhu J. Oriented protein nanoarrays on block copolymer template. Macromol Rapid 
Commun. 2016;37(6) 
272. Shen L, Zhu J. Heterogeneous surfaces to repel proteins. Adv Colloid Interface Sci. 2016;228 
273. Marzinek JK, Lian GP, Marzinek JK, Mantalaris A, Pistikopoulos EN, Zhao YY, Han LJ, Chen LJ, 
Bond PJ, Noro MG. Molecular and thermodynamic basis for EGCG-keratin interaction-part I: Molecular 
dynamics simulations. AIChE Journal. 2013;59(12) 
274. Kazemzadeh-Narbat M, Lai BF, Ding C, Kizhakkedathu JN, Hancock RE, Wang R. Multilayered 
coating on titanium for controlled release of antimicrobial peptides for the prevention of implant-
associated infections. Biomaterials. 2013;34(24) 
275. Cetinel S, Caliskan HB, Yucesoy DT, Donatan AS, Yuca E, Urgen M, Karaguler NG, Tamerler C. 
Addressable self-immobilization of lactate dehydrogenase across multiple length scales. Biotechnol J. 
2013;8(2) 
276. Gao W, Hu CM, Fang RH, Luk BT, Su J, Zhang L. Surface functionalization of gold nanoparticles 
with red blood cell membranes. Adv Mater. 2013;25(26) 
157 
 
277. Zhang K, Sugawara A, Tirrell DA. Generation of surface-bound multicomponent protein 
gradients. Chembiochem. 2009;10(16) 
278. Sharma V, Blackwood K, Haddow D, Dye DJ. Protein binding functionalization of plasma-
derivatized silicone surfaces. Wound Repair and Regeneration. 2013;21(6) 
279. Chen RJ, Zhang Y, Wang D, Dai H. Noncovalent sidewall functionalization of single-walled carbon 
nanotubes for protein immobilization. J Am Chem Soc. 2001;123(16) 
280. Gkaniatsou E, Sicard C, Ricoux R, Mahy JP, Steunou N, Serre C. Metal-organic frameworks: A 
novel host platform for enzymatic catalysis and detection. Materials Horizons. 2017;4(1) 
281. Barbosa O, Ortiz C, Berenguer-Murcia A, Torres R, Rodrigues RC, Fernandez-Lafuente R. 
Strategies for the one-step immobilization-purification of enzymes as industrial biocatalysts. Biotechnol 
Adv. 2015;33(5) 
282. Kuila T, Bose S, Khanra P, Mishra AK, Kim NH, Lee JH. Recent advances in graphene-based 
biosensors. Biosens Bioelectron. 2011;26(12) 
283. Garcia-Galan C, Berenguer-Murcia A, Fernandez-Lafuente R, Rodrigues RC. Potential of different 
enzyme immobilization strategies to improve enzyme performance. Advanced Synthesis & Catalysis. 
2011;353(16) 
284. Deforest CA, Tirrell DA. A photoreversible protein-patterning approach for guiding stem cell fate 
in three-dimensional gels. Nat Mater. 2015;14(5) 
285. Censi R, Di Martino P, Vermonden T, Hennink WE. Hydrogels for protein delivery in tissue 
engineering. J Control Release. 2012;161(2) 
286. Tully J, Yendluri R, Lvov Y. Halloysite clay nanotubes for enzyme immobilization. 
Biomacromolecules. 2016;17(2) 
287. Shi XW, Du YM, Wei XQ, Wu HP. Electrical signals guided protein immobilization and controlled 
release. Abstracts of Papers of the American Chemical Society. 2011;241 
288. Choi JS, Yoo HS. Nano-inspired fibrous matrix with bi-phasic release of proteins. J Nanosci 
Nanotechnol. 2010;10(5) 
289. Chen B, Qi W, Li X, Lei C, Liu J. Heated proteins are still active in a functionalized nanoporous 
support. Small. 2013;9(13) 
290. Liu Y, Ai K, Lu L. Polydopamine and its derivative materials: synthesis and promising applications 
in energy, environmental, and biomedical fields. Chem Rev. 2014;114(9) 
291. Hudson S, Cooney J, Magner E. Proteins in mesoporous silicates. Angew Chem Int Ed Engl. 
2008;47(45) 
292. Brady D, Jordaan J. Advances in enzyme immobilisation. Biotechnol Lett. 2009;31(11) 
293. Wisdom C, Vanoosten SK, Boone KW, Khvostenko D, Arnold PM, Snead ML, Tamerler C. 
Controlling the biomimetic implant interface: Modulating antimicrobial activity by spacer design. J Mol 
Eng Mater. 2016;4(1) 
294. Care A, Bergquist PL, Sunna A. Solid-binding peptides in biomedicine.  Peptides and Peptide-
based Biomaterials and their Biomedical Applications: Springer; 2017. 
295. Donatan S, Sarikaya M, Tamerler C, Urgen M. Effect of solid surface charge on the binding 
behaviour of a metal-binding peptide. J R Soc Interface. 2012;9(75) 
296. Kim DE, Chivian D, Baker D. Protein structure prediction and analysis using the Robetta server. 
Nucleic Acids Res. 2004;32(Web Server issue) 
297. Kabsch W, Sander C. DSSP: definition of secondary structure of proteins given a set of 3D 
coordinates. Biopolymers. 1983;22 
298. Daniele-Silva A, Machado RJ, Monteiro NK, Estrela AB, Santos EC, Carvalho E, Araujo Junior RF, 
Melo-Silveira RF, Rocha HA, Silva-Junior AA, Fernandes-Pedrosa MF. Stigmurin and TsAP-2 from Tityus 
stigmurus scorpion venom: Assessment of structure and therapeutic potential in experimental sepsis. 
Toxicon. 2016;121 
158 
 
299. Ma QQ, Dong N, Shan AS, Lv YF, Li YZ, Chen ZH, Cheng BJ, Li ZY. Biochemical property and 
membrane-peptide interactions of de novo antimicrobial peptides designed by helix-forming units. 
Amino Acids. 2012;43(6) 
300. Nguyen LT, Haney EF, Vogel HJ. The expanding scope of antimicrobial peptide structures and 
their modes of action. Trends Biotechnol. 2011;29(9) 
301. Mann S. Biomineralization: principles and concepts in bioinorganic materials chemistry: Oxford 
University Press on Demand; 2001. 
302. Paital SR, Dahotre NB. Calcium phosphate coatings for bio-implant applications: Materials, 
performance factors, and methodologies. Materials Science and Engineering: R: Reports. 2009;66(1–3) 
303. Mcentire BJ, Bal BS, Rahaman MN, Chevalier J, Pezzotti G. Ceramics and ceramic coatings in 
orthopaedics. Journal of the European Ceramic Society. 2015;35(16) 
304. Utku FS, Seckin E, Goller G, Tamerler C, Urgen M. Electrochemically designed interfaces: 
Hydroxyapatite coated macro-mesoporous titania surfaces. Applied Surface Science. 2015;350 
305. Goodman SB, Yao Z, Keeney M, Yang F. The future of biologic coatings for orthopaedic implants. 
Biomaterials. 2013;34(13) 
306. Legeros RZ. Properties of osteoconductive biomaterials: calcium phosphates. Clin Orthop Relat 
Res. 2002;395(395) 
307. Gungormus M, Fong H, Kim IW, Evans JS, Tamerler C, Sarikaya M. Regulation of in vitro calcium 
phosphate mineralization by combinatorially selected hydroxyapatite-binding peptides. 
Biomacromolecules. 2008;9(3) 
308. Combes C, Bareille R, Rey C. Calcium carbonate-calcium phosphate mixed cement compositions 
for bone reconstruction. J Biomed Mater Res A. 2006;79(2) 
309. Chow LC. Solubility of calcium phosphates.  Octacalcium phosphate. 18: Karger Publishers; 2001. 
310. Ye Q, Spencer P, Yuca E, Tamerler C. Engineered peptide repairs defective adhesive-dentin 
interface. Macromol Mater Eng. 2017;302(5) 
311. Gungormus M, Oren EE, Horst JA, Fong H, Hnilova M, Somerman MJ, Snead ML, Samudrala R, 
Tamerler C, Sarikaya M. Cementomimetics-constructing a cementum-like biomineralized microlayer via 
amelogenin-derived peptides. Int J Oral Sci. 2012;4(2) 
312. Chiu D, Zhou W, Kitayaporn S, Schwartz DT, Murali-Krishna K, Kavanagh TJ, Baneyx F. 
Biomineralization and size control of stable calcium phosphate core-protein shell nanoparticles: 
potential for vaccine applications. Bioconjug Chem. 2012;23(3) 
313. Tsuji T, Onuma K, Yamamoto A, Iijima M, Shiba K. Direct transformation from amorphous to 
crystalline calcium phosphate facilitated by motif-programmed artificial proteins. Proc Natl Acad Sci U S 
A. 2008;105(44) 
314. Shaw WJ, Campbell AA, Paine ML, Snead ML. The COOH terminus of the amelogenin, LRAP, is 
oriented next to the hydroxyapatite surface. Journal of Biological Chemistry. 2004;279(39) 
315. White SN, Luo W, Paine ML, Fong H, Sarikaya M, Snead ML. Biological organization of 
hydroxyapatite crystallites into a fibrous continuum toughens and controls anisotropy in human enamel. 
J Dent Res. 2001;80(1) 
316. Cristache CM, Burlibasa M, Cristache G, Drafta S, Popovici IA, Iliescu AA, Zisi S, Burlibasa L. 
Zirconia and its biomedical applications. Metalurgia International. 2011;16(7) 
317. Chen YW, Moussi J, Drury JL, Wataha JC. Zirconia in biomedical applications. Expert Rev Med 
Devices. 2016;13(10) 
318. Xuefeng Z, Tianzhu Z, Xiaoli J, Ning G. The surface modification of medical polyurethane to 
improve the hydrophilicity and lubricity: The effect of pretreatment. Journal of Applied Polymer Science. 
2010;116(3) 
319. Gotz AW, Williamson MJ, Xu D, Poole D, Le Grand S, Walker RC. Routine Microsecond Molecular 
Dynamics Simulations with AMBER on GPUs. 1. Generalized Born. J Chem Theory Comput. 2012;8(5) 
159 
 
320. Cui Q, Nussinov R. Making biomolecular simulations accessible in the post-Nobel Prize era. PLoS 
Comput Biol. 2014;10(8) 
321. Brooks BR, Brooks CL, 3rd, Mackerell AD, Jr., Nilsson L, Petrella RJ, Roux B, Won Y, Archontis G, 
Bartels C, Boresch S, Caflisch A, Caves L, Cui Q, Dinner AR, Feig M, Fischer S, Gao J, Hodoscek M, Im W, 
Kuczera K, Lazaridis T, Ma J, Ovchinnikov V, Paci E, Pastor RW, Post CB, Pu JZ, Schaefer M, Tidor B, 
Venable RM, Woodcock HL, Wu X, Yang W, York DM, Karplus M. CHARMM: The biomolecular simulation 
program. Journal of Computational Chemistry. 2009;30(10) 
322. Ribeiro AA, Ortiz V. A chemical perspective on allostery. Chem Rev. 2016;116(11) 
323. Papaleo E, Saladino G, Lambrughi M, Lindorff-Larsen K, Gervasio FL, Nussinov R. The role of 
protein loops and linkers in conformational dynamics and allostery. Chem Rev. 2016;116(11) 
324. Liu J, Nussinov R. Allostery: An overview of its history, concepts, methods, and applications. PLoS 
Comput Biol. 2016;12(6) 
325. Motlagh HN, Wrabl JO, Li J, Hilser VJ. The ensemble nature of allostery. Nature. 2014;508(7496) 
326. Tamerler C, Sarikaya M. Molecular biomimetics: Genetic synthesis, assembly, and formation of 
materials using peptides. Mrs Bulletin. 2008;33(5) 
327. Liu J, Nussinov R. The role of allostery in the ubiquitin-proteasome system. Crit Rev Biochem Mol 
Biol. 2013;48(2) 
328. Ma B, Tsai CJ, Haliloglu T, Nussinov R. Dynamic allostery: linkers are not merely flexible. 
Structure. 2011;19(7) 
329. Zdanov A, Wu S, Dimaio J, Konishi Y, Li Y, Wu X, Edwards BF, Martin PD, Cygler M. Crystal 
structure of the complex of human alpha-thrombin and nonhydrolyzable bifunctional inhibitors, 
hirutonin-2 and hirutonin-6. Proteins. 1993;17(3) 
330. Szewczuk Z, Gibbs BF, Yue SY, Purisima E, Zdanov A, Cygler M, Konishi Y. Design of a linker for 
trivalent thrombin inhibitors - interaction fo the main chain of the linker with thrombin. Biochemistry. 
1993;32(13) 
331. Lin X, Koelsch G, Loy JA, Tang J. Rearranging the domains of pepsinogen. Protein Science. 
1995;4(2) 
332. Chen X, Zaro JL, Shen WC. Fusion protein linkers: property, design and functionality. Adv Drug 
Deliv Rev. 2013;65(10) 
333. Crasto CJ, Feng JA. LINKER: a program to generate linker sequences for fusion proteins. Protein 
Eng. 2000;13(5) 
334. Berova N, Nakanishi K, Woody R. Circular dichroism: principles and applications: John Wiley & 
Sons; 2000. 
335. Mavridis L, Janes RW. PDB2CD: a web-based application for the generation of circular dichroism 
spectra from protein atomic coordinates. Bioinformatics. 2017;33(1) 
336. Molski MA, Goodman JL, Chou F-C, Baker D, Das R, Schepartz A. Remodeling a small beta-
peptide bundle. Chemical Science. 2013;4(1) 
337. Wiedemann C, Bellstedt P, Gorlach M. CAPITO--a web server-based analysis and plotting tool for 
circular dichroism data. Bioinformatics. 2013;29(14) 
338. Hoang HN, Abbenante G, Hill TA, Ruiz-Gómez G, Fairlie DP. Folding pentapeptides into left and 
right handed alpha helices. Tetrahedron. 2012;68(23) 
339. Burck J, Roth S, Wadhwani P, Afonin S, Kanithasen N, Strandberg E, Ulrich AS. Conformation and 
membrane orientation of amphiphilic helical peptides by oriented circular dichroism. Biophys J. 
2008;95(8) 
340. Sreerama N, Woody RW. Estimation of protein secondary structure from circular dichroism 
spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. Anal 
Biochem. 2000;287(2) 
160 
 
341. Yuca E, Karatas AY, Seker UO, Gungormus M, Dinler-Doganay G, Sarikaya M, Tamerler C. In vitro 
labeling of hydroxyapatite minerals by an engineered protein. Biotechnology and Bioengineering. 
2011;108(5) 
342. Bagheri M, Arasteh S, Haney EF, Hancock RE. Tryptic stability of synthetic bactenecin derivatives 
is determined by the side chain length of cationic residues and the peptide conformation. J Med Chem. 
2016;59(7) 
343. Gray JJ, Chaudhury S, Lyskov S. The PyRosetta interactive platform for protein structure 
prediction and design: a set of educational modules: Lulu. com; 2010. 
344. Olsson MH, Sondergaard CR, Rostkowski M, Jensen JH. PROPKA3: Consistent treatment of 
internal and surface residues in empirical pKa predictions. J Chem Theory Comput. 2011;7(2) 
345. Grzymala-Busse JW. MLEM2—discretization during rule induction.  Intelligent Information 
Processing and Web Mining: Springer; 2003. 
346. Kwon S, Kim B, Noh H. Study of Physical Properties of UV Protective Film with Acrylate Polymers. 
Polymer-Korea. 2017;41(2) 
347. Carson D, Hnilova M, Yang X, Nemeth CL, Tsui JH, Smith AS, Jiao A, Regnier M, Murry CE, 
Tamerler C, Kim DH. Nanotopography-Induced Structural Anisotropy and Sarcomere Development in 
Human Cardiomyocytes Derived from Induced Pluripotent Stem Cells. ACS Appl Mater Interfaces. 
2016;8(34) 
348. Baran KL, Chimenti MS, Schlessman JL, Fitch CA, Herbst KJ, Garcia-Moreno BE. Electrostatic 
effects in a network of polar and ionizable groups in staphylococcal nuclease. J Mol Biol. 2008;379(5) 
349. Leprince JG, Palin WM, Hadis MA, Devaux J, Leloup G. Progress in dimethacrylate-based dental 
composite technology and curing efficiency. Dent Mater. 2013;29(2) 
350. Spencer P, Ye Q, Park J, Topp EM, Misra A, Marangos O, Wang Y, Bohaty BS, Singh V, Sene F, 
Eslick J, Camarda K, Katz JL. Adhesive/Dentin interface: The weak link in the composite restoration. 
Annals of Biomedical Engineering. 2010;38(6) 
351. Chisini LA, Collares K, Cademartori MG, De Oliveira LJC, Conde MCM, Demarco FF, Correa MB. 
Restorations in primary teeth: A systematic review on survival and reasons for failures. Int J Paediatr 
Dent. 2018;28(2) 
352. Demarco FF, Correa MB, Cenci MS, Moraes RR, Opdam NJ. Longevity of posterior composite 
restorations: not only a matter of materials. Dent Mater. 2012;28(1) 
353. Spencer P, Ye Q, Misra A, Goncalves SE, Laurence JS. Proteins, pathogens, and failure at the 
composite-tooth interface. J Dent Res. 2014;93(12) 
354. Zhang K, Melo MA, Cheng L, Weir MD, Bai Y, Xu HH. Effect of quaternary ammonium and silver 
nanoparticle-containing adhesives on dentin bond strength and dental plaque microcosm biofilms. Dent 
Mater. 2012;28(8) 
355. Jedrychowski JR, Caputo AA, Kerper S. Antibacterial and mechanical properties of restorative 
materials combined with chlorhexidines. J Oral Rehabil. 1983;10(5) 
356. Backlund CJ, Worley BV, Schoenfisch MH. Anti-biofilm action of nitric oxide-releasing alkyl-
modified poly(amidoamine) dendrimers against Streptococcus mutans. Acta Biomater. 2016;29 
357. Mashburn-Warren L, Downey JS, Goodman SD. Novel method for the depletion of cariogenic 
bacteria using dextranomer microspheres. Molecular Oral Microbiology. 2017;32(6) 
358. Gorr SU, Abdolhosseini M. Antimicrobial peptides and periodontal disease. J Clin Periodontol. 
2011;38 Suppl 11 
359. Gorr SU. Antimicrobial peptides of the oral cavity. Periodontol 2000. 2009;51 
360. Tao R, Jurevic RJ, Coulton KK, Tsutsui MT, Roberts MC, Kimball JR, Wells N, Berndt J, Dale BA. 
Salivary antimicrobial peptide expression and dental caries experience in children. Antimicrob Agents 
Chemother. 2005;49(9) 
161 
 
361. Mai S, Mauger MT, Niu LN, Barnes JB, Kao S, Bergeron BE, Ling JQ, Tay FR. Potential applications 
of antimicrobial peptides and their mimics in combating caries and pulpal infections. Acta Biomater. 
2017;49 
362. Su M, Yao S, Gu L, Huang Z, Mai S. Antibacterial effect and bond strength of a modified dental 
adhesive containing the peptide nisin. Peptides. 2018;99 
363. Breschi L, Mazzoni A, Ruggeri A, Cadenaro M, Di Lenarda R, De Stefano Dorigo E. Dental 
adhesion review: aging and stability of the bonded interface. Dent Mater. 2008;24(1) 
364. Spencer P, Wang Y. Adhesive phase separation at the dentin interface under wet bonding 
conditions. Journal of Biomedical Materials Research Part A. 2002;62(3) 
365. Abedin F, Ye Q, Good HJ, Parthasarathy R, Spencer P. Polymerization-and solvent-induced phase 
separation in hydrophilic-rich dentin adhesive mimic. Acta Biomater. 2014;10(7) 
366. Moszner N, Salz U. Recent developments of new components for dental adhesives and 
composites. Macromolecular Materials and Engineering. 2007;292(3) 
367. Moszner N. New monomers for dental application. Macromolecular Symposia. 2004;217 
368. Asmussen E, Hansen EK, Peutzfeldt A. Influence of the solubility parameter of intermediary resin 
on the effectiveness of the gluma bonding system. J Dent Res. 1991;70(9) 
369. Peutzfeldt A. Resin composites in dentistry: the monomer systems. European Journal of Oral 
Sciences. 1997;105(2) 
370. Moszner N, Salz U. New developments of polymeric dental composites. Progress in Polymer 
Science. 2001;26(4) 
371. Murphy EF, Lu JR, Lewis AL, Brewer J, Russell J, Stratford P. Characterization of protein 
adsorption at the phosphorylcholine incorporated polymer-water interface. Macromolecules. 
2000;33(12) 
372. Kiritoshi Y, Ishihara K. Preparation of cross-linked biocompatible poly(2-methacryloyloxyethyl 
phosphorylcholine) gel and its strange swelling behavior in water/ethanol mixture. J Biomater Sci Polym 
Ed. 2002;13(2) 
373. Yuan B, Chen Q, Ding WQ, Liu PS, Wu SS, Lin SC, Shen J, Gai Y. Copolymer coatings consisting of 
2-methacryloyloxyethyl phosphorylcholine and 3-methacryloxypropyl trimethoxysilane via ATRP to 
improve cellulose biocompatibility. ACS Appl Mater Interfaces. 2012;4(8) 
374. Lewis AL, Hughes PD, Kirkwood LC, Leppard SW, Redman RP, Tolhurst LA, Stratford PW. 
Synthesis and characterisation of phosphorylcholine-based polymers useful for coating blood filtration 
devices. Biomaterials. 2000;21(18) 
375. Lewis AL. Phosphorylcholine-based polymers and their use in the prevention of biofouling. 
Colloids and Surfaces B-Biointerfaces. 2000;18(3-4) 
376. Clarke S, Davies MC, Roberts CJ, Tendler SJB, Williams PM, O'byrne V, Lewis AL, Russell J. Surface 
mobility of 2-methacryloyloxyethyl phosphorylcholine-co-lauryl methacrylate polymers. Langmuir. 
2000;16(11) 
377. Zhang N, Zhang K, Melo MA, Chen C, Fouad AF, Bai Y, Xu HH. Novel protein-repellent and 
biofilm-repellent orthodontic cement containing 2-methacryloyloxyethyl phosphorylcholine. J Biomed 
Mater Res B Appl Biomater. 2016;104(5) 
378. Zhang N, Weir MD, Romberg E, Bai Y, Xu HH. Development of novel dental adhesive with double 
benefits of protein-repellent and antibacterial capabilities. Dent Mater. 2015;31(7) 
379. Zhang N, Melo MA, Chen C, Liu J, Weir MD, Bai Y, Xu HH. Development of a multifunctional 
adhesive system for prevention of root caries and secondary caries. Dent Mater. 2015;31(9) 
380. Zhang N, Melo MA, Bai Y, Xu HH. Novel protein-repellent dental adhesive containing 2-
methacryloyloxyethyl phosphorylcholine. Journal of Dentistry. 2014;42(10) 
381. Song L, Ye Q, Ge X, Misra A, Tamerler C, Spencer P. Probing the neutralization behavior of 
zwitterionic monomer-containing dental adhesive. Dent Mater. 2017;33(5) 
162 
 
382. Liang C, Yuan F, Liu F, Wang Y, Gao Y. Structure and antimicrobial mechanism of varepsilon-
polylysine-chitosan conjugates through Maillard reaction. International Journal of Biological 
Macromolecules. 2014;70 
383. Pranantyo D, Xu LQ, Hou Z, Kang ET, Chan-Park MB. Increasing bacterial affinity and 
cytocompatibility with four-arm star glycopolymers and antimicrobial alpha-polylysine. Polymer 
Chemistry. 2017;8(21) 
384. Ferraro MJ. Methods for dilution antimicrobial susceptibility tests for bacteria that grow 
aerobically: NCCLS; 2000. 
385. Min KR, Galvis A, Williams B, Rayala R, Cudic P, Ajdic D. Antibacterial and antibiofilm activities of 
a novel synthetic cyclic lipopeptide against cariogenic Streptococcus mutans UA159. Antimicrob Agents 
Chemother. 2017;61(8) 
386. Tu H, Fan Y, Lv X, Han S, Zhou X, Zhang L. Activity of synthetic antimicrobial peptide GH12 
against oral Streptococci. Caries Res. 2016;50(1) 
387. Page B, Page M, Noel C. A new fluorometric assay for cytotoxicity measurements in-vitro. Int J 
Oncol. 1993;3(3) 
388. Simoncini D, Nakata H, Ogata K, Nakamura S, Zhang KY. Quality assessment of predicted protein 
models using energies calculated by the fragment molecular orbital method. Molecular Informatics. 
2015;34(2-3) 
389. Sankar K, Jia K, Jernigan RL. Knowledge-based entropies improve the identification of native 
protein structures. Proc Natl Acad Sci U S A. 2017;114(11) 
390. Casanova-Morales N, Alavi Z, Wilson CaM, Zocchi G. Identifying Chaotropic and Kosmotropic 
Agents by Nanorheology. Journal of Physical Chemistry B. 2018;122(14) 
391. Henry GD, Sykes BD. [18] Methods to study membrane protein structure in solution.  Methods 
in enzymology. 239: Elsevier; 1994. 
392. Buck M. Trifluoroethanol and colleagues: cosolvents come of age. Recent studies with peptides 
and proteins. Quarterly Reviews of Biophysics. 1998;31(3) 
393. Pandey R, Usui K, Livingstone RA, Fischer SA, Pfaendtner J, Backus EH, Nagata Y, Frohlich-
Nowoisky J, Schmuser L, Mauri S, Scheel JF, Knopf DA, Poschl U, Bonn M, Weidner T. Ice-nucleating 
bacteria control the order and dynamics of interfacial water. Sci Adv. 2016;2(4) 
394. Balelli I, Milisic V, Wainrib G. Random walks on binary strings applied to the somatic 
hypermutation of B-cells. Math Biosci. 2018;300 
 
163 
 
 
 
 
 
 
 
 
 
 Appendix A. Nomenclature 
  
164 
 
AAindex1: amino acid index 1 
ADP1: amelogenin-derived peptide 1 
APD2: antimicrobial peptide database 2 
APD3: antimicrobial peptide database 3 
AMP: antimicrobial peptide 
ANN: artificial neural network 
BLAST: basic local alignment search tool 
BisGMA: bisphenol A-glycidyl methacrylate 
Ca: calcium 
CAMD: computer-aided molecular design 
CAMP: collections of antimicrobial peptides 
CD: circular dichroism 
CHX: chlorhexidine gluconate 
CLN: condition limit number 
DA: discriminant analysis 
DSSP: dictionary of secondary structure in proteins 
CLN-MLEM2: condition-limit number modified learning from experience method 2 
EFC: evolutionary feature construction 
EFC-FBCF: evolutionary feature construction without fast correlation-based filter selection 
EFC+307-FCBF: evolutionary feature construction and fast correlation-based filter selection with 307 
features 
FBCF: fast correlation-based filter selection 
FDR: false discovery rate 
FMOC: fluorenylmethoxycarbonyl protecting group 
FN: false negative 
FP: false positive 
GA: genetic algorithm 
GH12: 12 amino acid antimicrobial peptide 
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GH12-M2: GH12 modification 1 
GH12-M2: GH12 modification 2 
GRAVY: grand average of hydropathy 
HABP1: hydroxyapatite binding peptide 1 
HEMA: 2-hydroxyethylmethacrylate 
HMM: hidden Markov model 
iAMP-2L: antimicrobial peptide prediction two-level 
IC50: concentration of 50% inhibition 
IRIM: interesting rule induction method 
LR: logistic regression 
MCC: Matthew’s correlation coefficient 
MIC: minimum inhibitory concentration 
MLEM2: Modified Learning from Experience Module 2  
MPC: 2-methacryloyloxyethyl phosphorylcholine 
MRE: mean residue ellipticity 
NCBI: National Center for Biotechnology Information 
NIH: National Institutes of Health 
NMR: nuclear magnetic resonance 
PUABP: poly-urethane acrylic binding peptide 
QM: quantitative matrix 
QSAR: quantitative structure activity relationship 
RST: rough set theory 
SAM: self-assembled monolayer 
SFE: spacer frequency error 
SPPS: solid-phase peptide synthesis 
SVM: support vector machine 
TEGDMA: triethylene glycol dimethacrylate 
Ti: titanium 
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TFE: trifluoroethanol 
TN: true negative 
TP: true positive
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 Appendix B. PyRosetta Folding Code  
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The following is an implementation of the PyRosetta folding method in Python 2.7 for generating 
peptide structure decoys. 
############################################################################ 
# input for script is a FASTA file with peptides to be modelled  
##################################################################################### 
###Import 
import os, sys, random, time, copy, math, subprocess 
import rosetta as r 
#////////////////////////////////////////////////////////////////////////////////////////////////////////////
////////# 
#provides access to Rosetta pose data structure and Rosetta score function 
r.init() 
scorefxn = r.ScoreFunction() 
scorefxn.set_weight(fa_atr, 0.8) #lennard-jones attractive forces 
scorefxn.set_weight(fa_rep, 0.4) #lennard-jones repulsive forces 
scorefxn.set_weight(fa_sol, 0.75) #lazaridis-jarplus solvation energy 
scorefxn.set_weight(fa_pair, 1.0) #favors salt bridges 
#scorefxn.set_weight(fa_plane, 0.25) #pi-pi interactions, by default is zero 
scorefxn.set_weight(rama, 1.0) #weights ramachandran plot information 
scorefxn.set_weight(hbond_lr_bb, 1.2) #long-range hydrogen bonds 
scorefxn.set_weight(hbond_sr_bb, 0.585) #short-range hydrogen bonds 
scorefxn.set_weight(hbond_bb_sc, 1.2) #backbone-side chain hydrogen bonds 
scorefxn.set_weight(hbond_sc, 1.1) #side chain-side chain hydrogen bonds 
scorefxn.set_weight(dslf_ss_dst, 1.5) #distance score in current disulfide 
scorefxn.set_weight(dslf_cs_ang, 1.5) #csangles score in current disulfide 
scorefxn.set_weight(dslf_ss_dih, 1.5) #dihedral score in current disulfide 
scorefxn.set_weight(dslf_ca_dih, 1.5) #ca dihedral score in current disulfide 
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coarseFastRelax = r.FastRelax() 
coarseFastRelax.set_scorefxn(scorefxn) 
 
scorefxn2 = r.get_fa_scorefxn() 
fastRelax = r.FastRelax() 
fastRelax.set_scorefxn(scorefxn2) 
#classicRelax = rosetta.ClassicRelax() 
#classicRelax.set_scorefxn(scorefxn2) 
 
###Global Variables 
date = 'dateTag' 
scriptDir = 'dirPath' 
if ('annealedPDB' + date) not in os.listdir(scriptDir): 
 os.makedirs(scriptDir + '/annealedPDB'+date) 
  
 
fileTagList = ['fastaFileTag'] 
fragmentFile9List = ['fragmentID'] 
fragmentFile3List = ['fragmentID'] 
 
disulfideTagList = [f + '_disulfide.txt' for f in fileTagList] 
 
##################################################################################### 
###Classes 
class Sequence: 
    def __init__(self,name,seq): 
        self.name = name 
        self.seq = seq 
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class DisulfidePairs: 
    def __init__(self,name, pairs): 
        self.name = name 
        self.pairs = pairs #list of paired tuples for known disulfide bonds 
#imported classes from swarmIntFolding 
##################################################################################### 
#Move defines how the backbone angles of a single residue are optimized 
class Move: 
    def __init__(self, pose, residue, initialAngleNum, disulfidePair, isStochastic=False): 
        self.pose = pose 
        self.residue = residue 
        self.disulfidePair = disulfidePair 
        self.isStochastic = isStochastic  
        self.offset = random.randint(0,360)%(360/float(initialAngleNum)) 
        self.choice = 0 
        self.degreesOfFreedom = initialAngleNum 
        self.angleOpt() #returns empty 
        self.disulfideDist = self.pickFromPool() #sets energy but also changes pose to chosen state 
 
    def angleOpt(self): #returns energy of optimized state 
        phiList = [360/float(self.degreesOfFreedom)*x + self.offset for x in range(self.degreesOfFreedom)] 
        psiList = [360/float(self.degreesOfFreedom)*x + self.offset for x in range(self.degreesOfFreedom)] 
         
        #C-terminus has no omega bond 
        if self.residue == self.pose.n_residue(): 
            omegaList = [0] 
        else: 
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            omegaList = [180,-180] 
        angleList = [phiList, psiList, omegaList] 
         
        #Initial case of recursive search 
        self.pool = self.crossPools(angleList) 
        self.genSearch(self.degreesOfFreedom/2) 
 
    def pickFromPool(self): 
        #Pick the tuple based on kind 
        #Default kind is greedy 
        if self.isStochastic: 
            self.choice = self.selectLogChoice() 
        self.setAngles(self.pool[self.choice][1], self.pool[self.choice][2], self.pool[self.choice][3]) 
        return self.pool[self.choice][0] 
 
    def crossPools(self, angleList): 
        #print angleList 
        pool = [(self.poseScore(phi, psi, omega), phi, psi, omega) for phi in angleList[0] for psi in angleList[1] 
for omega in angleList[2]] 
        pool.sort(key=lambda t: t[0]) 
        return pool 
 
    def mutatePool(self, increment): 
        phiList = list(set([self.pool[x][1] for x in range(len(self.pool))])) 
        phiList += [x + increment for x in phiList] + [x - increment for x in phiList] 
        psiList = list(set([self.pool[x][2] for x in range(len(self.pool))])) 
        psiList += [x + increment for x in psiList] + [x - increment for x in psiList] 
        omegaList = list(set([self.pool[x][3] for x in range(len(self.pool))])) 
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        return [phiList, psiList, omegaList] 
     
    def poseScore(self, phi, psi, omega): 
        self.setAngles(phi, psi, omega) 
        return disulfideDistance(self.pose, self.disulfidePair) 
 
    def setAngles(self, phi, psi, omega): 
        self.pose.set_phi(self.residue, phi) 
        self.pose.set_psi(self.residue, psi) 
        if omega != 0: 
            self.pose.set_omega(self.residue, omega) 
 
    def genSearch(self, increment): 
        N = min(75, len(self.pool)) 
        #print "N" 
        #print N 
        tempPool = self.pool + self.crossPools(self.mutatePool(increment)) 
        #print "temp pool length" 
        #print len(tempPool) 
        tempPool.sort(key=lambda t: t[0]) 
        self.pool = tempPool[0:N] 
        del tempPool 
        #print "self.pool length" 
        #print len(self.pool) 
        if increment <= 1: 
            return 
        else: 
            self.genSearch(increment/2) 
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    def selectLogChoice(self): 
        if len(self.pool) == 1: 
            return self.pool[0] 
        #calculates energy differences between tuples 
        deltaEnergy = [self.pool[x][0]- self.pool[0][0] for x in range(len(self.pool))] 
         
        #By definition of lognormvariate, r > 0 and r grows to infinity with a logarithmic probability 
        extraEnergy = random.lognormvariate(0, 1) 
 
        #Picks highest energy choice that is suboptimal by at most of the amount of extra energy 
        return len(filter(lambda x: x <= extraEnergy, deltaEnergy))-1 
##################################################################################### 
# The instances are lists of numbers from 1 to N | N is the length of the sequence 
bulkiness = {'A': 11.500, 'R': 14.280, 'N': 12.820, 'D': 11.680, 'C': 13.460, 'Q': 14.450, 'E': 13.570, 'G':  
3.400, 'H': 13.690, 'I': 21.400,  
                 'L': 21.400, 'K': 15.710, 'M': 16.250, 'F': 19.800, 'P': 17.430, 'S':  9.470, 'T': 15.770, 'W': 21.670, 
'Y': 18.030, 'V': 21.570} 
 
  
class MoveOrder: 
    def __init__(self, kind, pose): 
        self.kind = kind 
        self.pose = pose 
        self.moveList = [] 
        if kind == 'singleResidue': 
            self.moveList = self.singleResidue() 
        if kind == 'smallFragment': 
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            self.moveList = self.smallFragment() 
            print self.moveList 
        if kind == 'foldInHalfOrder': 
            self.moveList = self.foldInHalfOrder() 
        if kind == 'shuffleOrder': 
            self.moveList = self.shuffleOrder() 
        if kind == 'linearOrder': 
            self.moveList = self.linearOrder() 
        if kind == 'bulkinessOrder': 
            self.moveList = self.bulkinessOrder() 
 
    def foldInHalfOrder(self): #sorts by distance from the middle residue 
        mid = (self.pose.n_residue()-1)/2 + 1 
        midSeqTuples = [(x, abs(x-mid)) for x in range(1, self.pose.n_residue()+1)] 
        midSeqTuples.sort(key=lambda t:t[1]) 
        return [t[0] for t in midSeqTuples] 
 
    def shuffleOrder(self): 
        residues = range(1,self.pose.n_residue()+1) 
        random.shuffle(residues) 
        return residues 
 
    def linearOrder(self): 
        return range(1, self.pose.n_residue()+1) 
 
    def bulkinessOrder(self): 
        bulkSeqTuples = [(y, bulkiness[x]) for x,y in zip(self.pose.sequence(), range(1, 
self.pose.n_residue()+1))] 
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        bulkSeqTuples.sort(key=lambda t:t[1]) 
        return [t[0] for t in bulkSeqTuples] 
 
    def smallFragment(self): 
        n = random.randint(2,5) 
        r = random.randint(1,self.pose.n_residue()) 
        fragment1 =  [((r+x) % self.pose.n_residue()) + 1 for x in range(n)] 
        fragment2 = sorted(fragment1,reverse=True) 
        return random.choice([fragment1, fragment2]) 
 
    def singleResidue(self): 
        return [random.randint(1,self.pose.n_residue())] 
 
#////////////////////////////////////////////////////////////////////////////////////////////////////////////
////////# 
 
 
#////////////////////////////////////////////////////////////////////////////////////////////////////////////
////////# 
##################################################################################### 
###Functions 
def copyPoseList(poseList): 
    copyList = list() 
    for pose in poseList: 
        poseCopy = r.Pose() 
        poseCopy.assign(pose) 
        copyList.append(poseCopy) 
    return copyList 
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def pdbDump(poseList, prependString, scorefxn): 
    global date 
    global fileTag 
    #outLog = open(os.getcwd() + '\\' + outfile, 'a') 
    for pose in poseList: 
        name = prependString + pose.pdb_info().name().rstrip('*') 
        pose.dump_scored_pdb('annealedPDB'+date+'\\' + name + '_' + fileTag + '.pdb', scorefxn) 
        print "PDB File Created: " + name + '_' + fileTag + '.pdb' 
    return 
 
def fromFASTAtoSeqList(fileName): 
    fastaFileName = fileName 
    seqList = list() 
    #Open fasta file 
    fastafile = open(fastaFileName) 
    fastaLines = fastafile.readlines() 
    #Make each fasta object a Sequence object 
    for line in fastaLines: 
        if line[0] == '%' or line[0] == '\n': 
            continue 
        if line[0] == '>': 
            seqName = line.split('>')[1].rsplit('\n')[0] 
        else: 
            seqSequence = line.rsplit('\n')[0] 
            #Add it to the sequence list 
            seqList.append(Sequence(seqName,seqSequence)) 
    return seqList 
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def fromSeqListToPoseList(seqList): 
    poseList = list() 
    for sequence in seqList: 
        pose = r.pose_from_sequence(sequence.seq) 
        pose.pdb_info().name(sequence.name) 
        print pose.sequence() 
        poseList.append(pose) 
    return poseList 
 
def coarseRelaxPose(poseList, iterNum): 
    for pose in poseList: 
        coarseFastRelax.apply(pose) 
    prependNames(poseList, 'coarseRelax_' + str(iterNum) + '_') 
    #pdbDump(poseList, '',coarseFastRelax.get_scorefxn()) 
    return 
 
def relaxPose(poseList, iterNum): 
    for pose in poseList: 
        fastRelax.apply(pose) 
    prependNames(poseList, 'relax_' + str(iterNum) + '_') 
    pdbDump(poseList, '', fastRelax.get_scorefxn()) 
    return 
         
def fragmentMover(poseList, fragset9, fragset3, iterNum, knownDisulfideBondList): 
    movemap = r.MoveMap() 
    movemap.set_bb(True) 
    mover_9mer = r.ClassicFragmentMover(fragset9, movemap) 
178 
 
    mover_3mer = r.ClassicFragmentMover(fragset3, movemap) 
    #Combines sequences into a single long protein to get fragments 
    totalSequence = '' 
    for pose in poseList: 
        totalSequence = totalSequence + pose.sequence() 
    totalPose = r.pose_from_sequence(totalSequence) 
    #Inserts fragments at an average of one change per position 
    n = len(totalSequence) 
    repeat_9mer = r.RepeatMover(mover_9mer,n) 
    repeat_9mer.apply(totalPose) 
    insertAllBackBoneAngles(poseList, totalPose) 
 
    prefold(poseList, knownDisulfideBondList, iterNum) 
 
    trialFrag(poseList, totalPose, mover_9mer, movemap) 
    trialFrag(poseList, totalPose, mover_3mer, movemap) 
    seqMover = r.SequenceMover() 
    seqMover.add_mover(mover_9mer) 
    seqMover.add_mover(mover_3mer) 
    seqMover.add_mover(mover_3mer) 
    trialFrag(poseList, totalPose, seqMover, movemap) 
    #pdbDump(poseList, '',coarseFastRelax.get_scorefxn()) 
    return 
 
#Finds the next set of fragments based on lowering energy via Metropolis criterion 
def trialFrag(poseList, totalPose, mover, movemap): 
    numOfPasses = 10 
    kT = 4.0 
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    for i in range(numOfPasses): 
        kT = max([0.5*kT, 0.0001]) 
        totalIndex = 1 
        for pose in poseList: 
            movemap.set_bb_true_range(totalIndex, totalIndex + pose.total_residue()-1) 
            currentEnergy = scorefxn(pose) 
            for j in range(pose.total_residue()): 
                copyPose = r.Pose() 
                copyPose.assign(pose) 
                #fragment insertion 
  for k in range(i): 
                 mover.apply(totalPose) 
                #copyAngles to pose 
                insertBackBoneAngles(pose, totalPose, totalIndex, totalIndex + pose.total_residue()-1) 
                newEnergy = scorefxn(pose) 
  if newEnergy < currentEnergy: 
      currentEnergy = newEnergy 
                    copyBackBoneAngles(pose, totalPose, totalIndex, totalIndex + pose.total_residue()-1) 
                elif math.exp(-(newEnergy-currentEnergy)/kT) > random.random(): 
                    currentEnergy = newEnergy 
                    copyBackBoneAngles(pose, totalPose, totalIndex, totalIndex + pose.total_residue()-1) 
                else: 
                    pose.assign(copyPose) 
                    copyBackBoneAngles(pose, totalPose, totalIndex, totalIndex + pose.total_residue()-1) 
 
            totalIndex += pose.total_residue() 
    return 
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def copyBackBoneAngles(pose, totalPose, start, stop): 
    for i in range(1, stop-start): 
        totalPose.set_phi(start+i-1, pose.phi(i)) 
        totalPose.set_psi(start+i-1, pose.psi(i)) 
        totalPose.set_omega(start+i-1, pose.omega(i)) 
    totalPose.set_phi(stop, pose.phi(stop-start)) 
    totalPose.set_psi(stop, pose.psi(stop-start)) 
 
def insertBackBoneAngles(pose, totalPose, start, stop): 
    for i in range(1, stop-start): 
        pose.set_phi(i, totalPose.phi(start+i-1)) 
        pose.set_psi(i, totalPose.psi(start+i-1)) 
        pose.set_omega(i, totalPose.omega(start+i-1)) 
    pose.set_phi(stop-start, totalPose.phi(stop)) 
    pose.set_psi(stop-start, totalPose.psi(stop)) 
 
def insertAllBackBoneAngles(poseList, totalPose):     
    #Read the backbone angles from totalPose back into the original poses 
    totalIndex = 0 
    for pose in poseList: 
        for i in range(1, pose.total_residue()+1): 
            totalIndex += 1 
            #print str(i) +'/' + str(totalIndex) 
            if i == pose.total_residue: 
                pose.set_phi(i, totalPose.phi(totalIndex)) 
                pose.set_psi(i, totalPose.psi(totalIndex)) 
            else: 
                pose.set_phi(i, totalPose.phi(totalIndex)) 
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                pose.set_psi(i, totalPose.psi(totalIndex)) 
                pose.set_omega(i, totalPose.omega(totalIndex)) 
            #chi angles are not included in fragment insertion file 
    return 
 
 
def prependNames(poseList, prependString): 
    for pose in poseList: 
        pose.pdb_info().name(prependString + pose.pdb_info().name()) 
    return 
 
def getPMM(): 
    pmm = r.PyMOL_Mover() 
    #pmm.keepHistory(True) 
    return pmm 
 
def updatePyMOLPoses(poseList, pmm): 
    for pose in poseList: 
        pmm.apply(pose) 
 
def disulfideDistance(pose, pair): 
     return (pose.residue(pair[0]).xyz(6) - pose.residue(pair[1]).xyz(6)).norm 
 
#Initial code from: D060_Folding.py in PyRosetta/test/ 
# locates all cysteines, make bonds between them, output the bonds that lower 
#    the score 
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def guess_disulfides(pose, cutoff = 10.0): 
    """ 
    A quick method for probing a protein for cysteine residues close to each 
    other (within  <cutoff>  ) 
    """ 
    disulfide = False 
    # find all cysteine residues and consider possible disulfides 
    cys = [i for i in range(1, pose.total_residue() + 1) if pose.residue(i).name1() == 'C'] 
    partners = [0]*sum( range(len(cys)) )    # all disulfides possible 
    i = 0 
    # create all combinations 
    for first in range(len(cys[:-1])): 
        for second in cys[first + 1:]: 
            partners[i] = (cys[first], second) 
            i += 1 
    # try each disulfide, if it lowers the score, print it to screen 
    print '='*80 
    print 'Potential Disulfides:' 
    for pair in partners: 
    # for a fullatom cysteine in PyRosetta, the 6th atom is sulfur 
        separation = (pose.residue(pair[0]).xyz(6) - pose.residue(pair[1]).xyz(6)).norm 
        if separation < cutoff: 
            print 'between (pose numbered) residue %d and %d | %4g Angstrom separation'%(pair[0],pair[1], 
separation) 
            r.form_disulfide(pose.conformation(), pair[0], pair[1]) 
            disulfide = True 
    print '='*80 
    if disulfide: 
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        pose.pdb_info().name(pose.pdb_info().name() + '_disulfideBond') 
    # to manipulate disulfide bonds, use: 
    # formation:    form_disulfide(pose.conformation(), 6, 16) 
    # cleavage:     change_cys_state(6, 'CYS', pose.conformation() ) 
    #               change_cys_state(16, 'CYS', pose.conformation() ) 
 
def prefold(poseList, knownDisulfideBondList, iterNum): 
    disulfideLength = 4.5 
    bondDict = dict() 
    for disulfideList in knownDisulfideBondList: 
 bondDict[disulfideList.name] = disulfideList 
  
    for pose in poseList: 
 disulfidePairList = bondDict[pose.pdb_info().name()] 
        #all residues between cysteines can be moved 
        ntermC = min([min(pair) for pair in disulfidePairList.pairs]) 
        ctermC = max([max(pair) for pair in disulfidePairList.pairs]) 
        moveList = range(ntermC, ctermC+1) 
        numPairs = 0 
        print "Pose: " + pose.pdb_info().name() 
        for pair in disulfidePairList.pairs: 
     if pair[0] == 0 or pair[1] == 0: 
      continue 
            maxIter=10 
            iteration = 0 
            for iteration in range(maxIter): 
                if disulfideDistance(pose, pair) <= disulfideLength: 
                    break 
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                print "\tDisulfide Pair: " + str(pair) + "\tOptimization Iteration: " + str(iteration+1) 
                moveOrdering = MoveOrder('shuffleOrder', pose) 
                for residue in moveOrdering.moveList: 
                    if residue in moveList:  
                        Move(pose,residue,6,pair) 
                        if disulfideDistance(pose, pair) <= disulfideLength: 
                            break             
            if disulfideDistance(pose, pair) > disulfideLength: 
                pose.pdb_info().name('prefoldFail' + pose.pdb_info().name()) 
                print "Pre-fold failure: ran out of iterations" 
                continue 
            if pair[0] != 0 and pair[1] != 0: 
  r.form_disulfide(pose.conformation(), pair[0], pair[1]) 
         numPairs += 1 
         print "Disulfides formed: " + str(numPairs) 
         for residue in pair: 
              if residue in moveList: 
                  moveList.remove(residue) 
    prependNames(poseList, 'prefold_') 
     #pdbDump(poseList, str(iterNum),coarseFastRelax.get_scorefxn())  
 
                 
def fragmentToAnnealed(poseList, i, fragset9, fragset3, knownDisulfideBondList): 
    fragmentMover(poseList, fragset9, fragset3, i, knownDisulfideBondList) 
    coarseRelaxPose(poseList, i) 
    relaxPose(poseList, i) 
     
    return 
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def createDisulfideBonds(poseList, knownDisulfideBondList): 
 #knownDisulfideBondList is a list with an entry for each pose, where the entry is a list of binary 
tuples of residue numbers  
 #sorting by name is to match the poses with the correct disulfide bonds 
 bondDict = dict() 
 for disulfideList in knownDisulfideBondList: 
  bondDict[disulfideList.name] = disulfideList 
 
 for pose in poseList: 
  if pose.pdb_info().name() in bondDict: 
   disulfideList = bondDict[pose.pdb_info().name()] 
   for pair in disulfideList.pairs: 
    if not 0 in pair: 
     print pair 
         r.form_disulfide(pose.conformation(), pair[0], pair[1]) 
 return 
 
def getDisulfideBonds(disulfideFile): 
    #disulfideFile is a txt file in which each entry begins with a > and a name (which will be used to match 
with the name of the pose) 
    #The data line is of the form: x,y; ... where x and y are residue numbers of cysteines that form a 
disulfide bond and ; separates pairs. 
 
    #the function returns a disulfideList, a list of sequence name in the order in the file with the known 
disulfide pairs 
    disulfideList = list() 
    #Open file 
    f = open(disulfideFile) 
186 
 
    fLines = f.readlines() 
    #Make each dataline a DisulfidePairs object with a name 
    for line in fLines: 
        if line[0] == '%' or line[0] == '\n': 
            continue 
        if line[0] == '>': 
            seqName = line.split('>')[1].rsplit('\n')[0] 
        else: 
            if line.startswith('na'): 
                disulfideList.append(DisulfidePairs(seqName,[])) 
            else: 
                disulfidePairArray = line.rsplit('\n')[0].split(';') 
                pairs = [(int(pair.split(',')[0]), int(pair.split(',')[1])) for pair in disulfidePairArray] 
                #Add it to the sequence list 
                disulfideList.append(DisulfidePairs(seqName,pairs)) 
    return disulfideList 
 
#####################################################################################
#################### 
##################################################################################### 
###Script 
for fileTag,disulfideFile,fragmentFile9,fragmentFile3 in 
zip(fileTagList,disulfideTagList,fragmentFile9List,fragmentFile3List): 
    seqList = fromFASTAtoSeqList(fileTag + '.fasta') 
    for seq in seqList: 
        print seq.name 
        print seq.seq 
    poses = fromSeqListToPoseList(seqList) 
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    knownDisulfideBondList = getDisulfideBonds(disulfideFile) 
    start = time.time() 
 
    fragset9 = r.ConstantLengthFragSet(9) 
    fragset9.read_fragment_file('fragments/' + fragmentFile9) 
    fragset3 = r.ConstantLengthFragSet(3) 
    fragset3.read_fragment_file('fragments/' + fragmentFile3) 
    iterStart = 1 
    iterEnd = 1000 
    iterNum = iterEnd - iterStart + 1 
    print "Starting " + str(iterNum) + " modeling iterations" 
    finTimeFile = 'finishFile.txt' 
    finTime = open(finTimeFile,'w') 
    finTime.close() 
    for i in range(iterStart,iterEnd+1): 
        finTime = open(finTimeFile,'a') 
        copiedList = copyPoseList(poses) 
        fragmentToAnnealed(copiedList, i, fragset9, fragset3, knownDisulfideBondList) 
        #print "\tModeling Iteration: " + str(i) + " of " + str(iterNum) 
        #print "\t\tElapsed Time: %.4f minutes"%((time.time()-start)/60) 
        #print "Time Left: %.4f minutes\n\n"%(((time.time()-start)*(iterNum-i)/float(60))/float(i)) 
        finTime.write("Modeling Iteration: " + str(i) + " of " + str(iterNum) + "\n") 
        finTime.write("Elapsed Time: %.4f minutes\n"%((time.time()-start)/60)) 
        finTime.write("Time Left: %.4f minutes\n\n"%(((time.time()-start)*(iterNum-i)/float(60))/float(i))) 
        finTime.close() 
 
